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Abstract 
 The present study aimed to identify, in exploring the protein fraction of camelid milks 
from several regions of Kazakhstan, original molecules (peptide, proteins) potentially 
responsible for the properties attributed to camel milk. We initially analyzed globally the 
composition of camel milk protein fraction (proteomic approach), focusing mainly on caseins 
and their molecular diversity. Regarding whey proteins, we focused our efforts on the whey 
acidic protein (WAP) whose protease inhibitory properties are well established and which is 
an originality of camelids (the only large mammal with pig expressing this protein in milk). 
Finally, we started to isolate extracellular vesicles from milk, which are known to carry 
genetic information (mRNA and microRNA) and proteins involved in the communication 
between cells and organisms, in order to characterize their proteome. 
Nearly 180 milk samples from two camel species (Camelus bactrianus and C. 
dromedarius, and their hybrids) we collected at different lactation stage, age and calving 
number, and submitted to different proven analytical techniques and proteomic approaches 
(SDS-PAGE, LC-MS/MS and LC-ESI-MS). A detailed characterization of 50 protein 
molecules, relating to genetic variants, isoforms arising from post-translational modifications 
and alternative splicing events, belonging to 9 protein families (κ-, αs1-, αs2-, β-; and γ-CN, 
WAP, α-LAC, PGRP, CSA/LPO) was achieved. We reported the occurrence of two unknown 
isoforms (sv1 and sv2) of camel αs2-CN arising from alternative splicing events. Using 
cDNA-sequencing, αs2-CNsv1 was characterized as a splicing-in variant of an in-frame 27-
nucleotide sequence, of which the presence at the genome level, flanked by canonic motifs 
defining an exon 13 encoding the nonapeptide ENSKKTVDM, was confirmed. Isoform αs2-
CNsv2, which appeared to be present at different phosphorylation levels ranging between 8P 
and 12P, was shown to include an additional decapeptide (VKAYQIIPNL), revealed by LC-
MS/MS, encoded by a 3’-extension of exon 16. In addition, we reported, for the first time to 
our knowledge, the occurrence of a αs2-CN phosphorylation isoform with at least one 
phosphorylated S/T residue that does not match with the usual canonic sequence (S/T-X-A) 
recognized by the mammary kinase, suggesting thereby the existence of two kinase systems 
involved in the phosphorylation of caseins in the mammary gland.  
This study also aimed to evaluate possible differences between species (genetic 
variability). We demonstrated that genetic variants, which hitherto seemed to be species- 
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specific (e.g. β-CN A for Bactrian and β-CN B for dromedary), are in fact present both in C. 
dromedarius and C. bactrianus. Regarding camel β-CN we also determined a short isoform 
(946 Da lighter than the full-length β-CN) arising very likely in both genetic variants (A and 
B) from proteolysis by plasmin. 
As far as camel WAP is concerned, we identified in C. bactrianus a new genetic variant 
(B), originating from a transition G => A, leading to a codon change (GTG/ATG) in the 
nucleotide sequence of cDNA, which modifies a single amino acid residue at position 12 of 
the mature protein (V12M). In addition, we describe the existence of a splicing variant of 
camel WAP, arising from an alternative usage of the canonical splice site recognized as such 
in the other mammalian species expressing WAP in their milk. We also report that the WAP 
isoform predominantly present in camelids milk, first described by Beg et al. (1986) as 
displaying an additional sequence of 4 amino acid residues (56VSSP59) in the peptide 
segment connecting the two 4-DSC domains, results from the usage of an unlikely intron 
cryptic splice site, extending camel exon 3 on its 5’ side by 12-nucleotides. In addition, we 
confirm that in the camel gene encoding WAP, intron 3 is a GC-AG intron, with a GC donor 
site showing a compensatory effect in terms of a dramatic increase in consensus at the 
acceptor exon position.    
 Finally, using an optimized protocol, we isolated camel milk-derived EVs satisfying 
the typical requirements for exosomal morphology, size and protein content. We identified a 
thousand of different proteins representing the first comprehensive proteome of camel milk-
derived EVs that appears wider than camel milk proteome, including markers associated with 
small extracellular vesicles, such as CD63, CD81, HSP70, HSP90, TSG101 and ADAM10. 
We also identified proteins present in other milk components. This is particularly the case for 
lactadherin/MFG-E8, Ras-related proteins or CD9 that have been reported to occur in MFG. 
Our results strongly suggest that milk-derived exosomes have different cellular origin.  
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Résumé 
La présente étude visait à identifier, en explorant la fraction protéique des laits de 
camélidés provenant de plusieurs régions du Kazakhstan, des molécules originales (peptides, 
protéines) potentiellement responsables des propriétés attribuées au lait de chamelle. Nous 
avons d'abord analysé globalement la composition de la fraction protéique des laits (approche 
protéomique), en nous concentrant principalement sur les caséines et leur diversité 
moléculaire. S’agissant des protéines du lactosérum, nous avons concentré nos efforts sur la 
WAP dont les propriétés « inhibiteur de protéase » sont bien établies et qui est une originalité 
des camélidés (seul gros mammifère avec le porc exprimant cette protéine dans le lait). Enfin, 
nous avons commencé à isoler des vésicules extracellulaires du lait, qui sont connus pour 
porter des informations génétiques (ARNm et microARN) et des protéines impliquées dans la 
communication entre les cellules et les organismes, afin de caractériser leur protéome. 
Près de 180 échantillons de lait de 2 espèces de camélidés (Camelus bactrianus, C. 
dromedarius et leurs hybrides) ont été collectés à différents stades de lactation, âge et nombre 
de vêlages, et soumis à différentes techniques analytiques et approches protéomiques (SDS-
PAGE, LC-MS/MS et LC-ESI-MS). Cinquante molécules protéiques correspondant à des 
variants génétiques, des isoformes issues de modifications post-traductionnelles et d'épissages 
différentiels, appartenant à 9 familles de protéines (κ-, αs1-, αs2-, β- et γ-CN, WAP, α-LAC, 
PGRP, CSA / LPO) ont été caractérisées. L’existence de deux isoformes inconnues (sv1 et 
sv2) de la caséine αs2 a été observée dans les deux esèces. Ces isoformes sont des variants 
d'épissage consécutif pour l’un à l’intégration d'une séquence de 27 nucléotides « in frame », 
codant pour le nonapeptide ENSKKTVDM, dont la présence a été confirmée au niveau 
génomique, flanquée de motifs canoniques définissant une structure exonique. La seconde 
isoforme, présente à différents niveaux de phosphorylation compris entre 8P et 12P, comporte 
un décapeptide supplémentaire (VKAYQIIPNL), révélé par LC-MS/MS, codé par une 
extension 3 'de l'exon 16. En outre, nous rapportons, pour la première fois à notre 
connaissance, l’existence d'une isoforme de phosphorylation de la caséine αs2 présentant au 
moins un résidu S/T phosphorylé n’appartenant pas à la séquence canonique habituelle (S/T-
X-A) reconnue par la kinase mammaire, suggérant ainsi l'existence de deux systèmes 
impliqués dans la phosphorylation des caséines, dans la glande mammaire. 
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Cette étude visait également à évaluer les différences entre espèces. Nous avons 
démontré que les variants génétiques, qui jusqu'ici semblaient être spécifiques d'espèce (β-CN 
A pour Bactrian et β-CN B pour dromadaire), sont présents chez C. dromedarius et C. 
bactrianus. En ce qui concerne la caséine β, nous avons également pu identifier dans les deux 
variants génétiques (A et B) une isoforme courte (946 Da plus légère que la caséine β) 
résultant très probablement d’une protéolyse par la plasmine. 
S’agissant de la WAP, nous avons identifié chez C. bactrianus un nouveau variant 
génétique (B), issue d'une transition G => A conduisant à un changement de codon 
(GTG/ATG) dans la séquence nucléotidique de l’ARNm, qui entraine un changement d’acide 
aminé en position 12 de la protéine mature (V12M). Un variant résultant de l’usage du site 
d'épissage canonique, reconnu comme tel chez les autres mammifères exprimant la WAP dans 
leur lait, a été identifié. La forme majoritaire de la WAP cameline, décrite pour la première 
fois par Beg et al. (1986) qui présente une insertion de 4 résidus d'acides aminés (56VSSP59) 
dans le segment peptidique reliant les deux domaines 4-DSC, résulte de l'utilisation d'un site 
d'épissage cryptique intronique improbable, prolongeant l'exon 3 du gène de 12 nucléotides 
sur son extrémité 5 '. De plus, nous confirmons que chez les camélidés, l'intron 3 du gène 
spécifiant la WAP, est un intron rare de type GC-AG, avec un site donneur faible qui 
s’accompagne d’un effet compensatoire au site consensus de l'exon accepteur. 
Finalement, en utilisant un protocole optimisé, nous avons isolé à partir des laits 
camelins des vésicules extracellulaires (VE) présentant toutes les caractéristiques 
morphologiques des exosomes (taille et contenu protéique). Nous avons identifié un millier de 
protéines différentes représentant un premier protéome des VE du lait de chamelle qui semble 
plus étendu que le protéome du lait de chamelle, y compris les marqueurs associés aux VE, 
tels CD63, CD81, HSP70, HSP90, TSG101 et ADAM10. Nous avons également identifié des 
protéines présentes dans d'autres compartiments du lait. C'est notamment le cas pour les 
protéines apparentées à Ras, pour la lactadhérine/MFG-E8, ou CD9 qui sont présentes dans 
les globules gras du lait. Nos résultats suggèrent par ailleurs fortement que les exosomes 
dérivés du lait ont des origines cellulaires différentes. 
 
 
 
6 
 
 
  
 
 
To my family, especially, my grandmother Zylikha, much appreciation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
 
  
Contents 
 
 
 
 
 
 
 
1.1 
1.2 
1.3 
1.3.1 
1.3.2 
1.3.3 
1.4 
1.4.1 
1.4.2 
1.4.3 
1.5 
1.6 
 
 
 
 
 
2.1 
2.2 
2.3 
2.3.1 
2.3.2 
2.3.3 
2.3.4 
2.3.5 
2.4 
2.4.1 
2.4.2 
2.4.3 
2.5 
 
 
 
 
 
 
3.1 
3.2 
3.3 
Abstract 
Résumé 
Abbreviations 
 
Chapter 1 
General Introduction 
Camelids: the other non-cattle dairy species of arid and semiarid rangelands 
Camel milk as a source of health promoting compounds 
The protein fractions of camel milk 
Caseins 
Whey proteins 
Milk fat globule membrane proteins 
Factors responsible for the molecular complexity of milk proteins 
Genetic variants 
Alternative splicing 
Post-translational modifications – Phosphorylation 
Extracellular vesicles 
Aim and outline of this study 
 
Chapter 2 
Combining different proteomic approaches to resolve complexity of the milk protein 
fraction of dromedary, Bactrian camels and hybrids, from different regions of Kazakhstan 
Abstract 
Introduction 
Materials and Methods 
Results 
Total protein content 
Identification of main milk proteins from 1D SDS-PAGE by LC-MS/MS 
Qualitative proteome of camel skimmed milk by LC-MS/MS 
Camel milk protein profiling by LC-ESI-MS 
Multiple spliced variants of CSN1S1 
Discussion 
Interspecies in-depth proteomic analysis of camel milk proteins 
Molecular diversity of camel caseins: genetic polymorphism and alternative splicing 
Post-translational modifications of milk proteins: phosphorylation of caseins 
Conclusions 
 
Chapter 3 
Alternative splicing events expand molecular diversity of camel CSN1S2 increasing its 
ability to generate potentially bioactive peptides 
Abstract 
Introduction 
Methods 
Results and Discussion 
2 
4 
9 
 
10 
 
11 
12 
13 
14 
16 
16 
17 
17 
18 
19 
19 
22 
 
34 
 
 
35 
36 
38 
45 
45 
45 
46 
50 
56 
56 
57 
61 
63 
64 
 
76 
 
 
77 
78 
80 
83 
8 
 
 
  
3.3.1 
3.3.2 
3.3.3 
3.3.4 
3.3.5 
 
 
 
 
 
 
 
4.1 
4.2 
4.3 
4.3.1 
4.3.2 
4.3.3 
4.4 
4.4.1 
4.4.2 
 
4.4.3 
4.5 
 
 
 
 
5.1 
5.2 
5.3 
5.3.1 
5.3.2 
5.3.3 
5.3.4 
5.4 
 
 
 
6.1 
6.2 
6.3 
6.4 
 
6.5 
What gene(s) UP1 and UP2 arise from? 
UP1 and UP2: new camel αs2-CN splicing variants 
Cross-species comparison of the gene encoding αs2-CN and primary transcript maturation 
Phosphorylation level enhances camel αs2-CN isoform complexity 
Alternate splicing isoforms of camel αs2-CN increase its ability to generate potential bioactive 
peptides 
 
Chapter 4 
The main WAP isoform usually found in camel milk arises from the usage of an 
improbable intron cryptic splice site in the precursor to mRNA in which a GC-AG intron 
occurs 
Abstract  
Background 
Methods 
Results 
Nucleotide sequence of camel WAP cDNA 
Identification and characterization of a new WAP genetic variant in Bactrian camel milk 
Camel WAP may exist as two isoforms differing in size 
Discussion 
Camel WAP is phosphorylated 
The usage of an unlikely intron cryptic splice site is responsible for the insertion of 4 amino acid 
residues in the major camel WAP isoform 
Intron 3 of camel WAP gene is a GC-AG intron type 
Conclusions 
 
Chapter 5 
Comprehensive Proteomic Analysis of Camel Milk-derived Extracellular Vesicles 
Abstract 
Introduction 
Materials and methods 
Results and Discussion 
Isolation of camel milk-derived EVs 
Morphology of isolated camel milk-derived EVs 
In-depth proteomic analysis of camel milk-derived EVs 
Exosomes are a rich source of potential milk biomarkers 
Conclusions 
 
Chapter 6 
General Discussion 
Global analysis: complexity of the camel milk proteome 
Complexity of the "casein" fraction: the case of αs2-CN and potential impact in terms of function 
WAP: originality of the protein and of the gene 
EVs: Beyond their role in the communication between cells, what possible effects on the 
consumer (offspring or adult) 
What should be implemented now? 
Acknowledgements 
Curriculum vitae 
Résumés 
83 
86 
91 
94 
96 
 
 
107 
 
 
 
108 
109 
112 
115 
115 
116 
118 
119 
120 
120 
 
122 
123 
 
130 
 
131 
132 
134 
138 
138 
138 
140 
145 
147 
 
154 
 
156 
159 
160 
162 
 
163 
169 
171 
174 
9 
 
 
  
Abbreviations 
 
 
α-LAC α-lactalbumin 
aa Amino Acid 
AL Almaty region 
B Bactrian  
bp Base pair 
BTN Butyrophilin  
CN Casein  
CSA Camel serum albumin  
D Dromedary 
Da Dalton 
EVs Extracellular vesicles 
FAS Fatty acid synthase 
GlyCAM1 Glycosylation-dependent cell adhesion molecule 1 
H Hybrid  
KZ Kyzylorda region 
LDH Lactadherin  
LC-MS/MS Liquid chromatography coupled to tandem mass spectrometry 
LC-ESI-MS Liquid chromatography-electrospray ionization-tandem mass spectrometry 
LPO Lactoperoxidase  
LTF Lactoferrin  
MEC Mammary epithelial cells  
MFG Milk fat globule 
MFGM Milk fat globule membrane 
P Phosphate group   
PCR Polymerase chain reaction 
PGRP Peptido Glycan Recognition Protein 
PP3 Protease peptone component 3 
PTM Post-translational modifications 
RP-HPLC Reversed-Phase High-Performance Liquid Chromatography 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SH Shymkent region  
SIBLING Small integrin-binding ligand N-linked glycoproteins 
sv0, sv1, sv2 and sv3 Splicing variants 0, 1, 2 and 3 
UP1 and UP2 Unknown proteins 1 and 2 
WAP Whey Acidic Protein 
WP Whey protein 
XO Xanthine oxidase 
ZKO Atyrau region 
4-DSC Four-disulfide cores 
10 
 
 
  
Chapter 1  
 
General Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
 
  
1.1 Camelids: the other non-cattle dairy species of arid and 
semiarid rangelands 
 According to the most recent statistics, the world camel population is estimated to be 
about 29 millions (FAO, 2017). Camelus dromedarius is the most frequent and widespread 
domestic camel species, with 90% of the total camel population (Mohandesan et al., 2017). 
Camels have been domesticated in a number of arid regions, including Northern and Eastern 
Africa, the Arabian Peninsula and Central and South West Asia. Camelus bactrianus forms 
numerical inferiority, mostly inhabits in Mongolia, China, and Central Asia. Alternatively, 
there are also crossed camels (hybrids) which are found mainly in Russia, Iran, Turkmenistan, 
and in Kazakhstan. Kazakhstan is a specific region where both domesticated species (Camelus 
dromedarius and Camelus bactrianus) along with wild Bactrian camels (Camelus ferus) and 
their hybrids have been maintained in mixed herds (Nurseitova et al., 2014).  
 Dairy camel farming is a well-established part of a local economy in many arid and 
semiarid rangelands (Tulgat & Schaller, 1992). Camel dairy products provide not only food, 
but also give nomadic herders a rich source of income. The adoption of non-cattle species for 
milk provision was nevertheless significant and their importance can be associated with the 
adaptation of such species to specific geographical areas and also to local cultural beliefs and 
behaviors (Faye & Konuspayeva, 2012). Camel milk production accounts for only 0.34% (2.8 
millions of tons) of world milk production (Faye & Konuspayeva, 2012), but interest for 
“white gold of the desert” is growing (Wernery, 2006). Situated in Central Asia, Kazakhstan 
dairy camel farming represents a vivid example of the vital adaptation of the regional 
economy. Camel milk is consumed as fresh milk and as a traditional fermented drink called 
shubat, which is very popular in Central Asia countries. However, suitability for cheese 
production of camel milk is being low, in spite of the availability of a specific chymosin 
nowadays on the market and camel cheese making is in development. To our knowledge, 
there is no national statistical data available on camel milk industry in Kazakhstan; on average 
there are 35,000 of total 180,000 camel heads reared for milk production, and about 35,000 
tons (1.25% of the camel milk produced in the world) of fresh and fermented milk per year 
are consumable (FAO, 2017). Besides its nutritional qualities, camel milk have been reported 
to display potential health-promoting properties (Mati et al., 2017). Fresh and fermented 
camel milk are widely consumed in alternative medicine for prophylactic and curative 
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purposes of cancer (Korashy et al., 2012), diabetes (Agrawal et al., 2013), autoimmune 
diseases (Al-Ayadhi et al., 2015), and hepatitis (El-Fakharany et al., 2017).  
1.2 Camel milk as a source of health promoting 
compounds 
 Milk is a complete and complex food suited to the specific offspring requirements for 
growth and development. Camel milk has an overall composition very similar to that of 
bovine milk, especially as far as macro nutrients (protein, fat and lactose) are concerned. 
Camel milk is characterized by a high content of vitamin C.  
 There is increasing substantial evidence that milk contains many health-promoting 
compounds, influencing physiological functions or reducing disease risk. Bioactive 
components in milk might come from a variety of sources, such as lipids, carbohydrates and 
proteins as well as for minerals or vitamins. Some are synthesized and secreted by the 
mammary tissue, whereas others are drawn from maternal serum and carried across the 
mammary epithelium by receptor-mediated transport (Walther & Sieber, 2011). Furthermore, 
the secretion of the milk fat globule (MFG) into the acini lumen by the mammary epithelium 
carries with it a collection of membrane-bound proteins and lipids that are present into the 
milk (Figure 1.1).  
 Proteins are found mostly in the aqueous phase, either in soluble (whey proteins), or 
colloidal (caseins) states, but also in the lipid phase, associated with the milk fat globule 
membrane (MFGM). Over the last century, protein research has investigated mainly the 
importance of essential amino acids and their relevance for nutrition and health. Some 
peptides, with particular amino acid sequences encrypted in camel milk proteins, which are 
inactive in the intact protein, may play a beneficial role in human health once they are 
released from milk either in vivo during normal digestion or by proteolysis during bacterial 
fermentation (Walther & Sieber, 2011). However, other compounds that may play a role in 
the health-promoting properties of camel milk have to be found. Extracellular vesicles, which 
are vectors of nucleotide sequences (small and long non-coding RNA) and proteins, could be 
also involved in these biological properties. Hence, to go further into the evaluation of the 
potential suitability of non-bovine milks, including camel milk, in human/infant nutrition, a 
detailed characterization of their protein fraction that contributes largely to the nutritional 
13 
 
 
  
value and technological properties of milk, as well as the successful development of camel 
dairy industry, is required. 
 
 
 
 
 
 
 
 
Figure 1.1. Major secretory pathways in mammary epithelial cells during lactation adapted from Mather & 
Keenan, 1998. (A) Paracellular route through leaky `tight’ junctions; (B) Transcellular route through basal and 
apical endosomes and possibly through the secretory pathway; (C) Bidirectional transport of ions and small 
molecules via specific transporters in basal/lateral and apical plasma membranes; (D) Pathway for the assembly 
and secretion of milk-lipid droplets; and (E) Classical secretory pathway for the processing and secretion of milk 
proteins, lactose, water and ions. AE: apical endosome; APM: apical plasma membrane; BPM: basal plasma 
membrane; CM: casein micelle; GA: Golgi apparatus; LD: lipid droplet; N: nucleus; RER: rough endoplasmic 
reticulum; SV: secretory vesicle; BE: basal endosome; BM: basal membrane; TJ: `tight’ junction. 
 
1.3 The protein fractions of camel milk 
 Given the growing interest in camel milk, due to the health potential of its bioactive 
components (Al haj & Al Kanhal, 2010), the milk protein fraction of Camelids has been 
extensively investigated over the past 20 years and more during the last decade, with regards 
to casein, whey proteins and milk fat globule membrane proteins (Saadaoui et al., 2013). 
Whether it was on milk of one-humped Camels (C. dromedarius) (Alhaider et al., 2013; 
Elagamy et al., 1996; Ereifej et al., 2011; Erhardt et al., 2016; Felfoul et al., 2017; Hinz et al., 
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2012; Kappeler et al., 1999; Merin et al., 2001; Saadaoui et al., 2013; Salmen et al., 2012; 
Shuiep et al., 2013; Wangoh et al., 2009) or on milk of two-humped Camels (C. bactrianus) 
(Konuspayeva et al., 2007; Ochirkhuyag et al., 1997; Yang et al., 2013), all these studies from 
all around the world have explored, with more or less efficient approaches, the composition of 
the major milk proteins. 
1.3.1 Caseins 
 As in cow milk, ca. 80% of the total protein fraction of camel milk are represented by 
caseins (CN) that are synthesized under multi-hormonal control in the mammary gland. 
Associated with amorphous calcium phosphate nanoclusters they form large and stable 
colloidal aggregates, referred to as CN micelles. Casein micelles are present in the milk of all 
mammals. In bovine milk, still the most thoroughly studied milk to date, casein micelles are 
made of four distinct polypeptide chains: αs1-, β-, αs2- and κ-CN arising from the expression 
of four single copy autosomal genes (Figure 1.2). 
 
 
 
 
 
 
 
 
 
Figure 1.2. Evolution of the casein locus organization. Casein locus organization of human (Homo sapiens), 
horse (Equus caballus), mouse (Mus musculus), cattle (Bos taurus), pig (Sus scrofa) and camel (Camelus 
dromedarius) genomes (adopted from Martin et al., 2013 with additional genomic information from the NCBI) is 
compared. Genes are given by colored arrow boxes, showing the orientation of transcription. Putative genes 
based on similarity are indicated by empty boxes. Intergenic region sizes are given in kb.        
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 Genes encoding CNs (CSN1S1, CSN2, CSN1S2 and CSN3) are tightly linked on the 
same chromosome, BTA6 in cattle, CHI6 in goats (Hayes et al., 1993; Threadgill & Womack, 
1990), and HSA4 in humans (Menon et al., 1992). The evolution of the CN gene cluster is 
postulated to have occurred by a combination of successive intra- and inter-genic exon 
duplications (Groenen et al., 1993; P. Martin et al., 2013; Rijnkels, 2002). In some mammals, 
including horse, donkey, rodents and rabbit, there are two αs2-CN encoding genes 
differentiating in size (CSN1S2A and CSN1S2B), which may have arisen by a relatively recent 
gene-duplication event in rabbit (Cosenza et al., 2010; Dawson et al., 1993). However, the 
existence of a second αs2-CN encoding gene in camel has not been reported so far. 
 CN micelles (Figure 1.3), which figure as calcium-transport vehicles, provide neonates 
with calcium at a very high concentration, which is achieved during their packaging in the 
secretion pathway (Semo et al., 2007). The CN micelle properties have a major influence on 
the technological properties of milk (Glantz et al., 2010). Micelles are characterized by a 
different size distribution in the milk from different mammals (Farrell et al., 2006). The 
average size of camel micelles is noticeably the largest: about 280 nm in diameter (Farah & 
Rüegg, 1989), 260 nm in goat, 190 nm in cow, and 180 nm in sheep milk (Park et al., 2007). 
The average diameter is inversely related to κ-CN and calcium phosphate concentrations; it 
has been established that large micelles are richer in calcium phosphate and smaller in κ-CN 
(Bornaz et al., 2009).  
 
 
 
 
 
 
 
Figure 1.3. Field-emission scanning electron microscopy image of a casein micelle (a) and schematic 
representation of its structure (b) adopted from Dalgleish & Corredig, 2012. The αs- and β-CNs (orange) are 
attached to and link the calcium phosphate nanoclusters (grey spheres). Some β-CN (blue) hydrophobically binds 
to other caseins and can be removed by cooling. The para κ-CN (green) and the caseinomacropeptide chains 
(black) are on the outermost parts of the surface.  
κ-CN
β-CN
Calcium phosphate nanoclaster
Matrix of all caseins
a) b) 
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1.3.2 Whey proteins 
 Camel whey is characterized by the presence of protective proteins, which display a 
wide range of bioactivities (Davoodi et al., 2016), including immuno-modulating (Legrand et 
al., 2004), anti-carcinogenic (Habib et al., 2013), antibacterial, and antifungal activities 
(Kanwar et al., 2015). The WPs of camel milk mainly consist of α-lactalbumin (α-LAC), 
glycosylation-dependent cell adhesion molecule 1 (GlyCAM1) or lactophorin which is closely 
related to the bovine proteose peptone component 3 (PP3), the innate immunity Peptido 
Glycan Recognition Protein (PGRP) and the Whey Acidic Protein (WAP). PGRP is an 
intracellular component of neutrophils, which modulates anti-inflammatory reaction of the 
immune response (Kappeler et al., 2004). Present at a very low level in ruminant milks 
(Tydell et al., 2002), PGRP has been detected in mammary secretions of porcine and camel 
(Kappeler et al., 2004) and was shown to participate in granule-mediated killing of gram-
positive and negative bacteria (Dziarski et al., 2012). Lactoferrin (LTF) interacts with 
lipopolysaccharides of Gram-negative bacteria whereas lysozyme C binds and hydrolyzes 
peptidoglycans, preferably of Gram-positive bacteria, but with a lower affinity than PGRP 
(Sharma et al., 2011). PP3 plays an important immunological role in the lactating camel, to 
prevent the occurrence of mastitis, or for its newborn by inhibiting pathogen multiplication in 
the respiratory and gastrointestinal tracts of the suckling young (Girardet et al., 2000). WAP 
plays an important role in regulating the proliferation of mammary epithelial cells by 
preventing elastase-type serine proteases from carrying out extracellular matrix laminin 
degradation. In addition, a bacteriostatic activity of rat WAP against Staphylococcus aureus 
was reported (Iwamori et al., 2010). Whereas camel α-lactalbumin (α-LAC), a small milk 
calcium-binding globular protein, is known to possess noticeable anticancer activity, which is 
determined by the ability of this protein to form complexes with oleic acid (Uversky et al., 
2017). Previously it was reported, that HAMLET (human α-LAC made lethal to tumor cells), 
a protein lipid complex formed by α-LAC and oleic acid, induces apoptosis-like death in 
tumor cells (Svanborg et al., 2003).  
1.3.3 Milk fat globule membrane proteins 
Additionally, camel milk contains proteins from milk fat globules which represent 1–4% of 
total protein fraction (Cavaletto et al., 2008). Due to the functional and nutritional properties, 
increasing attention is being paid to the components of MFGM, especially to their protein 
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components (Yang et al. 2015). Thus, MFGM proteins are known to be involved in many 
biological functions, such as inhibition of pathogen adhesion and participation in 
antimicrobial defense (Smolenski et al., 2007). Large-scale studies have been published for 
goat (Cebo et al., 2010), ovine (Pisanu et al., 2011), and bovine MFGM proteins (Reinhardt et 
al., 2012). More recently proteomic profiling of the MFGM from camel (C. dromedarius) 
milk has been performed by Saadaoui et al. (2013). In result, 322 proteins associated with the 
dromedary MFGM, such as major MFGM proteins including fatty acid synthase (FAS), 
xanthine oxidase (XO), butyrophilin (BTN), and lactadherin (LDH/MFG-E8), were identified. 
Due to the secretion process, the protein composition of MFGM reflected those of the ER and 
apical plasma membrane. The MFGM proteomic dataset also contained a large number of 
cytoplasmic proteins as found in other studies. Thus, the MFGM can reflect dynamic changes 
within the mammary epithelial cells (MEC) and may provide a “snapshot” of mammary gland 
biology under particular conditions. 
1.4 Factors responsible for the molecular complexity of 
milk proteins 
 Milk protein polymorphism is a unique biological paradigm, which helps to 
understand protein transport, micelle formation and organization, biodiversity and evolution, 
the release of bioactive peptides with implications in human health. Therefore, there is a need 
to obtain insight into the primary structure and the way of modifications of proteins, 
characterize the polymorphism at the protein and mRNA levels for better understanding the 
genetic basis of milk quality in dairy animals (Claverol et al., 2003). Genetic variants and 
post-translational modifications (PTM) of some camel milk proteins were reported by several 
previous studies (Pauciullo et al., 2013; Shuiep et al., 2013).  
1.4.1 Genetic variants 
 Genetic differences can be due to point mutations such as single nucleotide 
polymorphisms or due to DNA rearrangements such as structure variations, insertions or 
deletions. When changes occur in regulatory region, alteration may occur at the transcription 
level, and may result in different levels of expression and different amounts of proteins. When 
non-synonymous changes occur in coding regions, this will result in aa substitutions. One or 
more differences in aa sequence result in different protein variants, which may possess 
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different physical and chemical qualities. Recently, the impact of milk protein variants on 
milk composition, production and on technological properties has been reported (Lodes et al., 
1996). Effects of milk proteins on human nutrition and health have further increased the 
interest in milk protein variants and genetic determination. In camel milk, genetic variants of 
the two caseins (αs1- and β-CNs) arising from single-point mutations have been detected so 
far. Shuiep et al. (2013) demonstrated the genetic variation of camel αs1-CN at the protein 
level leading (E30D) to the expression of two distinct variants called A and C. Pauciullo et al. 
(2014) described two genetic variants A and B of camel β-CN resulting from aa exchange in 
position 186 (M186I).  
1.4.2 Alternative splicing  
 In mammals, alternative splicing is a major mechanism for the enhancement of 
transcriptome and proteome diversity that greatly expands the repertoire of protein function 
(Keren et al., 2010). Splicing of precursor mRNA (pre-mRNA) is a crucial regulatory stage in 
the pathway of gene expression: introns are removed and exons are ligated to form mRNA. 
The inclusion of different exons in mRNA - alternative splicing - results in the generation of 
different isoforms from a single gene (Keren et al., 2010). The sequences required for splicing 
in higher eukaryotes consist of conserved elements at the 5’ and 3’ splice sites and a weakly 
conserved element, the branch point sequence, at the site of lariat formation (Martin & 
Leroux, 1992). Each of these elements seems to play multiple roles in the splicing reaction, 
which takes place in a large ribonuclear protein complex called the spliceosome, and progress 
through a two-step pathway. First, cleavage occurs at the 5’ splice site and the intron 5’ end is 
joined to a 2’ OH of an adenosyl phosphate residue (A*) at the branch point sequence: 
YTRA*Y, generating the lariat intermediate (Harris & Senapathy, 1990; Zhuang & Weiner, 
1989). Second, cleavage occurs at the 3’ splice junction with concomitant ligation between 
the two contiguous exons. In addition, exon sequences play a role in splice site selection 
(Reed & Maniatis, 1986). However, the weak conservation of abovementioned elements in 
higher eukaryotes does not usually allow the prediction of some sequences, which are 
recognized and used.  
 Such an alternative splicing event has been first demonstrated in goat αs1-CN, the 
alternatively processed transcript of which was lacking of exons 9, 10 and 11 together 
encoding 37 aa residues (Leroux et al., 1992). Multiple forms of αs1-CN have been also 
reported in sheep (Chianese et al., 1996; Ferranti et al., 1999), in camel (Kappeler et al., 1998) 
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and later in lama (Pauciullo & Erhardt, 2015). In camel αs1-CN, two cDNAs (short and long) 
encoding two protein isoforms of 207 and 215 aa were described (Kappeler et al., 1998). The 
nucleotide sequence of the most frequent variant transcript was shown to be deleted of an 
octapeptide (EQAYFHLE) encoded by exon 16.  
1.4.3 Post-translational modifications - Phosphorylation 
 The term PTM (Post-Translational Modifications) denotes changes in the polypeptide 
chain due to either the addition or removal of distinct chemical moieties to amino acid 
residues, proteolytic processing of the protein termini, or the introduction of covalent cross-
links between domains of the protein. PTMs are involved in most cellular processes including 
the maintenance of protein structure and integrity, regulation of metabolism and defense 
processes, and in cellular recognition events and morphology changes (Larsen et al., 2006). 
Phosphorylation of proteins is one of the most frequent PTM in eukaryotic cells. It has 
become a common knowledge that phosphorylation of CN occurs at S or T aa residues in 
tripeptide sequences S/T-X-A where X represents any aa residue and A is an acidic aa residue 
(Mercier, 1981). This consensus sequence is recognized by FAM20C, a Golgi CN-kinase, 
which phosphorylates secreted phosphoproteins, including both CN and members of the small 
integrin-binding ligand N-linked glycoproteins (SIBLING) protein family, which modulate 
biomineralization (Ishikawa et al., 2012). PTM, occurring in the endoplasmic reticulum 
and/or Golgi complex after synthesis of the polypeptide chain, play a critical role in micelle 
formation and stability (Holland, 2008).  
1.5 Extracellular vesicles 
 Milk is usually consider as a complex biological liquid in which supramolecular 
structures (casein micelles and milk fat globules) are found beside minerals, vitamins and 
soluble proteins (whey proteins) as well as cells. It was recently shown that milk contains also 
extracellular vesicles that are released by cells as mediators of intercellular communication. 
Indeed, cell communicate with neighboring cells or with distant cells through the secretion of 
extracellular vesicles (Tkach & Théry, 2016). Phospholipid bilayer-enclosed extracellular 
vesicles (EVs) are naturally generated and released from several cell domains of life 
(Bacteria, Archaea, Eukarya) into the extracellular space under physiological and 
pathological conditions (Delcayre et al., 2005; G. Raposo, 1996). EVs are commonly 
classified according to their sub-cellular origin into three major subtypes, such as 
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microvesicles, exosomes, and apoptotic bodies. Contents of vesicles vary with respect to 
mode of biogenesis, cell type, and physiologic conditions (Abels & Breakefield, 2016). 
Exosomes represent the smallest population among EVs, ranging in size from 30 to 150 nm in 
diameter (Hromada et al., 2017). They are generated inside multivesicular bodies in the 
endosomal compartment during the maturation of early late endosomes and are secreted when 
these compartments fuse with the plasma membrane (Figure 1.4) (van der Pol et al., 2012). 
Found in all biofluids exosomes harbor different cargos as a function of cell type and 
physiologic state (Abels & Breakefield, 2016).  
 Milk is the sole source of nutrients for the newborn and very young offspring, as well 
as being an important means to transfer immune components from the mother to the newborn 
of which the immune system is immature (Abels & Breakefield, 2016; Hromada et al., 2017). 
Milk is therefore thought to play an important role in the development of the immune system 
of the offspring. Milk is also a source of delivers molecules, via exosomes and/or 
microvesicles, acting on immune modulation of neonates due to their specific proteins, 
mRNA, long non-coding RNA and miRNA contents. Exosomes and wider EVs have come in 
the limelight as biological entities containing unique proteins, lipids, and genetic material. It 
was shown that the RNA contained in these vesicles could be transferred from one cell to 
another, through an emerging mode of cell-to-cell (Colombo et al., 2014; Simons & Raposo, 
2009). RNAs conveyed by EVs are translated into proteins within transformed cells (mRNA), 
and/or are involved in regulatory functions (miRNA). For this reason, EVs are recognized as 
potent vehicles for intercellular communication, capable for transferring messages of 
signaling molecules, nucleic acids, and pathogenic factors (Kabani & Melki, 2016).  
 Over the last decade, EVs were widely explored as biological nanovesicles for the 
development of new diagnostic and therapeutic applications as a promising source for new 
biomarkers in various diseases (Kanada et al., 2015). For example, exosomes secreted by 
dendritic cells have been shown to carry MHC-peptide complexes allowing efficient 
activation of T lymphocytes, thus displaying immunotherapeutic potential as promoters of 
adaptive immune responses (Keller et al., 2006). Recently, cell culture studies showed that 
bovine milk-derived EVs act as a carrier for chemotherapeutic/chemopreventive agents 
against lung tumor xenografts in vivo (Munagala et al., 2016). Nevertheless, their 
physiological relevance has been difficult to evaluate because their origin, biogenesis and 
secretion mechanisms remained enigmatic.   
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 Despite a significant number of publications describing the molecular characteristics 
and investigating the potential biological functions of milk-derived exosomes (Reinhardt et 
al., 2012; van Herwijnen et al., 2016), there are only one dealing with exosomes derived from 
camel milk (Yassin et al., 2016). These authors report for the first time isolation and 
characterization using proteomic (SDS-PAGE and western blot analysis) and transcriptomic 
analyses exosomes from dromedary milk at different lactation stages. However, there is no 
comprehensive investigation on exosomal protein variations and variability in composition 
between individual camels. Milk-derived EVs from Bactrian and hybrid milks have never 
been explored before.  
 
Figure 1.4. a) Release of microvesicles (MVs) and exosomes adapted from Raposo & Stoorvogel, 2013. MVs 
bud directly from the plasma membrane, whereas exosomes are represented by small vesicles of different sizes 
that are formed as the intraluminal vesicle by budding into early endosomes and MVEs and are released by 
fusion of multivesicular endosome (MVEs) with the plasma membrane. b) Schematic of protein and RNA 
transfer by EVs adapted from Graça Raposo and Stoorvogel (2013). Membrane-associated (triangles) and 
transmembrane proteins (rectangles) and RNAs (curved symbols) are selectively incorporated into the 
intraluminal vesicle of MVEs or into MVs budding from the plasma membrane. MVEs fuse with the plasma 
membrane to release exosomes into the extracellular milieu. MVs and exosomes may dock at the plasma 
membrane of a target cell (1). Bound vesicles may either fuse directly with the plasma membrane (2) or be 
endocytosed (3). Endocytosed vesicles may then fuse with the delimiting membrane of an endocytic 
compartment (4). Both pathways result in the delivery of proteins and RNA into the membrane or cytosol of the 
target cell.  
 
 
a) b)
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1.6 Aim and outline of this study 
 The main objective of this thesis was to investigate the fine protein composition of 
Camelus (Bactrian, dromedary and hybrids) milks coming from different regions of 
Kazakhstan and of milk-derived extracellular vesicles with special emphasis on their protein 
contents, combining the most innovative proteomic and molecular biology approaches. We 
expected: i) identifying known and eventually unknown proteins from camel milk exhibiting 
potentially bio-activities properties; ii) providing a solid foundation for health allegations and 
to get a better understanding of the mechanisms involved in the true or expected effect of 
camel milk on human health; iii) asserting or not the originality of camel milk amongst the 
other dairy species. Thus, to gain an insight into the molecular diversity of camel milk 
proteins, we report in Chapter 2 a complete profiling of the milk protein fraction, including 
in-depth characterization of the camel caseins and whey proteins comprising variants related 
to genetic polymorphisms, splicing defects, phosphorylation levels. In Chapter 3, we report 
the characterization of two unknown camel αs2-CN splicing isoforms, resulting from 
translation of mRNAs yielded during the processing of primary transcripts encoding αs2-CN. 
In Chapter 4, we describe a new genetic variant of camel WAP (variant B) and a splicing 
variant, arising from the usage of an unlikely intron cryptic splice site. In addition, we report 
the occurrence of a GC-AG intron (intron 3) in the camel gene encoding WAP. In Chapter 5, 
we provide results on the isolation and in-depth morphological and proteome characterization 
of camel milk-derived extracellular vesicles. Chapter 6 was devoted to a general discussion 
of the results obtained during the course of this thesis focusing onto the consequences in terms 
of bioactive properties of camel milks.     
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Abstract 
 Nutritional suitability of milk is not only related to gross composition, but is also 
strongly affected by the microheterogeniety of the protein fraction. Hence, to go further into 
the evaluation of the potential suitability of non-bovine milks in human/infant nutrition it is 
necessary to have a detailed characterization of their protein components. Combining proven 
proteomic approaches (SDS-PAGE, LC-MS/MS and LC-ESI-MS) and cDNA sequencing, we 
provide here in depth characterization of the milk protein fraction of dromedary and Bactrian 
camels, and their hybrids, from different regions of Kazakhstan. A total 391 functional groups 
of proteins were identified from 8 camel milk samples. A detailed characterization of 50 
protein molecules, relating to genetic variants and isoforms arising from post-translational 
modifications and alternative splicing events, belonging to nine protein families (κ-, αs1-, αs2-, 
β-; and γ-CN, WAP, α-LAC, PGRP, CSA/LPO) was achieved by LC-ESI-MS. The presence 
of two unknown proteins UP1 (22,939 Da) and UP2 (23,046 Da) was also reported as well as 
the existence of a β-CN short isoform (946 Da lighter than the full-length β-CN), arising very 
likely in both genetic variants (A and B) from proteolysis by plasmin. In addition, we report, 
for the first time to our knowledge, the occurrence of a αs2-CN phosphorylation isoform with 
12P groups within two recognition motifs, suggesting thereby the existence of two kinase 
systems involved in the phosphorylation of caseins in the mammary gland. Finally, we 
demonstrate that genetic variants, which hitherto seemed to be species- specific (e.g. β-CN A 
for Bactrian and β-CN B for dromedary), are in fact present both in Camelus dromedarius and 
C. bactrianus. 
 
Key words: Camelus dromedarius, Camelus bactrianus, hybrids, milk, casein, whey proteins, 
post-translational modifications, splicing, genetic polymorphism, phosphorylation, proteomics  
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2.1 Introduction 
 According to the most recent statistics, the world camel population is estimated to be 
about 29 million (FAO, 2017). Camelus dromedarius is the most frequent and widespread 
domestic camel species composing 90% of the total camel population (Mohandesan et al., 
2017). Camels have been domesticated in a number of arid regions, including Northern and 
Eastern Africa, the Arabian Peninsula and Central and South West Asia. Camelus bactrianus 
forms numerical inferiority, mostly inhabits in Mongolia, China, and Central Asia. 
Alternatively, there are also crossed camels (hybrids) which are found mainly in Russia, Iran, 
Turkmenistan, and in Kazakhstan. 
  Kazakhstan is a specific region where both domesticated species (C. dromedarius and 
C. bactrianus) are maintained in mixed herds (Nurseitova et al., 2014). There are about 
35,000 camel heads reared in this country for milk production (FAO, 2017). Camel milk is 
consumed as fresh milk and as a traditional fermented drink called shubat, which is very 
popular in Central Asia countries. Besides nutritional qualities, camel fresh and fermented 
milk have been reported to display potential health-promoting properties (Agrawal et al., 
2003; Al-Ayadhi & Elamin, 2013; El-Fakharany et al., 2017; Korashy et al., 2012; Manaer et 
al., 2015; Sboui et al., 2010) which depend very heavily on its unique protein content.  
 Advanced improvement in proteomic techniques allow nowadays obtaining a precise 
image of the protein fraction of milk. Recently, proteomic approaches, based on mass 
spectrometry (Alhaider et al., 2013) and isobaric tag for relative and absolute quantification 
(Yang et al., 2013), have been used to analyze the proteome of dromedary camel milk and 
Bactrian camel milk whey, respectively. These techniques were useful to gain knowledge on 
the detection, quantification and characterization of camel milk proteins. These studies 
confirm that camel milk is a rich source of biologically active proteins and peptides (Hsieh et 
al., 2015; Mati et al., 2017). 
 Whey proteins which were reported to display a wide range of bioactivities (Davoodi 
et al., 2016), including immuno-modulating (Legrand et al., 2004), anti-carcinogenic (Habib 
et al., 2013), antibacterial, and antifungal activities (Kanwar et al., 2015), account for 20% of 
total camel milk proteins. Pattern-recognition proteins, such as the peptidoglycan recognition 
protein (PGRP), an intracellular component of neutrophils, modulate anti-inflammatory 
reaction of the immune response (Kappeler et al., 2004). LTF interacts with 
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lipopolysaccharides of Gram-negative bacteria whereas lysozyme C binds and hydrolyzes 
peptidoglycans, preferably of Gram-positive bacteria, but with a lower affinity than PGRP 
(Sharma et al., 2011). Present at a very low level in ruminant milks (Tydell et al., 2002), 
PGRP has been detected in mammary secretions of porcine and camel (Kappeler et al., 2004) 
and was shown to participate in granule-mediated killing of gram-positive and negative 
bacteria (Dziarski et al., 2012). Proteose peptone component 3 (PP3 or Lactophorin or 
GlyCAM1) plays an important immunological role in the lactating camel, to prevent the 
occurrence of mastitis, or for its newborn by inhibiting pathogen multiplication in the 
respiratory and gastrointestinal tracts of the suckling young (Girardet et al.,	  2000). Likewise, 
camel milk contains the whey acidic protein (WAP), also found in rodents and lagomorphs 
(Hennighausen & Sippel, 1982). The biological function of this protein is unknown. However, 
proteins such as elafin and antileukoproteinase 1, containing WAP domains, are known to 
function as protease inhibitor involved in the immune defense of multiple epithelia and has 
been identified as candidate molecular markers for several cancers (Bouchard et al., 2006). 
 As in cow milk, ca. 80% of the total protein fraction of camel milk are represented by 
caseins (CN) that are synthesized under multi-hormonal control in the mammary gland of 
mammals. Associated with amorphous calcium phosphate nanoclusters they form large and 
stable colloidal aggregates, the so-called CN micelles, which figure as calcium-transport 
vehicles. These CN micelles provide neonates with calcium at a very high concentration, 
which is achieved during their packaging in the secretion pathway (McMahon & Oommen, 
2013). Recently it was reported that αs1- and αs2-CN display molecular chaperone-like activity 
inhibiting CN aggregation and triggering micelle structure (Sakono et al., 2011).  
 However, there is no comprehensive investigation on milk protein variations and 
variability in composition between individual camels. In addition, proteomic studies did not 
consider the molecular diversity of each type of protein, arising from genetic polymorphisms 
(mutations), defects in the processing of primary transcripts and post-translational 
modifications (PTM) such as phosphorylation, factors that significantly have a pronounced 
impact on protein structure, and finally on milk properties. Milk protein polymorphism is a 
unique biological paradigm that could help to understand CN intracellular transport, micelle 
formation and organization, biodiversity and evolution (Martin et al., 2013), the release of 
bioactive peptides with implications in human health (Balteanu et al., 2013).  
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 Therefore, to gain an insight into the molecular diversity of camel milk proteins, we 
design a comprehensive strategy combining classical (SDS-PAGE) and advanced proteomic 
approaches (LC-MS/MS, LC-ESI-MS), as well as cDNA sequencing. Here we report a 
complete profiling of the milk protein fraction of Bactrian and dromedary camels from 
Kazakhstan, including a detailed characterization of camel CN and WPs including variants 
related to genetic polymorphisms, splicing defects, phosphorylation levels. In addition, we 
introduce a reference point for further investigation in camel milk protein polymorphism.  
2.2 Materials and Methods 
2.2.1 Ethics statements  
 All animal studies were carried out in compliance with European Community 
regulations on animal experimentation (European Communities Council Directive 
86/609/EEC) and with the authorization of the Kazakh Ministry of Agriculture. Milk 
sampling was performed in appropriate conditions supervised by a veterinary accredited by 
the French Ethics National Committee for Experimentation on Living Animals. No 
endangered or protected animal species were involved in this study. No specific permissions 
or approvals were required for this study with the exception of the rules of afore-mentioned 
European Community regulations on animal experimentation, which were strictly followed.  
2.2.2 Milk samples collection and preparation 
 In total 181 raw milk samples (Table 2.1.) were collected during morning milking on 
healthy dairy camels belonging to two camel species: C. bactrianus (n=72) and C. 
dromedarius (n=65), and their hybrids (n=42), at different lactation stages, ranging between 
30 and 90 days postpartum. Bactrian camels were originating from Kazakh type whereas 
dromedary camels were from Turkmen Arvana breed. Unfortunately, the information about 
the nature and the level of hybridization of hybrids was not available. All species are well 
adapted to the local environment of Kazakhstan.  
  Camels grazed on four various natural pastures with the distance more than 3,500 kms 
between the regions at extreme points of Kazakhstan: Almaty (AL) at the foot of Tien Shan 
Mountain, Shymkent (SH) along deserts Kyzylkum and Betpak-Dala, Kyzylorda (KZ) on the 
edge of the steppe, and Atyrau (ZKO) at the mouth of the Caspian Sea (Figure 2.1). Whole-
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milk samples were centrifuged at 2,500 g for 20 min at 4oC (Allegra X-15R, Beckman 
Coulter, France) to separating fat from skimmed milk. Samples were quickly frozen and 
stored at -80°C (fat) and -20°C (skimmed milk) until analysis. 
 
 Table 2.1. Camel milk samples collected (n = 181) in the 3 species of the 4 regions of Kazakhstan 
ID Region Coding 
Bactrian  
(B) 
Dromedary  
(D) 
Hybrid 
(H) 
Total number 
of camels 
 for each 
region 
1 Almaty AL B/D/H 13 20 1 34 
2 Shymkent SH B/D/H 20 21 20 61 
3 Kyzylorda KZ B/D/H 18 16 20 54 
4 Atyrau ZKO B/D/H 21 8 3 32 
 
Figure 2.1. Geographical location of camel milk sampling 
 
Almaty
Kyzylorda
Atyrau
Shymkent
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2.2.3 Selection of milk samples for analysis 
 Of the 181 milk samples collected, 63, including C. bactrianus (n=19), C. 
dromedarius (n=20), and hybrids (n=24) from four different regions of Kazakhstan were 
selected for SDS-PAGE analysis (Figure 2.2). Each Bactrian and dromedary camel group 
formed by 5 animals, except Bactrians of Atyrau regions (n=4). For hybrids, there were 4 
groups comprising 10 animals (Kyzylorda and Shymkent regions), whereas there were only 1 
and 3 animals for Almaty and Atyrau regions, respectively. This selection was based on 
lactation stages and number of parities (from 2 to 14) of each camel group composed by the 
species and grazing regions. It should be emphasized that data available on animals: breed, 
age, lactation stage and calving number, were estimated by a local veterinarian, since no 
registration of camels in farms is maintained. Due to the lack of sufficient information, 
dromedary milk samples (n=5) from Almaty region were excluded from subsequent analyses. 
Then, 8 of the 58 remaining milk samples from three different regions (C. bactrianus, n=3, C. 
dromedarius, n=3, and hybrids, n=2) exhibiting the most representative SDS-PAGE patterns 
were analyzed by LC-MS/MS after a tryptic digestion of excised gel bands. Additionally, 30 
milk samples (C. bactrianus, n=10; C. dromedarius, n=10; hybrids, n=10), taken from the 63 
milks analyzed by SDS-PAGE, were analyzed by LC-ESI-MS (Bruker Daltonics).  
2.2.4 Coomassie blue (Bradford) protein assay   
 To estimate the concentration of total protein in a milk sample the Coomassie Blue 
Protein Assay was used (Bradford, 1976). Absorbance at 590 nm was measured using the 
UV-Vis spectrophotometer (UVmini-1240, Shimadzu). The reference standard curve was 
done with commercial bovine serum albumin (BSA) powder dissolved in MilliQ water and 
diluted to a concentration of 1 mg/mL. Series of dilutions (0.1, 0.2, 0.4, 0.6, and 0.8 µg/µL) 
were prepared from the stock solution, in duplicate to ensure the protein concentration is 
within the range of the assay. 
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Figure 2.2. Diagram of the experimental scheme designed for quantification and identification of camel milk 
proteins   
 
2.2.5 1D sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
 Both major and low-abundant proteins resolved by SDS-PAGE were identified after 
excision by mass analysis of the tryptic hydrolysate. The method used in the study was based 
on that from Laemmli (Laemmli, 1970). Twenty-five micrograms of each individual skimmed 
milk sample were loaded into 12.5% acrylamide resolving gel and subjected to 
electrophoresis. Samples were prepared with Laemmli Lysis-Buffer (Sigma-Aldrich). 
Separations were performed in a vertical electrophoresis apparatus (Bio-Rad, Marnes-la-
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Coquette, France). After GelCode Blue Safe Protein staining and gel scanning using Image 
Scanner iii (Epson ExpressionTM 10,000 XL, Sweden), resolved bands were excised from the 
gel and submitted to digestion by trypsin. Thereafter, tryptic peptides were analyzed by LC-
MS/MS.  
2.2.6 Identification of proteins by LC-MS/MS analysis 
 In order to identify the main protein contained in each electrophoretic band,  mono 
dimensional electrophoresis (1D SDS-PAGE) followed by trypsin digestion and by LC-
MS/MS analysis, was used essentially as described (Saadaoui et al., 2014). Briefly, after a 10 
cm migration of samples in such an 1D SDS-PAGE, the 16 main electrophoretic bands (1.5 
mm3) were cut on each gel lane, transferred into 96-well microtiter plates (FrameStar, 4titude, 
0750/Las). Reduction of disulfide bridges of proteins was carried out by incubating at 37oC 
for one hour with dithiothreitol (DTT, 10 mM, Sigma), meanwhile the alkylation of free 
cysteinyl residues with iodoacetamide (IAM, 50 mM, Sigma) at RT for 45 min in total 
obscurity. After gel pieces were washed twice, first, with 100 µL 50% ACN/50 mM 
NH4HCO3 and then with 50 µL ACN, they were finally dried. The hydration was performed at 
37oC overnight using digestion buffer 400 ng lys-C protease + trypsin. Hereby, peptides were 
extracted with 50% ACN/0.5% TFA and then with 100% ACN. Peptide solutions were dried 
in a concentrator and finally dissolved into 70 µL 2% ACN in 0.08% TFA. The identification 
of peptides was obtained using UltiMate™ 3000 RSLCnano System (Thermo Fisher 
Scientific) coupled either to LTQ Orbitrap XL™ Discovery mass spectrometer or QExactive 
(Thermo Fischer Scientific). Four µL of each sample was injected with flow of 20 µL/min on 
a precolumn cartridge (stationary phase: C18 PepMap 100, 5 µm; column: 300 µm x 5 mm) 
and desalted with a loading buffer 2% ACN and 0.08% TFA. After 4 min, the precolumn 
cartridge was connected to the separating RSLC PepMap C18 column (stationary phase: 
RSLC PepMap 100, 2 µm; column: 75 µm x 150 mm). Elution buffers were A: 2% ACN in 
0.1% formic acid (HCOOH) and B: 80% ACN in 0.1% HCOOH. The peptide separation was 
achieved with a linear gradient from 0 to 35% B for 34 min at 300 nL/min. One run took 42 
min, including the regeneration and the equilibration steps at 98% B.  
 Peptide ions were analyzed using Xcalibur 2.1 with the following machine set up in 
CID mode: 1) full MS scan in Orbitrap with a resolution  of 15 000 (scan range [m/z] = 300-
1600) and 2)  top 8 in MS/MS using CID (35% collision energy) in Ion Trap. Analyzed 
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charge states were set to 2-3, the dynamic exclusion to 30 s and the intensity threshold was 
fixed at 5.0 x 102. 
 Raw data were converted to mzXML by MS convert (ProteoWizard version 3.0.4601). 
UniProtKB Cetartiodactyla database was used (157,113 protein entries, version 2015), in 
conjunction with contaminant databases were searched by algorithm X!TandemPiledriver 
(version 2015.04.01.1) with the software X!TandemPipeline (version 3.4) developed by the 
PAPPSO platform (http://pappso.inra.fr/bioinfo/). The protein identification was run with a 
precursor mass tolerance of 10 ppm and a fragment mass tolerance of 0.5 Da. Enzymatic 
cleavage rules were set to trypsin digestion (“after R and K, unless P follows directly after”) 
and no semi-enzymatic cleavage rules were allowed. The fix modification was set to cysteine 
carbamido methylation and methionine oxidation was considered as a potential modification. 
Results were filtered using inbuilt X!TandemParser with peptide E-value of 0.05, a protein E-
value of -2.6, and a minimum of two peptides.       
2.2.7 LC-ESI-MS 
 Fractionation of camel milk proteins and determination of their molecular masses, 
performed by coupling RP-HPLC to ESI-MS (micrOTOFTM II focus ESI-TOF mass 
spectrometer; Bruker Daltonics), were essentially as described (Saadaoui et al., 2014). In total 
20 µL of skimmed milk samples were first clarified by the addition of 230 µL of clarification 
solution 0.1 M bis-Tris buffer pH 8.0, containing 8 M urea, 1.3% trisodium citrate, and 0.3% 
DTT. Clarified milk samples (25 µL) were directly injected onto a Biodiscovery C5 reverse 
phase column (300 Å pore size, 3 µm, 150 x 2.1 mm; Supelco, France). The mobile phase of 
the column corresponded to a gradient mixture of Solvent A (H2O/TFA 100:0.25, v/v) and 
Solvent B (ACN/TFA 100:0.20, v/v). Elution was achieved using a linear gradient from 5% to 
27% B in 20 min, from 27% to 33% B in 0.1 min, from 33% to 34% B in 11.1 min, from 34% 
to 40% B in 0.1 min, from 40% to 41% B in 14.9 min, and from 41% to 90% B in 0.1 min. 
This gradient elution was followed by an isocratic elution at 90% B for 4.9 min, and a linear 
return to 5% B in 0.1 min. The temperature of the column was adjusted to 52oC and the flow 
rate to 0.2 mL/min. Eluted peaks were detected by UV-absorbance at 214 nm. The liquid 
effluent was introduced to the mass spectrometer. Positive ion mode was used, and mass 
scans were acquired over a mass-to-charge ratio (m/z) ranging between 600 and 3000 Da. 
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 The LC/MS system was controlled by the HyStar software (Bruker Daltonics). Peak 
profiles from UV 214 nm and Extracted Ion Chromatograms (EIC), multicharged ion spectra, 
deconvoluted spectra and determination of masses were obtained with DataAnalysis Version 
4.0 SP1 software (Bruker Daltonics).    
2.2.8 Milk fat globule collection and RNA extraction 
 Total RNA was extracted from MFG fraction stored at -80°C using Trizol (Invitrogen) 
following the protocol from the manufacturer as described by Brenaut et al., (2012).  
2.2.9 First-strand cDNA synthesis and PCR amplification 
 First-strand cDNA was synthesized from 5 to 10 ng of total RNA primed with 
oligo(dT)20 and random primers (3:1, vol/vol) using Superscript III reverse transcriptase 
(Invitrogen Life Technologies Inc., Carlsbad, CA) according to the manufacturer’s 
instructions. One microliter of 2 U/µL RNase H (Invitrogen Life Technologies) was then 
added and the reaction mix was incubated for 20 min at 37°C to remove RNA from 
heteroduplexes. Single-strand cDNA thus obtained was stored at -20°C. cDNA samples 
covering the entire coding regions of caseins were amplified. PCR was performed in an 
automated thermocycler GeneAmp® PCR System 2,400 (Perkin-Elmer, Norwalk, USA) with 
GoTaq® G2 Flexi DNA Polymerase Kit (Promega Corporation, USA). Reactions were 
carried out with 0.2 mL thin-walled PCR tubes with flat cap strips (Thermo Scientific, UK), 
in 50 µL volumes containing 5X Green or Colorless GoTag® Flexi Buffer, MgCl2 Solution 
25 mM, PCR Nucleotide Mix 10 mM each, GoTag® G2 Flexi DNA Polymerase (5 U/µL), 10 
mM each oligonucleotide primer, template DNA and nuclease-free water, up to the final 
volume. Primer pairs, purchased from Eurofins (Eurofins genomics, Germany), were designed 
using published Camelus nucleic acid sequence (NCBI, NM_001303566.1). Sequencing of 
PCR fragments was performed with primer pairs used for PCR and sequenced from both 
strands, according to the Sanger method by Eurofins. 
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2.3 Results 
2.3.1 Total protein content  
 Using the Bradford assay for estimating the protein concentration in milk samples, we 
observed that the highest protein concentration occurred with Bactrian camel milk samples, 
but the difference was slight comparing with crossed camel species. The total protein value in 
raw camel milk from Shymkent region was estimated to be ca. 33 g/L (33.15 ± 6.64 g/L) for 
C. bactrianus (n=5), and 31 g/L (30.83 ± 5.82 g/L) for C. dromedarius (n=7), whereas 
hybrids (n=9) displayed an intermediate value 31.5 g/L (31.43 ± 4.56 g/L). On average, 
Bactrian milk was considered to have a higher total protein content than that of Dromedary 
(Zhao et al., 2015) and hybrid milks. Our results are in agreement with data reported 
previously by Konuspayeva et al., (2009). No significant differences were found across 
species from different geographical locations.       
2.3.2 Identification of main milk proteins from 1D SDS-PAGE by 
LC-MS/MS  
 After first adjusting protein concentrations at the same value, 63 individual camel milk 
samples were separated onto SDS-PAGE. The comparative analysis of whole milk samples by 
SDS-PAGE displayed rather similar electrophoretic profiles with related migration 
characteristics and the same apparent molecular weights between individual milk samples of 
different species and regions. A typical gel pattern from which proteins were identified in 
individual C. bactrianus, C. dromedarius and hybrid milk samples of Kyzylorda region is 
shown in Figure 2.3. 
 Sixteen main bands relatively well-resolved were excised from the electrophoretic 
pattern. The most intense band observed around 26 kDa was identified as β-CN. Quantitative 
analyses on camel milk proteins carried out before have demonstrated significantly higher 
amounts of β-CN compared to the homologous bovine CN (Kappeler et al., 2003). The most 
representative other bands were characterized as being: WAP (12.5 kDa), α-LAC (14.3 kDa), 
GlyCAM 1 (15.4 kDa and 17.2 kDa), κ-CN (20.3 kDa), PGRP (21.3 kDa), αs2-CN (22.9 kDa), 
αs1-CN (25.7 kDa), neutrophil gelatinase (28.3 kDa), lipoprotein lipase (46.5 kDa), perilipin-2 
(47.2 kDa), butyrophilin (51.0 kDa), amine oxidase (55.3 kDa), lactadherin (56.2 kDa), heat 
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shock protein (70.0 kDa), LTF (77.1 kDa), lactoperoxidase (87.7 kDa), and xanthine oxidase 
(150 kDa). Masses mentioned above correspond to theoretical masses of proteins identified on 
the basis of tryptic profiles after LC-MS/MS analysis. Globally, the electrophoretic patterns of 
Kazakh camel milk samples agree with those reported recently for Israelian and Tunisian 
camel milk samples (Felfoul et al., 2017; Merin et al., 2001). However, surprisingly the 
prominent fact was the apparent absence in Kazakh milk samples of camel serum albumin 
(CSA), the major WP with a molecular mass equal to 66.0 kDa in camel colostrum (Merin et 
al., 2001). By contrast, this protein has been successfully identified, with the best E-value, in 
Tunisian fresh milk samples (Felfoul et al., 2017).  
 
 
 
 
 
 
 
 
Figure 2.3. 1D SDS-PAGE pattern of C. bactrianus (KZB), C. dromedarius (KZD) and hybrid (KZH) skimmed 
milk samples of Kyzylorda (KZ) region. In the given example pattern (Ex), red frames and black boxes aligned 
correspond to electrophoretic bands that were excised from the gel and subsequently analyzed for protein 
identification, after tryptic digestion, by LC-MS/MS. Molecular weight markers from 210 to 8 kDa are indicated 
at the right of the gel. 
 
2.3.3 Qualitative proteome of camel skimmed milk by LC-MS/MS  
 We took advantage of LC-MS/MS analysis to identify proteins in electrophoretic 
bands to go further into the description of the protein fraction of camel milk. Indeed, for each 
band analyzed by LC-MS/MS, between 10 and 70 different proteins were identified. In such a 
way, using UniprotKB taxonomy cetartiodactyla (SwissProt + Trembl) database, a total of 
391 functional groups of proteins (proteins belonging to a same group share common 
47 
 
 
  
peptides) were identified after LC-MS/MS analysis of 8 camel milk samples (S1 Table). A set 
of 235 proteins was observed as common to the 8 milk samples. As example, a list of the first 
70 common proteins found in milk samples of the three species from Shymkent region is 
given in Table 2.2. 
 Eight proteins were identified as authentically matching with proteins in C. 
dromedarius protein database, two with C. bactrianus protein database, 46 with C. ferus 
protein database, and the remaining (n=14) with the other mammalian species such as, Lama 
guanicoe, Bos taurus, Sus scrofa and Ovis aries protein databases. Immune-related proteins 
such as GlyCAM1, lactadherin (MFG-E8), and LTF, as well as milk fat globule membrane 
(MFGM)-enriched proteins such as xanthine oxidase (XO), butyrophilin (BTN), actin, ras-
related protein Rab-18, ADP-ribosylation factor 1, tyrosine-protein kinase and GTP-binding 
protein SAR1b, were detected. Likewise, proteins originating from blood such as serpin A3-1, 
apolipoprotein A-1, α-1-antitrypsin like protein, α-1-acid glycoprotein, β-2-microglobulin, 
complement C3-like protein were found in all milk samples analyzed.  
 
Table 2.2. Top 70 proteins identified by LC-MS/MS from individual C. bactrianus (B), C. dromedarius (D) and 
hybrid (H) milk samples of Shymkent region 
ID Accession Description Mr (-) log E-value Coverage, % Number of Spectra* 
   kDa B D H B D H B D H 
1 O97943-2 Short isoform of Alpha-S1-casein (C. 
dromedarius) 
25,7 453,63 535,3 585,79 88 92 92 574 679 842 
2 A0A077SL35 Beta-casein (C. bactrianus) 26,1 299,05 285,89 395,72 77 79 79 542 507 745 
3 O97944 Alpha-S2-casein (C. dromedarius) 22,9 285,16 320,65 276,39 70 70 66 357 451 376 
4 W6GH05 Lactoferrin (C. dromedarius) 77,1 723,25 557,5 1174,16 85 80 88 253 157 829 
5 P15522-2 Isoform B of Glycosylation-dependent cell 
adhesion molecule 1 (C. dromedarius) 
15,4 112,39 189,45 192,31 64 70 69 220 359 358 
6 L0P304 Kappa-casein (C. bactrianus) 20,3 127,64 149,66 194,03 51 53 51 217 222 329 
7 S9WF76 Lactadherin-like protein (C. ferus) 45,6 263,03 350,07 501,73 51 53 57 162 236 436 
8 P00710 Alpha-lactalbumin (C. dromedarius) 14,3 288,2 277,9 329,27 83 80 83 161 159 175 
9 Q9GK12 Peptidoglycan recognition protein 1 (C. 
dromedarius) 
21,3 308,94 359,49 336,8 73 73 79 112 156 140 
10 S9Z0L8 Amine oxidase [flavin-containing] (C. ferus) 55,3 233,97 231,94 277,32 74 70 75 110 138 190 
11 S9Y4T1 Xanthine dehydrogenase/oxidase (C. ferus) 150 270,07 435,86 330,26 40 45 41 79 138 121 
12 S9X3X3 Butyrophilin subfamily 1 member A1 (C. 
ferus)  
51,09 95,37 140,19 162,3 47 50 51 61 107 111 
13 S9X4G0 Neutrophil gelatinase-associated lipocalin-
like protein (C. ferus) 
28,3 104,88 98,15 165,14 48 45 62 44 33 82 
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14 S9X1L5 Lipoprotein lipase isoform 3 (Fragment) (C. 
ferus) 
46,5 107,66 133,72 54,73 43 55 27 43 56 29 
15 S9YK74 Perilipin (C. ferus) 47,2 116,47 169,78 167,59 56 60 52 39 67 46 
16 P09837 Whey acidic protein (C. dromedarius) 12,5 42,97 59,92 82,11 55 75 84 36 43 73 
17 S9X4X6 Uncharacterized protein (C. ferus) 43,1 47,87 14 17,5 30 13 16 36 9 16 
18 S9X7Q1 Lactoperoxidase isoform 1 preproprotein (C. 
ferus) 
87,7 83,1 62,59 65,16 26 22 20 25 19 17 
19 S9XDK9 Complement C3-like protein (C. ferus) 262,7 87,48 44,5 292,06 12 4 24 25 8 69 
20 S9XR87 Beta-2-microglobulin (C. ferus) 14,8 36,87 36,15 40,76 43 43 43 23 28 44 
21 O18831 Growth/differentiation factor 8 (S. scrofa) 42,7 44,62 49,29 67,44 28 24 32 23 22 17 
22 P68103 Elongation factor 1-alpha 1 (B. taurus) 50 58,23 42,59 78,3 31 27 31 20 12 24 
23 S9YCI6 Peptidyl-prolyl cis-trans isomerase (C. ferus) 23,8 44,54 43,1 71,24 54 54 57 20 21 22 
24 S9XP75 Monocyte differentiation antigen CD14 (C. 
ferus) 
29,7 49,75 44,58 73,91 27 27 27 17 16 22 
25 S9WCV2 Sulfhydryl oxidase (C. ferus) 72,2 31,64 76,49 14,43 18 27 8 16 26 6 
26 S9YC53 Alpha-1-antitrypsin-like protein (C. ferus) 51,9 64,76 64,84 51,84 28 31 32 14 21 15 
27 S9YS49 Putative E3 ubiquitin-protein ligase Roquin 
(C. ferus) 
158,5 56,65 90,28 8,84 10 14 2 14 29 3 
28 T0NN97 Uncharacterized protein (C. ferus) 151,4 38,86 53,95 36,72 12 13 11 13 16 15 
29 A0A0F6YEF6 Anti-HCV NS3/4A serine protease 
immoglobulin heavy chain (Fragment) (C. 
dromedarius) 
13,4 38,24 35 52,95 24 24 24 12 10 26 
30 S9X9X0 Vitelline membrane outer layer protein 1-
like protein (C. ferus) 
24,2 44,94 52,11 75,95 51 50 53 12 14 31 
31 S9X358 Tissue alpha-L-fucosidase (C. ferus) 42,7 25,83 23,27 24,46 23 18 18 12 12 7 
32 S9WS72 Sodium-dependent phosphate transport 
protein 2B-like protein (C. ferus) 
75,4 24,99 15,41 24,7 18 7 9 11 8 8 
33 S9X2V0 UDP-Gal:betaGlcNAc beta 1,4-
galactosyltransferase 1, membrane-bound 
form-like protein (C. ferus) 
37,3 30,18 13,09 38,99 23 11 33 11 7 15 
34 S9XSQ6 Vitamin D-binding protein-like protein (C. 
ferus) 
49,3 41,66 109,25 18,01 24 45 8 10 30 3 
35 S9WGZ9 Rab GDP dissociation inhibitor beta isoform 
1 (C. ferus) 
35,7 27,75 22,32 55,78 32 25 43 10 8 15 
36 P19120 Heat shock cognate 71 kDa protein (B. 
taurus) 
71,1 37,14 60,92 111,21 17 24 35 9 16 30 
37 S9XA25 Ezrin isoform 5-like protein (Fragment) (C. 
ferus) 
71 24,32 28,23 47,46 13 10 20 9 7 13 
38 S9XI30 Uncharacterized protein (C. ferus) 22 25,16 66,23 20,66 38 54 39 9 31 8 
39 S9Y2X0 Platelet glycoprotein 4 (C. ferus) 38,3 28,14 40,27 55,15 15 17 29 9 8 17 
40 G9F6X8 Protein disulfide-isomerase (S. scrofa) 56,3 20,09 20,62 21,76 17 15 9 9 10 3 
41 S9WZP7 Serpin A3-8 (C. ferus) 74,9 15,26 28,06 72,32 11 12 20 8 12 28 
42 A7MBJ4 Receptor-type tyrosine-protein phosphatase 
F (B. taurus) 
211,1 23,69 21,19 20,54 6 6 4 8 8 8 
43 S9YFG2 Complement factor D (C. ferus) 38,1 37,99 33,7 44,44 14 14 14 8 9 13 
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44 S9WPL9 Uncharacterized protein (C. ferus) 84,6 31,09 39,23 57,64 12 10 17 7 6 18 
45 S9XE02 Beta-2-glycoprotein 1-like protein (C. ferus) 30,9 46,22 64,63 48,09 42 43 27 7 12 5 
46 B8XH67 Na(+)/H(+) exchange regulatory cofactor 
NHE-RF (S. scrofa) 
39,2 20,94 37,33 32,94 22 22 30 7 9 11 
47 Q28452 Quinone oxidoreductase (L. guanicoe) 35,1 23,01 24,97 51,04 28 25 43 7 5 11 
48 S9YU13 Glutathione S-transferase-like protein (C. 
ferus) 
27,7 34,68 8,59 22 21 15 19 7 3 4 
49 P00727-2 Isoform 2 of Cytosol aminopeptidase (B. 
taurus) 
53,9 14,58 13,07 35,48 15 9 18 6 4 7 
50 S9WUC8 Ig kappa chain V-II region RPMI 6410-like 
protein (C. ferus) 
26,7 22,72 12,39 32,25 19 10 27 6 4 15 
51 S9WRY0 L-lactate dehydrogenase B chain isoform 1-
like protein (C. ferus) 
30,2 25,51 28,95 37,66 22 22 22 6 7 6 
52 S9X5V9 Fc of IgG binding protein (Fragment) (C. 
ferus) 
254,9 20,45 65,48 10,4 3 9 2 6 16 4 
53 B5B0D4 Major allergen beta-lactoglobulin (B. taurus) 19,8 9,94 54,67 12,3 21 59 25 6 27 7 
54 S9XE13 Uncharacterized protein (C. ferus) 82,6 12,16 32,28 71,26 5 10 15 5 17 22 
55 S9Y8C6 Phosphoglucomutase 1 isoform 3-like 
protein (C. ferus) 
68,3 11,37 18,27 42,46 9 11 22 5 6 11 
56 S9Y3S5 Olfactory receptor (C. ferus) 108,3 19,83 37,9 43,59 4 6 7 5 9 11 
57 S9XT33 Lipopolysaccharide-binding protein (C. 
ferus) 
47,5 11,05 9,43 16,89 12 10 17 5 4 7 
58 S9YL21 Apolipoprotein A-I (C. ferus) 22,5 19,05 68,11 82,98 27 49 57 5 12 14 
59 S9Y5X2 Cell death activator CIDE-A-like protein (C. 
ferus) 
41,2 16,09 22,41 15,11 11 14 10 4 11 4 
60 S9XC74 Osteopontin isoform OPN-c (C. ferus) 34,6 8,45 12,77 34,67 8 11 23 4 10 24 
61 T0NLV9 Epoxide hydrolase 1 (C. ferus) 54,3 7,1 11,53 12,54 9 14 10 4 6 4 
62 S9WKD1 Ribonuclease 4 (C. ferus) 26,8 11,56 25,5 29,63 12 22 23 3 7 9 
63 S9WDV3 Fibrinogen gamma chain isoform gamma-B 
(C. ferus) 
50,5 7,22 33,1 76,88 6 49 37 3 12 33 
64 S9XLJ3 Brain-specific serine protease 4-like protein 
(C. ferus) 
44,6 7,52 8,26 9,3 10 10 12 3 3 4 
65 S9WY98 Sodium/glucose cotransporter 1 (C. ferus) 78,3 9,01 5,72 14,27 4 3 5 3 2 5 
66 S9WX48 Alpha-1-acid glycoprotein (C. ferus) 22,9 6,65 7,25 29,92 14 8 44 3 2 17 
67 W5P9V5 Uncharacterized protein (O. aries) 85,3 7,14 7,74 8,54 3 3 3 3 3 3 
68 T0NLF0 Vitronectin (C. ferus) 56,2 11,18 7,8 25,19 7 4 10 3 2 4 
69 Q0IIG8 Ras-related protein Rab-18 (B. taurus) 22,9 3,49 15,33 21,19 10 28 24 2 5 4 
70 S9YNY9 Nucleobindin-1 (C. ferus) 53 4,54 48,27 20,28 5 41 21 2 16 9 
 
Molecular masses (Mr) of proteins are expressed in kDa, E-value in log, coverage in %. Spectra indicates the 
number of spectra permitting the identification of proteins. Major proteins identified in excised gel bands after 
SDS-PAGE are given in bold type.     
*abundance of each protein was estimated from spectral count. The number of spectra of C. bactrianus (B) 
classified the table. 
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2.3.4 Camel milk protein profiling by LC-ESI-MS  
 Thirty individual milk samples, including C. bactrianus (n=10), C. dromedarius 
(n=10), and hybrids (n=10) taken from the 58 milk samples analyzed in SDS-PAGE were 
submitted to LC-ESI-MS analysis. Milk proteins separated by RP-HPLC were identified 
based on their molecular mass, arising from ESI-MS. Putative genetic variants and post-
translational (glycosylation and phosphorylation) isoforms were determined by deconvoluting 
multiple charged ion spectra in a real mass scale. Knowing their primary structures, it is 
possible to determine molecular masses of non post-translationally modified proteins, and 
then we can precisely know the mass of phosphorylation isoforms resulting from the addition 
of phosphate groups (±79.98 Da). Likewise, masses of isoforms arising from cryptic splice 
site usage, usually leading to the loss of the first codon (CAG) of an exon specifying a 
glutaminyl residue (-128 Da), are easily deduced. A camel mass reference database was thus 
created for the main milk proteins by combining the data available from C. dromedarius, C. 
bactrianus, C. ferus, and Lama glama milk protein sequences published in UniProtKB 
(ExPASy SIB Bioinformatics Resource Portal) and the National Centre for Biotechnology 
Information (NCBI). 
 To illustrate the efficiency of such an approach, a typical protein profile obtained with 
a milk from a hybrid camel sampled in Kyzylorda region is given in Figure 2.4. The analysis 
of molecular isoforms, identified from mass data, are reported in Table 2.3, in which 
experimental and theoretical molecular masses of camel milk proteins are given and 
confronted. The mass accuracy has allowed distinguishing about 50 protein molecules 
corresponding to isoforms belonging to nine protein families, eluted from the reverse-phase 
column as 15 peaks. 
 In peak I, the two molecular masses (21,157 Da and 21,184 Da) found were associated 
with glycoforms of κ-CN. The molecular mass of 21,157 Da corresponds to mono-
phosphorylated variant A of κ-CN with tri-saccharides ((GaN-Ga-SA2) x 3 or (GaN-Ga) + 
(GaN-Ga-SA3) x 2, or (GaN-Ga-SA) + (GaN-Ga-SA2) + (GaN-Ga-SA3)). The molecular 
mass of 21,184 Da was expected to be non-phosphorylated variant B of κ-CN with penta-
saccharides ((GaN-Ga) x 3 + (GaN-Ga-SA2) x 2, or (GaN-Ga) + (GaN-Ga-SA) x 4, or (GaN-
Ga) x 2 + (GaN-Ga-SA) x 2 + (GaN-Ga-SA2), or (GaN-Ga) x 3 + (GaN-Ga-SA) + (GaN-Ga-
SA3)). Peak II contained molecules of which the molecular masses (18,210 Da and 18,236 
Da) were identified as non-phosphorylated variant B of κ-CN along with the A variant 
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modified at its N-terminal residue to form a pyro-glutamic acid (pyro-E), which is formed 
spontaneously by cyclization of the N-terminal E residue. The two molecular masses: 12,564 
Da and 12,644 Da, detected in peak III, were assigned to the WAP peptide chain without or 
with one P group, respectively. Peaks IV, V, and VI were shown to contain αs1-CN. The 
molecular mass of 23,878 Da observed in peak IV was interpreted as being a short isoform 
(201-residues) of αs1-CN variant A with 4P groups, arising from exons 13’ and 16 skipping 
events in the mature mRNA during the course of primary transcripts splicing, resulting in 
deleted sequences (residues E112-Q117 and E155-E162). Despite identification of only one 
splicing isoform with 4P groups (23,878 Da) in this milk sample, isoforms with 3P and 5P, 
along with cryptic splice site usage were identified in several other milk samples. Peak V 
consisted of three relative groups of three masses with sequential increments (s.i.) of 80 Da: 
24,547 Da - 24,707 Da, 24,675 Da - 24,835 Da, and 24,689 Da - 24,849 Da. The mass 
difference (128 Da) between the first and the second group (Table 2.3.) corresponds to the 
loss of glutaminyl residue 83 (∆Q83), encoded by the first codon (CAG) of exon 11. As 
reported previously (Kappeler et al., 1998), 24,755 Da was identified as the short isoform 
(207-residues) of the αs1-CN variant A originating from exon 16 skipping during the course of 
the primary transcript processing. The mass difference (14 Da) between the second (24,675 
Da) and the third (24,689 Da) group is due to the aa substitution E30D reported by Shuiep et 
al., (2013) characterizing the C variant. Thus, it is concluded that the third mass group gathers 
αs1-CN short isoforms (207-residues) of variant C, with 5P, 6P and 7P, respectively, described 
in C. dromedarius. While cryptic splice site isoforms (∆Q83) of variant C, with different 
phosphorylation levels, were not found in the milk sample shown at Figure 2.4, they were 
successfully found in several milk samples. Whereas, αs1-CN short isoform was 
systematically present in all camel milk samples with 5, 6 and 7P (Table 2.3.), by contrast, 
αs1-CN short isoforms of variant C occurred in some milk samples with 4P (24,611 Da) and 
up to 9P (24,929 Da). Herein, αs1-CN short isoforms of variants A and C carrying 6P groups 
are isoforms with the highest mass signal intensity values 50,634 vs. 47,392, respectively.    
 Peak VI was more complex to interpret. Masses found in this peak belonged to four 
different molecular mass groups: 14,430 Da (ascribed to α-LAC), 22,939-23,099 Da (s.i. of 
80 Da), 25,646 Da and 25,693-25,773 Da (s.i. of 80 Da), and 25,787 Da. Masses around 23 
kDa (22,939-23,099 Da), with a mass increment of two P groups (160 Da), were not 
referenced to any protein in our database. These findings strongly suggest the existence of an 
additional uncharacterized phosphorylated protein, namely UP1, which remains to be 
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identified. The third mass group, 25,646 Da and 25,693-25,773 Da, corresponds to a mixture 
of two long isoforms (214 and 215 aa residues, respectively) of αs1-CN variant C with 5P and 
6P (25,693-25,773 Da) which differs from variant A by an aa substitution (E30D) in the 
mature protein (Erhardt et al., 2016). The mass of 25,646 Da corresponds to a 214 aa residues 
isoform of αs1-CN variant C (∆Q83), with 6P. The last molecular mass (25,787 Da) found in 
this peak was related to the mature variant A of αs1-CN bearing 6P groups, which is by far 
much less abundant than the short αs1-CN A-6P isoform (intensity of the mass signals: 3,472 
vs. 50,634).  
 The four subsequent peaks (VII, VIII, IX, and X) all contained αs2-CN molecules, with 
phosphorylation levels ranging between 7P (21,825 Da, peak VII) and 12P (22,226 Da, peak 
X). Observed molecular masses of 21,825-21,984 Da were in perfect concordance with those 
predicted for αs2-CN displaying 7P and 9P, whereas αs2-CN with 8P (21,906 Da) was the most 
frequent isoform. In addition, the mass of 23,179 Da in peak VII probably corresponds to the 
UP1 found in fraction VI with one more P group. Masses ranging between 21,986 and 22,226 
Da (s.i. of 80 Da) found in peaks VIII, IX, and X were related to αs2-CN variant A with 9P to 
12P. These results suggest three more potential phosphorylation sites than reported by 
Kappeler et al., (1998) who mentioned a maximum of 9 S residues phosphorylated in camel 
αs2-CN. More recently, Felfoul et al., (2017) detected two αs2-CN isoforms with 10 and 11P 
groups in camel milk. Interestingly, peak X contains a second uncharacterized protein (UP2) 
with a molecular mass of 23,046 Da, not referring to any mass in our database for camel milk 
proteins. Such a mass was found in all camel milk samples analyzed so far (n=30). This 
suggests the possible existence of a further phosphoprotein in camel milk, very likely a CN, 
since two putative related isoforms with two (23,206 Da) and three (23,286 Da) additional P 
groups were detected in peak XI, in which the most abundant mass found (19,143 Da) was 
attributed to PGRP.   
 In the hybrid from Kyzylorda region (Table 2.3.), masses found in peak XII ranged 
between 66,481 and 67,342 Da. The most abundant masses 66,481 Da and 66,512 Da might 
be related to CSA of which the theoretical mass (peptide sequence predicted from the C. 
dromedarius genome, NCBI Accession number XP_010981066.1) is 66,477 Da. The mass 
differences of 4 Da and 35 Da could be attributed to putative genetic polymorphisms. The 
molecular weight reported by Felfoul et al., (2017) from fresh camel milk was estimated as 
66,600 Da. However, one cannot exclude that such masses could correspond to LPO 
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depending on cleavage sites of the propeptide, when comparing with bovine LPO and human 
myeloperoxidase (Dull et al., 1990).  
 Molecular masses of 24,793 - 24,953 Da (s.i. of 80 Da) found in peak XIII, were 
ascribed to β-CN variant A with 2P, 3P and 4P, first described in the C. bactrianus. Molecular 
masses of 24,891-24,970 Da, which differ from β-CN A-3P and 4P by a 18 Da, correspond to 
β-CN variant B, first described in C. dromedarius. The mass difference of 18 Da between 
variants A and B is due to the M186I substitution. Isoforms of β-CN with 4P predominate 
whatever the milk sample and the genetic variant were, with equivalent intensity values of the 
mass signal for variants A and B, exemplified by a heterozygous hybrid camel: 84,494 vs. 
87,973, respectively. In addition, the molecular mass of 24,842 Da, observed in peak XIII, 
corresponds to a splicing variant of β-CN B-4P. Such an isoform, which was so far considered 
as typical to the dromedary camel, was also found in hybrids and Bactrian camels. It is due to 
a cryptic splice site usage leading to the loss of the first codon (CAG) of exon 6, encoding 
residue Q29 in the protein.   
 Surprisingly, in the next peak (XIV), molecular masses around 24,000 Da (23,878 Da 
to 24,024 Da) were observed. Given the elution time and the mass range, these masses were 
very likely relative to the β-CN fraction, especially since a 18 Da mass differential existing 
between the pair of molecular masses (24,006 Da and 24,024 Da), is consistent with the 
occurrence of β-CN variants A and B, in both species. The important mass reduction, - 946 
Da, relatively to the full-length β-CN, is hypothesized to be due to the cleavage by plasmin of 
the first seven N-terminal residues (1REKEEFK7) of the mature protein, given that this 
heptapeptide accounts for 947 Da. Furthermore, molecular masses equivalent to 23,878 Da 
and 23,895 Da are supposed to originate in the cryptic splice site usage (ΔQ29), previously 
mentioned. Finally, in the last peak (XV) mass values 12,357 Da and 12,376 Da again with 
the mass difference in 18 Da were observed. These masses correspond very likely to camel γ2-
CN A and B (12,357 Da vs. 12,376 Da, respectively), which are degradation products of β-CN 
(Beg et al., 1986).  
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 This extensive analysis shows that mass accuracy provided by LC-ESI-MS was 
effective to allow protein identification of most of the protein isoforms by comparison of 
masses observed experimentally to theoretical molecular masses, and sufficiently powerful to 
recognize post-translational modifications (PTM) such as phosphorylation of CN, as well as 
genetic variants and long and short isoforms due to splicing inaccuracies.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. LC-ESI-MS profile of clarified crossed camel milk of Kyzylorda region. Nine major milk protein 
fractions were identified in the following order: peak I and II contained glycosylated ant natural isoforms of κ-
CN; peak III: WAP; peaks IV, V: αs1-CN; peak VI: α-LAC, αs1-CN and UP1; peak VII: αs2-CN and UP1; peaks 
VIII, IX, and X αs2-CN along with UP2 in peak X; peak XI: PGRP and UP2; peak XII: CSA/LPO; peaks XIII 
and XIV: β-CN, and peak XV: γ2-CN 
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Table 2.3. Identification of Camel milk protein (hybrid from Kyzylorda region) from observed molecular masses 
using LC-ESI-MS 
Peak Ret.Time, 
min 
Observed 
Mr, Da 
Theoretical
Mr, Da 
Protein description UniProt/  
NCBI GenBank 
Accession number 
Intensity 
I 4.50 21,157 21,158 κ-CN A, 1P, (GaN-Ga-SA2)x3*, pyro-E  1,361 
21,184 21,182 κ-CN B, 0P, (GaN-Ga)x3 + (GaN-Ga-SA2)x2**, pyro-E  5,810 
II 18.61 18,210 18,210 κ-CN B, 0P ? L0P304 161 
18,236 18,235 κ-CN A, 0P, pyro-E P79139 72 
III 24.32 12,564 12,564 WAP, 0P  P09837 1,756 
12,644 12,644 WAP, 1P  1,575 
IV 24.97 23,878 23,878 αs1-CN A - short isoform (∆ex 16 and ∆ex 13’), 4P  242 
V 26.23 24,547 24,547 αs1-CN C -short isoform (∆ex 16), 5P, splice variant (∆Q83)   4,885 
24,627 24,627 αs1-CN C - short isoform (∆ex 16), 6P, splice variant (∆Q83)  21,606 
24,707 24,707 αs1-CN C - short isoform (∆ex 16), 7P, splice variant (∆Q83)  6,990 
24,675 24,675 αs1-CN C - short isoform (∆ex 16), 5P  9,441 
24,755 24,755 αs1-CN C - short isoform (∆ex 16), 6P K7DXB9 47,392 
24,835 24,835 αs1-CN C - short isoform (∆ex 16), 7P  7,046 
24,689 24,689 αs1-CN A - short isoform (∆ex 16), 5P  9,748 
24,768 24,769 αs1-CN A - short isoform (∆ex 16), 6P O97943-2 50,634 
24,849 24,849 αs1-CN A - short isoform (∆ex 16), 7P  6,909 
VI 28.53 14,430 14,430 α-LAC P00710 17,797 
22,939 n/a Uncharacterized protein 1 (UP1) n/a*** 2,701 
23,020 n/a UP1+80Da n/a 2,489 
23,099 n/a UP1+160Da n/a 1,079 
25,646 25,645 αs1-CN C, 6P, splice variant (∆Q83)  3,501 
25,693 25,693 αs1-CN C, 5P  564 
25,773 25,773 αs1-CN C, 6P  7,880 
25,787 25,787 αs1-CN A, 6P O97943-1 3,472 
VII 30.05 21,825 21,826 αs2-CN, 7P  552 
21,906 21,906 αs2-CN, 8P O9794 5,242 
21,984 21,986 αs2-CN, 9P  403 
23,178 n/a UP1+240Da n/a 1,256 
VIII 31.11 21,986 21,986 αs2-CN, 9P  O97944 356 
22,066 22,066 αs2-CN, 10P  4,790 
IX 33.18 22,066 22,066 αs2-CN, 10P   148 
22,145 22,146 αs2-CN, 11P  1,964 
X 35.05 22,226 22,226 αs2-CN, 12P  894 
23,046 n/a Uncharacterized protein 2 (UP2) n/a 231 
XI 37.16 19,143 19,143 PGRP Q9GK12 7,207 
23,206 n/a UP2+160Da n/a 1,592 
23,286 n/a UP2+240Da n/a 735 
XII 38.09 66,481 66,477 CSA ? XP_010981066.1 1,096 
 66,491 LPO ? Q9GJW6  
66,512 n/a CSA ? LPO?  2,663 
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67,342 n/a CSA ? LPO?  1,010 
XIII 40.67 24,746 24,745 β-CN A, 3P, splice variant (∆Q29)  2,073 
24,793 24,792 β-CN A, 2P  5,469 
24,825 24,825 β-CN A, 4P, splice variant (∆Q29)  9,586 
24,873 24,872 β-CN A, 3P  10,177 
24,953 24,953 β-CN A, 4P A0A077SL35 84,494 
24,842 24,842 β-CN B, 4P, splice variant (∆Q29)  10,029 
24,891 24,890 β-CN B, 3P  10,365 
24,970 24,971 β-CN B, 4P Q9TVD0 87,973 
XIV 43.71 23,878 23,878 β-CN A-short isoform (∆946 Da), 4P, splice variant (∆Q29)  707 
23,963 23,958 β-CN A-short isoform (∆946 Da), 5P, splice variant (∆Q29)  244 
23,929 23,926 β-CN A-short isoform (∆946 Da), 3P  438 
24,006 24,006 β-CN A-short isoform (∆946 Da), 4P  9,026 
23,895 23,896 β-CN B-short isoform (∆946 Da), 4P, splice variant (∆Q29)  625 
24,024 24,024 β-CN B-short isoform (∆946 Da), 4P  5,545 
XV 47.02 12, 357 12,358 γ2-CN A, 0P  1,473 
12,376 12,376 γ2-CN B, 0P  1,065 
Major proteins within each peak are in bold. Proteins and isoforms previously described are on grey background     
*(GaN-Ga-SA2) x 3, or (GaN-Ga) + (GaN-Ga-SA3) x 2, or (GaN-Ga-SA) + (GaN-Ga-SA2) + (GaN-Ga-SA3)  
**(GaN-Ga) x 3 + (GaN-Ga-SA2) x 2, or (GaN-Ga) + (GaN-Ga-SA) x 4, or (GaN-Ga) x 2 + (GaN-Ga-SA) x 2 + (GaN-Ga-SA2), 
 or (GaN-Ga) x 3 + (GaN-Ga-SA) + (GaN-Ga-SA3)  
***n/a - not applicable 
 
2.3.5 Multiple spliced variants of CSN1S1 
 To confirm the occurrence of CSN1S1 multiple splice variants, we took advantage of 
the possibility to extract RNA from milk fat globules to sequence PCR fragments of cDNA 
encoding αs1-CN. Three different CSN1S1 transcripts were found in each species and both 
genetic variants A and C. The nucleotide sequence of the most frequent variant transcript was 
shown to be deleted of exon 16, encoding the octapeptide EQAYFHLE. Besides, we also 
observed an isoform displaying the same sequence in which the first codon of exon 11 was 
lacking. Finally, a full-length transcript including exon 16 and the first codon of exon 11 was 
also detected, at a lower concentration.  
2.4 Discussion 
 Given the growing interest in camel milk, due to the health potential of its bioactive 
components (Al haj & Al Kanhal, 2010) and frequently reported high anti-microbial activity 
(El-Agamy, 2009), over the past 20 years and even more during the last decade, the milk 
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protein fraction of Camelids, from all around the world has been extensively investigated 
(Alhaider et al., 2013; El-Agamy et al., 2009; Ereifej et al., 2011; Erhardt et al., 2016; Felfoul 
et al., 2017; Hinz et al., 2012; Kappeler et al., 1999; Konuspayeva et al., 2007; Merin et al., 
2001; Ochirkhuyag et al., 1997; Salmen et al., 2012; Shuiep et al., 2013; Wangoh et al., 1998; 
Yang et al., 2013; Youcef et al., 2009). All these studies have explored, with more or less 
efficient approaches, the composition of the major milk proteins. However, the molecular 
diversity of these major proteins had not yet been studied. Then, our main objective was i) to 
provide, if not a comprehensive, at least an in-depth description of the protein fraction of 
camel milk; ii) to go further into an extensive analysis of the molecular diversity of major 
milk proteins from Camelids (C. dromedarius, C. bactrianus, and hybrids) sampled from 
different regions in Kazakhstan. For these purposes, different proteomic tools and 
methodological approaches were applied. For short, up to 391 protein species were identified 
in cumulating LC-MS/MS analyses of 8 individual Camelus milk, and the extensive 
characterization of CN and WP polymorphisms, using LC-ESI-MS, revealed a minimum of 
50 molecular species. 
2.4.1 Interspecies in-depth proteomic analysis of camel milk 
proteins  
 To our knowledge, the number of proteins identified in this study was relatively higher 
compared to the numbers reported in previous studies on the camel proteome (Alhaider et al., 
2013; Yang et al., 2013). The largest camel milk proteome determined so far comprised about 
238 proteins including some known camel proteins and heavy-chain immunoglobulins 
(Alhaider et al., 2013). In the abovementioned study carried out on C. dromedarius, proteins 
were identified from 2D SDS-PAGE with subsequent matrix-assisted laser 
desorption/ionization (MALDI) time-of-flight mass spectrometry analysis. However, it should 
be mentioned that several of the 238 proteins identified matched with the same protein in 
different species. Hence, at most ca. 140 proteins may be considered as unique. By 
comparison, in the present study a total of 391 unique protein species were determined from 
LC-MS/MS analyses of C. bactrianus (n=3), C. dromedarius (n=3), and hybrids (n=2), 
sampled from three different regions (Atyrau, Shymkent and Kyzylorda). Proteins such as 
flavin monoamine oxidase, perilipin 2, neutrophil gelatinase-associated lipocalin-like protein, 
brain-specific serine protease 4-like protein and others, which were not determined 
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previously, were successfully detected. Conversely, about 30 proteins identified by Alhaider 
and co-workers (2013) were not found in our study.  
 However, as for other mammals, CN represent the major protein fraction of camel 
milk (80%), among which β-CN is the most abundant (Pauciullo et al., 2014). Quantitative 
analyses performed by Kappeler et al., (2003) on camel milk CN have demonstrated 
significant higher amounts of β-CN (15 g/L vs. 10 g/L) compared to the homologous bovine 
β-CN and significant lower amounts of κ-CN (0.8 g/L vs. 3.5 g/L). Regarding relative 
proportions, as previously reported (Kappeler et al., 1998), αs1-, αs2-, β- and κ-CN contribute 
to about 22%, 9.5%, 65%, and 3.5% of total CN, respectively. Taking into account the 30 
milk samples analyzed in LC-ESI-MS, relative proportions of individual CN, estimated from 
the mass signal intensity of each CN family (summing the mass signal of its phosphorylation 
and splicing isoforms) relatively to the sum of mass signal intensities of all CN families 
(considering that ionizing properties of caseins and their isoforms are comparable), were 37% 
αs1-CN, 6.1% αs2-CN, 53.1% β-CN, and 3.8% κ-CN. These values varied considerably 
compared to those reported previously by Kappeler et al., (1998) essentially as far as αs1-CN 
and β-CN are concerned. Whereas αs1-CN accounts for 36.1% for C. bactrianus, it reaches 
37.4% and 37.6% in C. dromedarius and hybrids, respectively (Table 2.4.). Percentage of αs1-
CN calculated in our study was 15% higher than the value reported by Kappeler et al., (1987). 
Such an increase is compensated in part by a decrease of 12% of β-CN. The small amount of 
κ-CN observed is probably underestimated, since most of the highly glycosylated isoforms 
were not detected. However, this is in agreement with the fact that the size distribution of CN 
micelles is inversely related to κ-CN content (Bijl et al., 2014; Ostersen et al., 1997), since 
camel CN micelles are the largest, ranging in size between 280-550 nm (Bornaz et al., 2009).  
 Even though, there are 2 potential phosphorylation sites in κ-CN (S141 and S159) 
conserved and phosphorylated in sheep and goats (Martin et al., 2013) only isoforms with a 
single or no P group in the first chromatographic peak comprising glycosylated isoforms with 
3 or 5 carbohydrate motifs were detected. Five glycosylated isoforms of camel κ-CN ranging 
in size between ca. 24 and 25.9 kDa were found in camel milk using 2D SDS-PAGE (Hinz et 
al., 2012).  
 In addition, γ2-CN, a C-terminal product resulting from a highly specific proteolysis of 
β-CN by the natural milk protease (plasmin) was successfully found in the milk samples 
analyzed. Previously published data suggested that the proportion of γ-CN in total CN 
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fraction is highest at the beginning and the end of lactation, and in very low yielding animals 
(Ostersen et al., 1997). The molecular masses observed in this study (12,357 Da and 12,376 
Da) were lower from those previously observed by Kappeler et al., (1998): 13.9 kDa, 15.7 
kDa and 15.75 kDa.  
 Immune-related proteins such as GlyCAM1, MFGE8 and LTF were detected in camel 
milk. GlyCAM1, also named lactophorin or PP3 is a cysteine free protein, which belongs to 
the family of GlyCAM-type molecules (Beg et al., 1987). Two splicing variants A and B were 
distinguished in camel milk (Kappeler et al., 1999). Variant A encoding 137 aa residues has a 
Mr of 15.7 kDa, while variant B encoding 122 aa residues has a Mr of 13.8 kDa. The primary 
structure of Variant A reveals 54% identity with a protein isolated from bovine milk 
(Sørensen & Petersen, 1993). Until late, it has been claimed that camel GlyCAM1 is neither 
glycosylated nor phosphorylated as bovine GlyCAM1. However, Girardet et al., (2000) 
suggested the probable existence of one O-glycosylation site (16TDT18) in variant A of 
which the apparent Mr was estimated as 22.5 kDa from SDS-PAGE. Using the same 
approach, two bands were found, in which we identified GlyCAM1 from LC-MS/MS analysis 
22 kDa and 10 kDa, corresponding probably to the glycosylated and putatively 
phosphorylated isoform of GlyCAM1 observed by Girardet et al., (2000), and to a product of 
proteolysis, respectively. Surprisingly, no molecular masses corresponding to camel 
GlyCAM1 A and B were identified by LC-ESI-MS analysis. Likewise, LC-ESI-MS did not 
permit to detect LTF, even though, SDS-PAGE and LC-MS/MS data confirm its presence in 
analyzed camel milk samples. On the other hand, molecular masses ranging between 74,338 
Da-79,621 Da could be attributed to camel LTF of which the theoretical mass reported by 
Kappeler et al., (1999) for the mature protein (689 aa residues long) without PTM is 75,250 
Da. Therefore, the mass difference observed is very likely attributable to PTM. In addition, 
Konuspayeva et al., (2005) reported that the level of LTF is affected by seasonal variations.   
 Elsewhere, MFGM-enriched proteins such as XO, BTN, fatty acid synthase, actin, ras-
related protein Rab-18, ADP-ribosylation factor 1, tyrosine-protein kinase, GTP-binding 
protein SAR1b were identified in Kazakh camel milk samples in accordance with previous 
results obtained with C. dromedarius (Saadaoui et al., 2013) and C. bactrianus (Yang et al., 
2013) milk samples. Surprisingly, whereas BTN was present in all milk samples, it seems to 
be absent in C. bactrianus from Atyrau region. This could be due to the way the band in the 
electrophoresis gel was cut, since BTN was found in the other seven samples analyzed. 
Regarding proteins originating from blood, such as serpin A3-1, apolipoprotein A-1, α-1-
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antitrypsin like protein, α-1-acid glycoprotein, β-2-microglobulin, complement C3-like 
protein, they were also found in Kazakh camel milks, in agreement with findings of Yang et 
al., (2013) reported for Bactrian camels from China. By contrast, as mentioned in the Results 
section, no trace of CSA was found in Kazakh milk samples from LC-MS/MS analyses, 
whereas its presence is suspected from LC-ESI-MS.  
 A heat shock protein (HSPA6 also called HSP70B’) occurred at rank 23 amongst the 
first third of the most represented proteins in Kazakh camel milks (Table 2.2.). Expression of 
heat shock proteins, including HSP70 is increased during heat stress and involved in defense 
against dehydration or thermal stress in arid environments (Rhoads et al., 2013; Sharma et al., 
2013). The entire sequence of this protein has been deduced from the nucleotide sequence of a 
full-length cDNA in C. dromedarius (Elrobh et al., 2011). Comprising 643 aa residues, the 
camel protein, of which the Mr is 70,543 Da in agreement with the molecular mass estimated 
from SDS-PAGE, shares a high similarity (94% identity) with cow and pig HSP70.  
 Against all expectations, peptides with sequence similarity with bovine β-
lactoglobulin, the major allergen in bovine milk, were identified in the 8 camel milk samples 
(Bactrian, dromedary and hybrids) from Kazakhstan, analyzed by LC-MS/MS. The coverage 
percentage ranged between 30 and 60% in individual milk samples, and reached 71% 
cumulating all the peptides found. Five peptides related to bovine β-lactoglobulin were also 
detected by Alhaider et al., (2013) in camel milk from Saudi Arabia and the United States. 
Youcef et al., (2009) revealed a weak cross reaction between dromedary WPs and IgG anti 
bovine β-lactoglobulin. Such findings disagree with the usually admitted notion that β-
lactoglobulin is absent in camel milk (Hinz et al., 2012; Restani et al., 1999). Even though we 
cannot exclude a possible contamination by bovine milk (unlikely with the 8 camel milk 
samples analyzed by LC-MS/MS) or the presence in camel milk of a Progesterone Associated 
Endometrial Protein (PAEP) displaying strong similarities with β-lactoglobulin. However, 
significant similarities between human PAEP and the peptides having allowed the 
identification of β-lactoglobulin in C. bactrianus milk, were not found.     
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Table 2.4. Relative proportion of each CN expressed in %, estimated from the mass signal intensity of each CN 
family relatively to the sum of mass signal intensities of all CN families in the three camel species  
 κ-CN αs1-CN αs2-CN β-CN 
 m σ m σ m σ m σ 
Bactrian 3,09 1,89 36,09 2,33 7,13 1,49 53,68 2,08 
Dromedary 3,63 2,13 37,39 3,89 5,79 0,98 53,19 3,46 
Hybrid 4,77 3,01 37,57 3,03 5,25 1,56 52,41 4,18 
m = mean; σ = standard deviation 
 
2.4.2 Molecular diversity of camel caseins: genetic polymorphism 
and alternative splicing 
 Regarding camel αs1-CN, the situation is particularly confusing. Kappeler et al., (1998) 
first described two cDNA (short and long), encoding two protein isoforms of 207 and 215 aa, 
named A and B variants. The A variant corresponds to the short isoform (207 aa), in which 
the octapeptide 155EQAYFHLE162 encoded by exon 16 was missing, whereas this 
octapeptide is present in the 215 aa-long isoforms. In our study, two isoforms long and short 
showing a 1,018 Da mass difference were found, in which the short isoform was the major 
component (ca. 90%) of total camel αs1-CN. Such an alternative splicing event has been first 
reported in goats (Leroux et al., 1992), sheep (Chianese et al., 1996; P. Ferranti et al., 1995) 
and later in lama (Pauciullo & Erhardt, 2015). In addition, we observed the existence of two 
distinct genetic variants called A and C, arising from the E30D aa substitution, as previously 
reported by Shuiep et al., (2013). Since, variants A and B described by Kappeler et al., (1998) 
displayed a E aa residue in position 30 of the mature peptide chain, it becomes obvious that 
Kappeler’s  A and B variants derived in fact from a single allele, of which the primary 
transcript is subject to exon 16 skipping during the splicing process. In other words, the B 
variant is nothing other than a splicing variant of a single allele that we propose to call 
CSN1S1*A. 
 Recently, Erhardt et al., (2016) reported in C. dromedarius from different regions of 
Sudan, the existence of a further variant, called D, clearly displaying a different IEF behavior. 
Excluding this D variant, which was not precisely characterized, there are αs1-CN long and 
short non-allelic isoforms arising from alternative splicing of a single primary transcript and 
only two perfectly characterized genetic variants A and C resulting from a single G>T 
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nucleotide substitution in exon 4 and leading to E30D aa substitution. This molecular 
diversity is becoming more complex due to different phosphorylation levels ranging between 
5-8P groups (see thereafter) and due to isoforms arising from cryptic splice site usage 
(Boumahrou et al., 2011; Ferranti et al., 1999; Leroux et al., 1992), leading to the loss of a Q 
residue corresponding to the first codon of exon 11. Results from cDNA sequencing 
substantiate this. 
 Electrophoretic and LC-MS analyses as well as cDNA sequencing confirmed that β-
CN occurs as two genetic variants A and B, with the aa substitution M186I (yielding a -18 Da 
mass difference). The most frequent form of β-CN had 4P groups, one P group more than 
reported for Somali, Turkana and Pakistani camels by Kappeler et al., (1998). Surprisingly, in 
Kazakh populations, a second series of β-CN components with lower molecular masses (mass 
difference: -946 Da), relatively to the full-length β-CN were found. This phenomenon, 
observed with both genetic variants, might be due to the cleavage by plasmin of the first seven 
N-terminal residues (REKEEFK) of the mature protein. A mass difference of 947 Da was 
observed between the native full-length protein with 4P (24,953 Da and 24,971 Da for A and 
B variants, respectively) and the plasmin cleavage product at the same phosphorylation level 
(24,006 Da and 24,024 Da for A and B variants, respectively). The occurrence of a K residue 
in position 7 of the mature β-CN does not occur in any other species, of which the N-terminal 
sequence is known (Martin et al., 2013). However, our results strongly suggest that the 
peptide bond 7K-T8 is sensible to plasmin that is, like trypsin, a serine protease. Indeed, 
REKEEFK was present amongst tryptic peptides identified in LC-MS/MS analysis. 
 There is another even less probable possibility, involving the deletion of exon 5 that 
encodes 8 aa residues (ESITHINK for a mass of 923 Da), since a similar event was previously 
characterized from mare (Miranda et al., 2004) and donkey (Cunsolo et al., 2017) milks. 
However, sequencing of camel β-CN cDNA has not revealed any deletion in the mRNA 
encoding this protein (results not shown), consistently with Kappeler et al., (1998) who only 
reported a full-length sequence for β-CN, conversely to αs1-CN. Since in our study we were 
not able to provide any further confirmation of the presence of shorter mRNA of camel β-CN 
in which exon 5 is spliced out, we give preference to the cleavage by plasmin of the first 
seven N-terminal residues of β-CN rather than an alternative splicing process.  
 Surprisingly, two so far uncharacterized proteins (UP1 and UP2) with molecular 
masses around 23,000 Da and different phosphorylation levels were observed, suggesting they 
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are possibly proteins related to CN. However, to prove this hypothesis further research for in 
depth characterization of these proteins is necessary.  
2.4.3 Post-translational modifications of milk proteins: 
phosphorylation of caseins 
 Among the various approaches developed in proteomics, electrospray ionization (ESI) 
mass spectrometry (MS) is eminently suitable for studying PTM, including phosphorylation 
and glycosylation, since the technique provides molecular mass determination of native 
proteins. Phosphorylation of proteins is one of the most frequent PTM in eukaryotic cells. It 
has become a common knowledge that phosphorylation of CN occurs at S or T aa residues in 
tripeptide sequences S/T-X-A where X represents any aa residue and A is an acidic residue 
(Mercier, 1981). This consensus sequence is recognized by FAM20C, a Golgi CN-kinase, 
which phosphorylates secreted phosphoproteins, including both CN and members of the small 
integrin-binding ligand N-linked glycoproteins (SIBLING) protein family, which modulate 
biomineralization (Ishikawa et al., 2012). Each phosphorylation event adds 79.98 Da to the 
molecular mass of the peptide chain (Larsen et al., 2006). (Larsen et al., 2006)It was predicted 
with high confidence 8 probably phosphorylated S residues in αs1-CN (S18, S68, S70, S71, 
S72, S73, S193, and S202), 9 potential phosphorylated S residues in αs2-CN (S8, S9, S10, 
S32, S53, S108, S110, S113, and S121), 4 S residues in β-CN (S15, S17, S18, and S19), and 2 
S residues in κ-CN (S141 and S159). However, up to 9P residues per αs1-CN molecule were 
observed whatever the genetic variant is. Theoretically, given the S/T-X-A consensus rule, 
there are 4 T residues that could be phosphorylated (T55, T80, T153, and T196), leading to a 
maximum of 12 P groups per molecule. Therefore, we can put forward that at least one of the 
four T residues is phosphorylated in the αs1-CN-9P.       
 With 11 potentially phosphorylated aa residues matching the S/T-X-A motif (Figure 
2.5), camel αs2-CN displays the highest phosphorylation level, in agreement with Felfoul et 
al., (2017), who reported recently 11P groups. To reach such a phosphorylation level, besides 
the nine SerP, two putative ThrP (T118 and T132) have to be phosphorylated. In all the 
Kazakh milk samples analyzed in LC-ESI-MS we found αs2-CN with 12 P groups, as the 
molecular mass of 22,226 Da observed corresponds to the mass of the peptide backbone 
(21,266 Da) increased by 960 Da, a mass increment which coincides with 12 P groups. That 
means that at least another S/T residue that does not match with the canonic sequence 
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recognized by the mammary kinase(s), is potentially phosphorylated. According to Allende et 
al., (1995) the sequence S/T-X-X-A follow-through with the minimum requirements for 
phosphorylation by the CN-kinase II (CK2). It is critical to highlight in this regard that E or D 
in this site can be replaced by SerP or ThrP. Two T residues, namely T39 and T129 in the 
camel αs2-CN fully meet the requirements of the above-mentioned motif (Figure 2.5) and 
could be phosphorylated. Such an event is the only hypothesis to reach 12P for camel αs2-CN. 
Since these two kinases are very likely secreted, the idea that phosphorylation at T39/T129 
may occur in the extracellular environment cannot be excluded. This warrants further 
investigation. Fam20C, which is very likely the major secretory pathway protein kinase 
(Tagliabracci et al., 2015), might be responsible for the phosphorylation of S and T residues 
within S/T-X-A motif, whereas a CK2-type kinase might be responsible for phosphorylation 
of T residue within an S/T-X-X-A motif. This is in agreement with the hypothesis put forward 
by Bijl et al., (2014) and Fang et al., (2016), who suggest from phenotypic correlations and 
hierarchical clustering the existence of at least 2 regulatory systems for phosphorylation of αs-
CN. Elsewhere, bovine milk osteopontin which is a multiphosphorylated glycoprotein also 
found in bone, was shown to contain 27 SerP and one ThrP (Sørensen et al., 1995). Twenty 
five SerP and one ThrP were located in S/T-X-E/S(P)/D motifs, whereas two SerP were found 
in the sequence S-X-X-E/S(P). 
        10         20         30         40         50 
KHEMDQGSSS EESINVSQQK FKQVKKVAIH PSKEDICSTF CEEAVRNIKE 
        60         70         80         90        100 
VESAEVPTEN KISQFYQKWK FLQYLQALHQ GQIVMNPWDQ GKTRAYPFIP  
       110        120        130        140        150 
TVNTEQLSIS EESTEVPTEE STEVFTKKTE LTEEEKDHQK FLNKIYQYYQ  
       160        170         
TFLWPEYLKT VYQYQKTMTP WNHIKRYF 
 
Figure 2.5. Amino acid sequence of mature camel αs2-CN with potential phosphorylation sites. Seryl and 
Threonyl residues matching the S/T-X-A motif are in red and blue, respectively, and underlined. Threonyl 
residues matching the S/T-X-X-A motif are in green and underlined 
 
2.5 Conclusions 
 In this study, six main findings combining proven proteomic and molecular biology 
approaches are provided. The first one is an enhancing of our knowledge of camel milk 
protein composition. The second one is deciphering the extreme complexity of camel CN 
fraction due to PTM (phosphorylation) and splicing events (exon skipping and cryptic splice 
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site usage). The third finding is the detection of two unknown proteins, UP1 and UP2 that 
remain to be characterized. In addition, we provide results substantiating the possible 
existence of a camel β-lactoglobulin. However, this result requires further investigation, 
currently in progress in the laboratory. Afterwards, we report for the first time the presence of 
αs2-CN-12P, and short isoforms of β-CN probably arising from proteolysis by plasmin, the 
natural protease of milk. The ultimate finding is the demonstration that genetic variants, 
which hitherto seemed specific to a species (β-CN A for Bactrian and β-CN B for dromedary), 
are in fact present in both dromedarius and bactrianus. 
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Abstract  
In a previous study on camel milk from Kazakhstan, we reported the occurrence of 
two unknown proteins (UP1 and UP2) with different levels of phosphorylation. Here we show 
that UP1 and UP2 are isoforms of camel αs2-CN (αs2-CNsv1 and αs2-CNsv2, respectively) 
arising from alternative splicing events. First described as a 178 amino-acids long protein 
carrying eight phosphate groups, the major camel αs2-CN isoform (called here αs2-CN) has a 
molecular mass of 21,906 Da. αs2-CNsv1, a rather frequent (35%) isoform displaying a higher 
molecular mass (+1,033 Da), is present at four phosphorylation levels (8P to 11P). Using 
cDNA-sequencing, αs2-CNsv1 was shown to be a variant arising from the splicing-in of an in-
frame 27-nucleotide sequence encoding the nonapeptide ENSKKTVDM, for which the 
presence at the genome level was confirmed. αs2-CNsv2, which appeared to be present at 8P 
to 12P, was shown to include an additional decapeptide (VKAYQIIPNL) revealed by LC-
MS/MS, encoded by a 3’-extension of exon 16. Since milk proteins represent a reservoir of 
biologically active peptides, the molecular diversity generated by differential splicing might 
increase its content. To evaluate this possibility, we searched for bioactive peptides encrypted 
in the different camel αs2-CN isoforms, using an in silico approach. Several peptides, 
putatively released from the C-terminal part of camel αs2-CN isoforms after in silico digestion 
by proteases from the digestive tract, were predicted to display anti-bacterial and 
antihypertensive activities.  
Key words: camel milk, protein, casein, polymorphism, post-translational modifications, 
bioactive peptides 
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3.1 Introduction 
Recently, combining different proteomic approaches, the complexity of camel milk 
proteins was resolved to provide a detailed characterization of fifty protein molecules 
belonging to the 9 main milk protein families, including caseins: κ-, αs2-, αs1- and β-CN and 
two unknown proteins (UP1 and UP2), exhibiting molecular masses around 23,000 Da 
(Ryskaliyeva et al., 2018). Since UP1 and UP2 co-eluted in RP-HPLC with αs-CN and 
displayed different phosphorylation levels, it was tempting to consider that these proteins 
could originate in CN. However, based on their molecular weight, UP1 and UP2 could be 
larger isoforms of αs2-CN or smaller isoforms of αs1-CN.  
However, the hypothesis of an additional casein in camel milk encoded by a 
supplementary gene could not be ruled out. Indeed, genes encoding CN are tightly linked on 
the same chromosome, BTA6 in cattle, CHI6 in goats (Hayes, Petit, Bouniol, & Popescu, 
1993; Threadgill & Womack, 1990) and HSA4 in humans (Menon, Chang, Jeffers, Jones, & 
Ham, 1992). The evolution of the CN gene cluster (Figure 3.1) is postulated to have occurred 
by a combination of successive intra- and inter-genic exon duplications (Groenen, Dijkhof, 
Verstege, & van der Poel, 1993; P. Martin, Cebo, & Miranda, 2013; Rijnkels, Elnitski, Miller, 
& Rosen, 2003). In some mammals, including horses, donkeys, rodents and rabbits, there are 
two αs2-CN encoding genes differentiating in size (CSN1S2-like or CSN1S2A and CSN1S2B), 
which may have arisen by a gene-duplication event that has occurred prior to the split of 
Eutherian mammalian species (Groenen et al., 1993). The second CSN1S2-like gene was lost 
in the Artiodactyla, including the camel, while further divergence occurred in both copies in 
the other species. In humans, there are also two CSN1S2 genes albeit no evidence of protein 
expression exists (Rijnkels et al., 2003).  
Alternative splicing is a process by which multiple mRNA isoforms are generated. It is 
a powerful means to extend protein diversity. Such a process which is another possibility to 
increase the number of molecular species has been frequently reported to occur, as far as 
caseins are concerned, especially αs-CN (Leroux, Mazure, & Martin, 1992; L. Ramunno et al., 
2001; Luigi Ramunno et al., 2005), without really knowing whether it is a fortuitous or a 
scheduled event to expand molecular diversity and functionality of milk proteins. To 
substantiate the hypothesis according to which UP1 and UP2 might originate in CN and more 
precisely in αs-CN, we undertook characterizing more precisely these proteins.  
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Figure 3.1. Evolution of the casein locus organization. Casein locus organization of human (Homo sapiens), 
horse (Equus caballus), mouse (Mus musculus), cattle (Bos taurus), pig (Sus scrofa) and camel (Camelus 
dromedarius) genomes (adapted from Martin, Cebo and Miranda (2013) and Lefèvre et al.(2009) with additional 
genomic information from the NCBI) was compared. Genes are given as colored arrow boxes, showing the 
orientation of transcription. Putative genes based on similarity are indicated as empty boxes. Intergenic region 
sizes are given in kb.      
   
In addition to their nutritional value, an increasing number of therapeutic effects and a 
variety of potential activities (Marcone, Belton, & Fitzgerald, 2017; Mohanty, Mohapatra, 
Misra, & Sahu, 2016) are attributed to milk proteins as well as to milk-derived bioactive 
peptides encrypted in milk protein sequences Meisel, 2004). Caseins, and especially αs-CN, 
have been shown to be a reservoir of bioactive peptides (Clare & Swaisgood, 2000; Farrell, 
Malin, Brown, & Mora-Gutierrez, 2009; Meisel, 2004), it is therefore legitimate to wonder 
whether these so far unknown and putatively derived αs-CN sequences could be responsible 
for the occurrence of novel bioactive peptides accounting for the original properties of camel 
milk. Recent studies have indeed shown that healing properties assigned to camel milk, which 
is consumed fresh or fermented and traditionally used for the treatment of tuberculosis, 
gastroenteritis, and allergies, in many countries, are proved (Mati et al., 2017). Whereas there 
is a substantial literature on bioactive peptides derived from bovine milk proteins (Meisel, 
2004) and more or less comprehensive databases of milk bioactive peptides exist (Kumar et 
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al., 2015; Minkiewicz, Dziuba, Iwaniak, Dziuba, & Darewicz, 2008; Nielsen, Beverly, Qu, & 
Dallas, 2017; Théolier, Fliss, Jean, & Hammami, 2014), studies aiming at identifying peptides 
derived from camel milk proteins having potential health-promoting activities are scarce. 
Investigations mainly focused on caseins (αs1-, β- and κ-CN), and data available to date 
mostly concern in vitro and in silico antioxidant, antihypertensive and antimicrobial activities 
(Erhardt et al., 2016; Mati et al., 2017). Therefore, using an in silico approach, we searched 
for potential biological activities of sequences generated from alternative splicing of primary 
transcript encoding αs-CN.  
3.2 Methods 
3.2.1 Ethics Statements  
All animal studies were carried out in compliance with European Community 
regulations on animal experimentation (European Communities Council Directive 
86/609/EEC) and with the authorization of the Kazakh Ministry of Agriculture. Milk 
sampling was supervised by a veterinarian accredited by the French Ethics National 
Committee for Experimentation on Living Animals.  
3.2.2 Milk Sample Collection and Preparation 
Raw milk samples were collected during morning milking on healthy dairy camels 
belonging to two species: C. bactrianus (n=72) and C. dromedarius (n=65), and hybrids 
(n=42) at different lactation stages, ranging between 30 and 90 days postpartum. Camels 
grazed on four various natural pastures from different regions of Kazakhstan, namely Almaty 
(AL), Shymkent (SH), Kyzylorda (KZ), and Atyrau (ZKO). Whole-milk samples were 
centrifuged at 3,000 g for 30 min at 4oC (Allegra X-15R, Beckman Coulter, France) to 
separate fat from skimmed milk. Samples were quickly frozen and stored at -80°C (fat) and -
20°C (skimmed milk) until analysis. 
3.2.3 Selection of Milk Samples  
Thirty milk samples: C. bactrianus (n=10), C. dromedarius (n=10), and hybrids 
(n=10)) were selected for LC-ESI-MS analysis from the 179 camel milks collected in a 
previous study (Ryskaliyeva et al., 2018), based on lactation stages and number of parities 
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(from 2 to 14). The most representative eight milk samples (C. bactrianus, n=3, C. 
dromedarius, n=3, and hybrids, n=2) were analyzed by LC-MS/MS (LTQ-Orbitrap 
Discovery, Thermo Fisher Scientific) after a tryptic digestion of bands, excised from each 
track, between 20 and 30 kDa of SDS-PAGE.  
3.2.4 RNA Extraction from Milk Fat Globules 
Total RNA was extracted from MFG using TRIzol® and TRIzol® LS solutions 
(Invitrogen, Life Technologies), respectively, according to the original manufacturer’s 
protocol modified as described by Brenaut et al. (2012).  
3.2.5 First-Strand cDNA Synthesis and PCR Amplification 
First-strand cDNA was synthesized from 5 to 10 ng of total RNA primed with 
oligo(dT)20 and random primers (3:1, vol/vol) using Superscript III reverse transcriptase 
(Invitrogen Life Technologies Inc., Carlsbad, CA) as described previously (Ryskaliyeva et al., 
2018). Primer pairs, purchased from Eurofins (Eurofins genomics, Germany), were designed 
using published Camelus nucleic acid sequences (NCBI, NM_001303566.1 for αs1-CN and 
NM_001303561.1 for αs2-CN). The forward primers for αs1-CN and αs2-CN amplification 
were 5’-CTTACCTGCCTTGTGGCTGT-3’ (starting from nucleotide 61, located in exon 2 of 
αs1-CN mRNA) and 5’-TCATTTTTACCTGCCTTTTGGCTGT-3’ (starting from nucleotide 
71, located in exon 2 of αs2-CN mRNA), respectively. The reverse primers were 5’-
GTGGAGGAGAAATTTAGAGCAT-3’ (terminating at nucleotide 751 of αs1-CN mRNA 
located in the last exon) and 5’-CGATTTTCCAGTTGAGCCATA-3’ (terminating at 
nucleotide 692 of αs2-CN mRNA located in the last exon), respectively. Thus, the amplified 
fragments cover regions of 691 nucleotides for αs1-CN and 622 nucleotides for αs2-CN, 
including the sequence coding the mature proteins, with genomic reference to the published 
sequences (NCBI, NM_001303566.1 for αs1-CN and NM_001303561.1 for αs2-CN). Five 
(two C. bactrianus, one C. dromedarius, and two hybrids) samples representative of the 30 
camel milks analyzed in LC-MS, were selected for amplification of αs1-CN and αs2-CN cDNA 
by RT-PCR and sequencing. Amplicons were sequenced from both strands with primers used 
for PCR according to the Sanger method by Eurofins (Eurofins genomics, Germany).  
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3.2.6 Identification of proteins and validation of peptides by LC-
MS/MS Analysis 
In order to identify the different αs1-CN and αs2-CN isoforms, mono dimensional 
electrophoresis (1D SDS-PAGE), followed by trypsin digestion and LC-MS/MS analysis, was 
used. After a long migration (10 cm) in 1D SDS-PAGE, bands (1.5 mm3) migrating in the 
range of 20-30 kDa, were cut on each of the eight gel lanes, and analyzed as described by 
Henry et al. (2015) and Saadaoui et al. (2014).  
3.2.7 LC-ESI-MS 
Fractionation of camel milk proteins and determination of their molecular masses were 
performed by coupling RP-HPLC to ESI-MS (micrOTOFTM II focus ESI-TOF mass 
spectrometer; Bruker Daltonics). Twenty µL of skimmed milk samples were clarified by 
addition of 230 µL of clarification solution 0.1 M bis-Tris buffer pH 8.0, containing 8 M urea, 
1.3% trisodium citrate, and 0.3% DTT. Clarified milk samples (25 µL) were directly injected 
onto a Biodiscovery C5 reverse phase column (300 Å pore size, 3µm, 150x2.1mm; Supelco, 
France) and analyzed as described by Miranda et al. (2004).  
3.2.8 In silico release of Peptides using PeptideCutter and 
BIOPEP analyses 
Protein sequences of αs2-CN from Bos taurus (entry P02663), Lama glama (entry 
A0A0D6DR01) and Camelus dromedarius (entry O97944 and new sequences identified in the 
present study) were selected from the Protein Knowledge Base (UniProtKB, ExPASy 
Bioinformatics Resource Portal) available at www.uniprot.org. Each sequence was then 
subjected to in silico release of peptides by pepsin (pH 1.3), pepsin+trypsin and 
pepsin+trypsin+chymotrypsin using “PeptideCutter”, a resource available at www.expasy.org. 
Thereafter, each αs2-CN sequence was entered in the “PeptideCutter”. After cutting the 
sequences, a list of probable peptides with cleavage sites, length and amino acid sequence of 
peptides was established. BIOPEP analyses were then performed at 
https://omictools.com/biopep-tool  by selecting the available option “Peptide Prediction 
Software Tools”. Peptide Structure Prediction/AHTpin (Kumar et al., 2015) and 
Antimicrobial Peptide Prediction/ Antimicrobial Peptide Scanner (Veltri, Kamath, & Shehu, 
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2018) (AMP Scanner Vr.2) sections were used one by one for prediction of the peptides with 
the sought properties. 
3.3 Results and Discussion 
3.3.1 What gene(s) do UP1 and UP2 arise from?  
The mass accuracy has allowed distinguishing about fifty protein molecules 
corresponding to isoforms of 9 protein families (κ-CN, WAP, αs1-CN, α-LAC, αs2-CN, PGRP, 
LPO/CSA, β-CN and γ2-CN) from LC-MS analysis as shown in Figure 3.2. The presence of 
two unknown proteins UP1 and UP2 with different phosphorylation levels was reported in our 
previous study8. Regarding UP1, molecular masses ranged between 22,939 and 23,179 Da, 
whereas UP2 masses ranged between 23,046 Da and 23,366 Da (Table 3.1), with successive 
increments of 80 Da (mass of one phosphate group). The eluting range of these two proteins 
was between 28.53-37.16 min, within the elution times of αs1- and αs2-CN, which confirms 
our first hypothesis about their αs-CN origin. However, UP1 and UP2 masses exceeded the 
observed mass of the major isoform of αs2-CN with 8P (21,906 Da) by 1,033 Da and 1,300 
Da, respectively, and were lighter than the C variant of αs1-CN-6P (25,773 Da) by 2,834 Da 
and 2,567 Da, respectively (Ryskaliyeva et al., 2018). Even though it was not possible to 
exclude a splicing event leading to the inclusion of an additional exon sequence in the αs2-CN 
mRNA, the most probable hypothesis was the occurrence of exon-skipping event(s) affecting 
αs1-CN mRNA and, leading to the loss of a peptide sequence accounting for a reduction of at 
least 2,567 Da. A possible scenario was the skipping of exon 3 on the short isoform of αs1-CN 
C already impacted by a cryptic splice site usage (∆CAG encoding Q83). The molecular mass 
of the protein proceeding from such a messenger (23,205 Da) corresponded to the mass of 
UP2 +160 Da (23,206 Da). However, sequencing cDNA encoding αs1-CN isoforms failed to 
reveal the existence of a messenger in which exon 3 was lacking. Therefore, the alternative 
possibility, in other words the αs2-CN avenue, had to be explored.   
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Figure 3.2. LC-ESI-MS profile of dromedary milk proteins. The chromatogram displays the presence of 15 
major milk protein fractions labeled from I to XV, with retention times from 4.50 to 48.71 min, respectively. 
Deconvolution of multicharged ions spectra with emphasis on phosphorylation degrees (P) of two unknown 
proteins (UP1 and UP2) which are related to chromatographic peaks VI and VII, X and XI respectively.  
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Table 3.1. Analysis of molecular masses contained in peaks V-XI of dromedary milk sample from the Shymkent 
region  
Peak Ret.Time, min 
Observed 
Mr, Da 
Theoretical 
Mr, Da 
Protein description UniProt accession Intensity 
V 26,31 24,547 24,547 αs1-CN C -short isoform (∆ex 16), 5P, splice variant (∆Q83)   3,954 
24,561 24,561 αs1-CN A - short isoform (∆ex 16), 5P, splice variant (∆Q83)  4,385 
24,627 24,627 αs1-CN C - short isoform (∆ex 16), 6P, splice variant (∆Q83)  16,348 
24,640 24,641 αs1-CN A - short isoform (∆ex 16), 6P, splice variant (∆Q83)  17,422 
24,675 24,675 αs1-CN C - short isoform (∆ex 16), 5P  7,758 
24,689 24,689 αs1-CN A - short isoform (∆ex 16), 5P  8,004 
24,722 24,721 αs1-CN A - short isoform (∆ex 16), 7P, splice variant (∆Q83)  4,453 
24,755 24,755 αs1-CN C - short isoform (∆ex 16), 6P K7DXB9 34,653 
24,768 24,769 αs1-CN A - short isoform (∆ex 16), 6P O97943-2 37,452 
24,835 24,835 αs1-CN C - short isoform (∆ex 16), 7P  5,026 
24,849 24,849 αs1-CN A - short isoform (∆ex 16), 7P  4,851 
VI 28.80 14,430 14,430 α-LAC P00710 12,948 
22,939 n/a* UP1  n/a 2,676 
23,019 n/a UP1, +80 Da   2,408 
23,099 n/a UP1, +160 Da   958 
25,645 25,645 αs1-CN C, 6P, splice variant (∆Q83)  1,736 
25,659 25,659 αs1-CN A, 6P, splice variant (∆Q83)  1,057 
25,693 25,693 αs1-CN C, 5P  916 
25,772 25,773 αs1-CN C, 6P  5,014 
25,787 25,787 αs1-CN A, 6P O97943-1 1,509 
VII 30.07 21,826 21,825 αs2-CN, 7P  709 
21,906 21,905 αs2-CN, 8P O97944 4,222 
21,985 21,986 αs2-CN, 9P  289 
23,179 n/a UP1, +240 Da  1,430 
VIII 31.26 21,986 21,985 αs2-CN, 9P  O97944 866 
22,066 22,065 αs2-CN, 10P  3,682 
IX 33.04 22,066 22,065 αs2-CN, 10P   120 
22,146 22,145 αs2-CN, 11P 1,408 
X 34.85 22,226 22,225 αs2-CN, 12P  806 
23,046 n/a UP2 n/a 295 
XI 37.15 19,143 19,143 PGRP Q9GK12 3,659 
23,126 n/a UP2, +80 Da   150 
23,206 n/a UP2, +160 Da  1,162 
23,286 n/a UP2, +240 Da  940 
 
n/a - not applicable 
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3.3.2 UP1 and UP2: new camel αs2-CN splicing variants  
Amplification of camel αs2-CN cDNA revealed the presence of a major PCR fragment 
(ca. 620 bp) and several minor PCR products differing in size between ca. 670 bp and 710 bp 
(supplementary data S1). Sequencing of PCR fragments generated two different nucleotide 
sequences: first identical from the forward primer to nucleotide 359, and then overlapping and 
shifted by 27 nucleotides (Figure 3.3). The main sequence corresponded to the 193-aa αs2-CN 
(including the signal peptide) reported by Kappeler et al. (1998). The second sequence, with 
weaker signals, showed the insertion of the following sequence: GAA AAT TCA AAA AAG 
ACT GTT GAT ATG, between exons 12’ and 14. Thus, this insertion introduced an 
additional peptide sequence (ENSKKTVDM), identical to the aa sequence encoded by exon 
13 in the bovine CSN1S2 gene (Figure 3.4). The level of exon 13 conservation in both species 
appeared to be extremely high. This exon is also present in the predicted sequence of the 
CSN1S2 gene from the Camelus ferus genome (NCBI Reference Sequence: XP_014418048.1) 
and the lama gene transcript (GenBank: LK999989.1) with two point mutations. The first 
mutation concerning the fourth codon (AAA=>AAT) is silent and the second one, that is a 
missense mutation, regards the last codon (ACG => ATG), leading to T => M substitution 
(Pauciullo & Erhardt, 2015). Exon 13 is present in one of the two copies of the CSN1S2 gene 
of most mammalian species. In mice, rats and rabbits the aa sequence encoded by this exon is 
present in CSN1S2-like or CSN1S2A) protein but not in CSN1S2B (Rijnkels, 2002). The 
insertion of this sequence leads to the increasing of the molecular mass of αs2-CN by 1,033 
Da, exactly the mass difference observed between αs2-CN-8P and UP1. 
 
Figure 3.3 Sequence of C. dromedarius αs2-CN cDNA spanning exons 14 and 15 (main sequence). A secondary 
sequence (*) identified by manual reading of overlapping weak signals is given below the main sequence, 
showing the existence of transcripts, in which exon 13 is included. The corresponding aa sequence is given 
below. cDNA sequences encoding CSN1S2sv1 were submitted to NCBI Genbank with the following submission 
IDs: BankIt2160486 Seq1 MK077758 (C. bactrianus) and BankIt2160533 Seq1 MK077759 (C. dromedarius).    
G A A  A A T  T C A A A A  A A G  A C T G T T G A T A T G  G A A T C A  A C A G A A  G T A T T C A C T A A G
E    N    S   K    K    T    V    D    M    E   S    T    E    V   F    T    K    
Exon	  13 Exon	  14
Exon	  14	  (ESTEVFTK) Exon	  15	  (KTELTEEEK…)
*
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Figure 3.4. Multiple alignment of αs2-CN protein sequences from different Artiodactyls species. Bos taurus 
(M16644), C. dromedarius (O97944 and splicing variants identified in the present study), Lama glama 
(A0A0D6DR01), and Sus scrofa (X54975) protein sequences are compared. Camel αs2-CN putative isoform (αs2-
CNsv3) comprising both additional sequences, encoded by exon 13 and exon16 extension, is in grey. Sequences 
are split into blocks of amino acid residues to visualize the exon modular structure of the protein as deduced 
from known splice junctions of the bovine gene (Koczan, Hobom, & Seyfert, 1991). Exon numbering (top of 
blocks) is that of the bovine gene taken as reference for Artiodactyls. Amino-acid sequences characterizing UP1 
(αs2-CNsv1) and UP2 (αs2-CNsv2) encoded by exon 13 and the extension of exon 16, respectively, are given in 
blue. Italics indicate the signal peptides, for which the vertical blue arrow points out the cleavage site. Dashes 
indicate missing aa residues. Amino acid mutations distinguishing camel and lama αs2-CN are in fuchsia. The 
highest sequence antimicrobial peptide density is indicated by red on a heat map above the bovine protein 
sequence. The regions of  Bioactive peptides encrypted in bovine αs2-CN f(150-188) with antibacterial activities 
reported by Zucht et al. (1995) are highlighted in yellow, while two antibacterial domains f(164-179) and f(183-
207) described by Recio and Visser (1999) are indicated in red. Amino acid residues increasing significantly 
antibacterial potency are in green. Full-length mature CSN1S2sv1 and CSN1S2sv2 aa sequences were submitted 
to Expasy UniProtKB database as splicing variants of C. dromedarius CSN1S2 with the following submission 
IDs: SPIN200013828 and SPIN200013835, respectively. 
 
 
EXON 2 EXON 3    EXON 4       EXON 5        EXON 6    EXON 7
BOVINE   MKFFIFTCLLAVALA KN  TMEHVSSSE  ESI-ISQE  TYKQEKNMAINPSK  ENLCSTFCK  EVVRNANEE 50  
LAMA        MKFFIFTCLLAVALA KH  EMDQGSSSE  ESINVSQQ  KLKQVKKVAIHPSK  EDICSTFCE  EAVRNIKEV  51
CAMEL       MKFFIFTCLLAVVLA KH  EMDQGSSSE  ESINVSQQ  KFKQVKKVAIHPSK  EDICSTFCE  EAVRNIKEV  51 
CAMEL SV1 MKFFIFTCLLAVVLA KH  EMDQGSSSE  ESINVSQQ  KFKQVKKVAIHPSK  EDICSTFCE  EAVRNIKEV  51 
CAMEL SV2 MKFFIFTCLLAVVLA KH  EMDQGSSSE  ESINVSQQ  KFKQVKKVAIHPSK  EDICSTFCE  EAVRNIKEV  51 
CAMEL SV3   MKFFIFTCLLAVVLA KH  EMDQGSSSE  ESINVSQQ  KFKQVKKVAIHPSK  EDICSTFCE  EAVRNIKEV 51
PIG         MKFFIFTCLLAVAFA KH  EMEHVSSSE  ESINISQE  KYKQEKNVINHPSK  EDICATSCE  EAVRNIKEV 51
EXON 8    EXON 9       EXON 10              EXON 11
BOVINE   EYSIGSSSE  ESAEVATE  EVKITVDDKHYQKAL  NEINQFYQK--FPQYLQYLYQGPIVLNPWDQVKRNAVPITPTL  123
LAMA        --------- ESVEVPTE  --------------- NKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTMVYPFIPTV  102
CAMEL --------- ESAEVPTE  --------------- NKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTRAYPFIPTV  102
CAMEL SV1   --------- ESAEVPTE  --------------- NKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTRAYPFIPTV  102
CAMEL SV2   --------- ESAEVPTE  --------------- NKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTRAYPFIPTV  102
CAMEL SV3 --------- ESAEVPTE  --------------- NKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTRAYPFIPTV  102
PIG         GYASSSSSE  ESVDIPAE  NVKVTVEDKHYLKQL  EKISQFYQK--FPQYLQALYQAQIVMNPWDQTKTSAYPFIPTV  124
EXON 12    EXON 12’  EXON 13   EXON 14      EXON 15
BOVINE --NREQLSTSE  -------- ENSKKTVDM  ESTEVFTK  KTKLTEEEKNRLNFL 164 
LAMA        --NTEQLSISE  ESTEVPTE  ENSKKTVDT  ESTEVFTK  KTELTEEEKDHQKFL  151
CAMEL       --NTEQLSISE  ESTEVPTE  --------- ESTEVFTK  KTELTEEEKDHQKFL  146 
CAMEL SV1   --NTEQLSISE  ESTEVPTE  ENSKKTVDM ESTEVFTK  KTELTEEEKDHQKFL  151 
CAMEL SV2   --NTEQLSISE  ESTEVPTE  --------- ESTEVFTK  KTELTEEEKDHQKFL  142 
CAMEL SV3   --NTEQLSISE  ESTEVPTE  ENSKKTVDM  ESTEVFTK  KTELTEEEKDHQKFL 151 
PIG         IQSGEELSTSE  EPVSSSQE  ENT-KTVDM  ESMEEFTK  KTELTEEEKNRIKFL 174     
EXON 16                 EXON 17 
BOVINE KKISQRYQKFALPQYLKTVYQHQKAMKPWIQPKTKV---IPYV RYL 207
LAMA        NKIYQYYQTFLWPEYLKTVYQYQKTMTPWNHIK---------- RYF  187
CAMEL NKIYQYYQTFLWPEYLKTVYQYQKTMTPWNHIK---------- RYF  178
CAMEL SV1   NKIYQYYQTFLWPEYLKTVYQYQKTMTPWNHIK---------- RYF  187
CAMEL SV2   NKIYQYYQTFLWPEYLKTVYQYKQTMTPWNHIKVKAYQIIPNL RYF  188
CAMEL SV3 NKIYQYYQTFLWPEYLKTVYQYQKTMTPWNHIKVKAYQIIPNL  RYF  197
PIG         NKIKQYYQKFTWPQYIKTVHQKQKAMKPWNHIKTNSYQIIPNL  RYF  220
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A deep and comprehensive analysis of the dromedary camel CSN1S2 gene sequence 
available in GenBank (gi|742343530|ref|NW_011591251.1|), overlaying exon 12’ 
(ESTEVPTE) to exon 14 (ESTEVFTK) allowed identifying a 27-nucleotide sequence 
corresponding to exon 13 (Figure 3.5). This sequence is flanked with consensus splice sites at 
the beginning (GTG/AAG) and end (polypyrimidine tract followed by XAG) of intron 
sequences. Therefore, this exon is included or not during the course of camel αs2-CN pre-
mRNA processing. This is possibly due to the weakness (presence of purine in the 
polypyrimidine tract at the 3’-end of the upstream intron) of the acceptor splice sequence. The 
short transcript (without exon 13) encodes the 193 aa residues (including the signal peptide) 
described by Kappeler et al.(1998) and the long transcript (with exon 13) codes for UP1 (202 
aa including signal peptide). The mature protein corresponding to UP1 is named thereafter 
αs2-CNsv1.  
To confirm such an additional exon 13 hypothesis, detection of αs2-CN peptides after 
trypsin action was performed using liquid chromatography coupled to tandem mass 
spectrometry (LC-MS/MS). A tryptic peptide composed of 12 aa residues TVDMESTEVFTK 
(Figure 3.6), identified through the Bubalus bubalis αs2-CN sequence (UniProt KB accession 
number E9NZN2), was attributed to two coherent arranged sequences (ENSKKTVDM and 
ESTEVFTK) encoded by exons 13 and 14, respectively. The sequence is identical to that of 
the Bos taurus (UniProt KB accession number P02663). The presence of a TVDM peptide 
sequence confirmed the existence of transcripts having included exon 13 during the course of 
pre-mRNA processing. Therefore, the existence of an exon 13 alternatively spliced in the 
camel CSN1S2 gene was successfully confirmed both at the protein (LC-MS and LC-MS/MS) 
and at the nucleotide (cDNA sequencing and genome data) levels. The same cDNA sequences 
encoding αs2-CN with and without a 27-nucleotide additional sequence (exon 13) were found 
in all individual samples analyzed, including C. bactrianus, C. dromedarius, and hybrids. 
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Figure 3.5. Nucleotide sequence view (from 417151 to 413731) of C. dromedarius (breed Arabia) taken from 
the unplaced genomic scaffold of CSN1S2 (LOC105090951). Already known exons 12’, 14, 15 and 16 are given 
in black, and additional exon 13 and extension of 30 additional nucleotides of exon 16 are in red. Exon 
subdivisions are boxed with amino acid sequences beneath. Intron donor and acceptor splice sites are underlined. 
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Figure 3.6. Identification and characterization of UP1 and UP2 as splicing variants of αs2-CN by LC-MS/MS 
analysis. A. Camel αs2-CN full-length sequence  is given and its coverage (81%) from peptides identified by LC-
MS/MS analysis is in bold. Blue arrows indicate a cleavage of camel αs2-CN by trypsin. Tryptic peptides 
indicating the presence of exon 13 and extension of exon 16 are in red. Camel αs2-CN peptide sequences encoded 
by exon 13 and by the extension of exon 16 matching with Bubalus bubalis (UniProt KB accession number 
E9NZN2) and Sus scrofa (UniProt KB accession number P39036) are framed. The signal peptide is in italics and 
in grey. B. Validation of the additional peptide sequence (AYQIIPNLR) with five and three ions from the “y” 
(including y7 double charged: y++7) and “b” series, respectively.  
 
 Concerning the second unknown protein detected (UP2) that showed molecular 
masses comprised between 23,046 Da and 23,286 Da with n and n+3 phosphate groups, in 
LC-ESI-MS, the mass difference observed was 1,140 Da, relative to the 8P-11P αs2-CN 
protein reported by Kappeler and co-workers (1998). LC-MS/MS analysis revealed the 
occurrence of a 9 aa-long peptide (AYQIIPNLR) matching with the C-terminal sequence of 
Sus scrofa αs2-CN (NP_001004030.1), strongly suggesting that mRNA described by Kappeler 
et al. (1998) was in fact the result of a cryptic splice site usage occurring in the 
antepenultimate exon of the camel CSN1S2 gene (Figure 3.6).  
 Examination of intron sequence downstream of exon 16 (Figure 3.5) highlighted a 30-
nucleotide segment: GTA AAA GCT TAC CAA ATT ATT CCC AAT TTG encoding 10 aa 
3.6.A
3.6.B
A	  	  	  	  Y	  	  	  	  Q	  	  	  	  I	  	  	  	  I	  	  	  	  P	  	  	  	  N	  	  	  	  L	  	  	  	  R	  
b3 b4 b5
y4y5y6 y2y++7
MKFFIFTCLLAVVLAKHEMDQGSSSEESINVSQQKFKQVKKVAIHPSKEDICSTFCEEAVRNI
KEVESAEVPTENKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTRAYPFIPTVNTEQLSISE
ESTEVPTEENSKKTVDMESTEVFTKKTELTEEEKDHQKFLNKIYQYYQTFLWPEYLKTVYQYQ
ENSKKTVDM (Bubalus bubalis)
KTMTPWNHIKVKAYQIIPNLRYF
TNSYQIIPNL (Sus scrofa)
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residues (VKAYQIIPNL). The intron donor splice site following the previously considered 
ending sequence of exon 16 CACATCAAG│GTAAA was recognized by the spliceosome 
machinery to generate the protein described by Kappeler et al. (1998). Alternatively, a second 
downstream intron donor splice site (CCC AAT TTG│GTGAG), which also fulfils all 
requirements of a splicing recognition signal, may also be used as well (Figure 3.5). As a 
result, this alternative splicing event is responsible for the occurrence of two mature peptide 
chains, the first one made of 178 aa residues (21,906 Da with 8P), and the second one 10 aa 
residues longer (23,046 Da with 8P). The mature protein corresponding to UP2 is named 
thereafter αs2-CNsv2. Interestingly, the 10 aa residue peptide (VKAYQIIPNL) included in the 
C-terminal part of the camel protein due to this alternative splicing event was highly similar 
with the porcine (TNSYQIIPNL) and donkey (TNSYQIIPVL) αs2-CN sequences. Recently a 
shorter αs2-CN isoform, in which a deletion of the heptapeptide YQIIPVL, was reported in 
donkey milk (Cunsolo et al., 2017; Saletti et al., 2012). 
3.3.3 Cross-species comparison of the gene encoding αs2-CN and 
primary transcript maturation  
Comparative analysis of camel CSN1S2 gene organization with orthologous bovine 
and pig genes is illustrated in Figure 3.7. The first camel αs2-CN sequence published by 
Kappeler et al. (1998) lacks three peptide sequences encoded in cattle by exons 8 
(EYSIGSSSE), 10 (EVKITVDDKHYQKAL), and 13 (ENSKKTVDM) composed of 27, 45 
and 27 nucleotides, respectively. By contrast, exon 12’ that encodes in camel and lama a 
peptide of 8 aa residues (ESTEVPTE), was believed to be missing in the bovine counterpart, 
while it was present in the porcine genome, coding for the EPVSSSQE peptide. Surprisingly, 
we succeed in finding a putative exon 12’, encoding the octapeptide VSANSSQE, in intron 12 
of the bovine gene. However, the downstream GTAAG donor splice site flanking this putative 
exon 12’ is mutated in GCAAG, apparently preventing its recognition as such as an exon. On 
the other hand, we failed to find a putative exon 8 in intron 7 of the camel gene. Exon 10 is 
present both in bovine and pig CSN1S2 genes. In addition, it is also present in intron 9 of the 
camel gene, being 9 nucleotides longer than in the other species (Figure 3.7), and bounded 
upstream and downstream by canonical intron consensus sequences. However, even though it 
seems to be perfectly eligible for splicing, we did not find any transcript nucleotide sequence, 
nor tryptic peptides at the protein level, signing its presence in multiple mRNA encoding αs2-
CN. By contrast, as demonstrated in the present study, exon 13 was actually present in some 
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camel CSN1S2 transcripts, as well as the peptide sequence it is coding for in isoform αs2-
CNsv1. Finally, the camel CSN1S2 gene, just as its lama counterpart (Pauciullo & Erhardt, 
2015), is made up of at least 17 exons, since we have no objective demonstration of the usage 
of exon 10, whereas its bovine and porcine counterparts are made up of 18 and 19 exons, 
respectively. Since a further exon sequence (exon 7’) occurs in the Equidaes CSN1S2B gene 
(not in CSN1S2-like A), we can hypothesize that the CSN1S2 gene can comprise up to 20 
exons with different combinatory splicing schemes across species. Interestingly, sequence 
alignments revealed that within the bovine intron 7, as well as in camels and pigs, the 
sequence corresponding to horse and donkey exon 7’ is partially deleted.     
Genomic and mRNA analyses carried out previously demonstrated that deletions of aa 
residues in CN across species occurred essentially by exon skipping during the processing of 
the primary transcripts (Johnsen, Rasmussen, Petersen, & Berglund, 1995; Leroux et al., 
1992; P. Martin et al., 2013; Patrice Martin & Leroux, 1992; Matéos et al., 2009; Pauciullo & 
Erhardt, 2015). This event, leading to a shortening of the peptide chain length, is caused by 
weaknesses in the consensus sequences, either at the 5’ and/or 3’ splice junctions or at the 
branch point, or both (P. Martin et al., 2013). Therefore, alternative splicing has to be 
regarded as a frequent event, mainly in αs-CN encoding genes, for which the coding region is 
divided into many short exons. Usage of cryptic splice sites is also responsible for the 
occurrence of multiple transcripts and finally for generating a protein molecular diversity. For 
example, the peptide sequence (VKAYQIIPNL) encoded by the “extension” of 30 nucleotides 
at the 3’ end of exon 16, not previously detected in camel nor in lama αs2-CN, was shown here 
to be alternatively included in camel CSN1S2 transcripts. Extending the comparison to other 
species including ruminants, pigs and Equidaes, we show that the true donor splice site 
(GTGAG…) defining the end of exon 16 and common to the considered species (Figure 3.8), 
is located 30 nt downstream of that preferentially used in Camelidaes. In other words, the 
isoform corresponding to UP2/αs2-CNsv2 is the genuine protein, whereas the isoform first 
described (Kappeler et al., 1998) corresponds to the protein arising from the usage of a cryptic 
splice site internal to an exon. 
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Figure 3.7. Structural organization of the bovine, porcine and camel CSN1S2 transcription units and splicing 
patterns for camel (CSN1S2, CSN1S2sv1 and CSN1S2sv2). CSN1S2 corresponds to the splicing pattern 
characterized by Kappeler et al. (1998). Solid bars represent introns, and exons are depicted by blocks: 5’ UTR 
and noncoding sequence are given in pink, leader peptide and coding frame are in black, exons absent from the 
camel protein are in green, exons absent from the bovine protein are in blue, exons found in our study are in red, 
and 3’ UTR in white. Exons and exon sequences present in bovine and porcine CSN1S2 but which were absent 
from the camel until now are highlighted in green, while exons present in the camel and pig are in blue. Exon 13 
and the extension of exon 16 identified in this study are in red. Exon numbering (referring to bovine) and sizes 
(in bp) are indicated at the top, and at the bottom of the structures, respectively.  
 
The combination of both splicing events such as exon skipping and cryptic splice site 
usage generates more transcript isoforms in the same species and is responsible for the 
differences across species in the aa sequences of αs2-CN. However, regarding αs2-CN in 
camels we were not able to detect any transcript in which both exon 13 and the extension of 
exon 16 were present (αs2-CNsv3). That does not mean that this structure does not exist, even 
though the protein corresponding to both events was not detected in LC-MS profiling. 
Therefore, given that such an isoform is putatively present at a very low level, cloning PCR 
fragments and screening of a significant number of clones should probably make it possible to 
identify such a transcript.    
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Figure 3.8. Alignment of nucleotide sequences of exon 16 3’-end and downstream intron across nine species. 
Accession numbers of different species are: camel (NCBI Gene ID: 105090951), pig (NCBI Gene ID: 445515), 
donkey (NCBI Gene ID: 106835119), horse (NCBI Gene ID: 100327035), rabbit (NCBI Gene ID: 100009288), 
bovine (NCBI Gene ID: 282209), goat (NCBI Gene ID: 100861229), sheep (NCBI Gene ID: 443383), and 
buffalo (NCBI Gene ID: 102395699). Exon sequences are in bold, intron sequences are in italics. Perfectly 
conserved nucleotides are dark-grey shaded. Nucleotides identical in more than eight animal species are light-
grey shaded. Dashes in ruminants indicate missing nucleotides that are highlighted in yellow in the other species. 
The dinucleotide GT, highlighted in green in the camel sequence, generates the preferential site of splicing 
occurring within exon 16 that leads to the main αs2-CN isoform first described by Kappeler et al. (1998).   
    
3.3.4 Phosphorylation level enhances camel αs2-CN isoform 
complexity  
The non-phosphorylated peptide chain of the mature αs2-CN protein, which comprises 
178 aa residues, yields a molecular weight of 21,266 Da (Kappeler et al., 1998). Compared 
with other Ca-sensitive CNs, αs2-CN is the most phosphorylated with 12 potential 
phosphorylation sites and it is therefore likely to be the major transporter of Ca-phosphate.  
 Structural characterization of the αs2-CN fraction and relevant mRNA analyses has 
demonstrated that camel αs2-CN should be theoretically present in milk as a mixture of at least 
18 isoforms derived from three mature peptide chains comprising 178 (αs2-CN), 187 (αs2-
CNsv1, UP1) and 188 (αs2-CNsv2, UP2) aa residues originating from alternative splicing 
phenomena (Figure 3.4). Each splicing variant should display six phosphorylation levels 
ranging between 7 and 12 P groups. Based on LC-ESI-MS data, we identified 14 
phosphorylation isoforms. Surprisingly, even though an additional peptide sequence does not 
provide further phosphorylation sites, the predominant phosphorylation level of each peptide 
	  	  	   	   	  	  	  	  exon	  16	   	   	   	   	   	   intron	  
camel      …GTAAAAGCTTACCAAATTATTCCCAATTTG  GTGAGTTCTAC 
pig        …ACAAACAGTTACCAAATTATCCCCAATTTG  GTGAGTTCTTC 
donkey     …ACAAATTCTTACCAAATTATCCCCGTTCTG  GTGAGTTCTCC 
horse      …ACAAATTCTTACCAAATTATCCCTGTTCTG  GTGAGTTCTCC 
rabbit     …ACAATTATTTACCAAAGTGTGCCCACTCTG  GTGAGTACTCT 
bovine     …ACAAAGGT---------TATTCCCTATGTG  GTGAGTTCTCC 
goat       …ACAAATGC---------TATTCCCTATGTG  GTGAGTTCTCC 
sheep      …ACAAACGC---------TATTCCCTATGTG  GTGAGTTCTCC 
buffalo    …ACAAACGT---------TATTCCCTATGTG  GTGAGTTCTCC 
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isoform was not the same: 8P for αs2-CN, 8P for αs2-CNsv1, and 10P for αs2-CNsv2. The 
addition of 10 aa residues in the C-terminal part of αs2-CNsv2 might induce conformational 
changes in the protein facilitating the modification of definite phosphorylable sites. Multiple 
non-allelic variants produced from at least three different mRNA were shown to occur in all 
thirty Kazakh individuals analyzed, apparently indicating a stabilized mechanism for the 
production of protein isoforms of different lengths, structures and possibly biological 
activities.  
 With 11 potentially phosphorylated aa residues matching the S/T-X-A motif, camel 
αs2-CN displays the highest phosphorylation level, as mentioned by Ryskaliyeva et al.8. To 
reach such a phosphorylation level, besides the nine SerP, two putative Threonine residues 
(T118 and T132) should be phosphorylated. However, in all the Kazakh milk samples 
analyzed in LC-ESI-MS we found αs2-CN with up to 12 P groups. This means that at least 
another S/T residue that does not match the canonical sequence recognized by the mammary 
kinase(s), is potentially phosphorylated. According to Allende et al. (1995)  the sequence S/T-
X-X-A is in agreement with the minimum requirements for phosphorylation by the CN-kinase 
II (CK2). In this regard, it is critical to highlight that the A residue in this site, usually E or D, 
can be replaced by SerP or ThrP. Two T residues, namely T39 and T129 in the camel αs2-CN 
fully meet the requirements of the above-mentioned motif and might be phosphorylated. Such 
an event is the only possible hypothesis to reach 12P for camel αs2-CN. Since these two 
kinases are very likely secreted, the idea that phosphorylation at T39/T129 may occur in the 
extracellular environment cannot be excluded. This warrants further investigation. Fam20C, 
which is very likely the major secretory pathway protein kinase (Tagliabracci et al., 2015), 
might be responsible for the phosphorylation of S and T residues within the S/T-X-A motif, 
whereas a CK2-type kinase might be responsible for phosphorylation of the T residue within 
an S/T-X-X-A motif. This was in agreement with the hypothesis put forward by Bijl et al. 
(2014) and Fang et al. (2016), who suggest, from phenotypic correlations and hierarchical 
clustering, the existence of at least two regulatory systems for phosphorylation of αs-CN. 
Interestingly, twelve phosphorylation sites were also predicted in llama αs2-CN (Pauciullo & 
Erhardt, 2015), including two Threonine residues at T118 (instead of T114 as erroneously 
mentioned) and T141 (also T141 in camel αs2-CNsv1). Phosphorylation sites matching the 
S/T-X-A motif in llama αs2-CN are actually 12. Indeed, S122 (llama’s numbering) that has 
been predicted as phosphorylated (Pauciullo & Erhardt, 2015) does not meet the criteria 
required by the S/T-X-A consensus motif and cannot be phosphorylated. By contrast, T128, 
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which is substituted by a methionine residue (M) in the camel αs2-CNsv1, is potentially 
phosphorylated provided S130 has been phosphorylated before. On the contrary, sites 
potentially phosphorylated by a second kinase (CK2-type) identified in the camel sequence 
are also present in the llama sequence and therefore the phosphorylation level that could be 
reached in this species is potentially13P. 
3.3.5 Alternate splicing isoforms of camel αs2-CN increase its 
ability to generate potential bioactive peptides 
A growing number of genes encoding milk proteins displays complex patterns of 
splicing, thus increasing their coding capacity to generate an extreme protein isoform 
diversity from a single gene. It is well established that milk proteins represent a reservoir of 
biologically active peptides (Meisel, 2004; Nagpal et al., 2011; Weimann, Meisel, & Erhardt, 
2009), capable of modulating different functions. Therefore, beside genetic polymorphisms, 
the molecular diversity generated by differential splicing mechanisms can increase its content.  
To evaluate this possibility, we undertook to search for bioactive peptides encrypted in 
the different camel αs2-CN isoforms, using an in silico approach. Since alternative splicing 
events impact the C-terminal part of the molecule (f(150-197)) which seems, in addition, to be 
the most accessible domain of the bovine protein (Farrell et al., 2009; Tauzin, Miclo, Roth, 
Mollé, & Gaillard, 2003), we therefore focused our attention on this region. Previous studies 
performed on the bovine αs2-CN have demonstrated that this casein is the least accessible in 
the micelles and that a limited number of tryptic peptides were released from its C-terminal 
part (Diaz, Gouldsworthy, & Leaver, 1996; Gagnaire & Léonil, 1998); of which some were 
subsequently shown to display antibacterial properties (Farrell et al., 2009). The first 
antibacterial peptide isolated from bovine αs2-CN (f(150-188) of the mature protein), 
inhibiting the growth of Escherichia coli and Staphylococcus carnosus, was called casocidin-I 
(Zucht et al., 1995). Two distinct antibacterial domains f(164-179) and f(183-207), also 
located in the C-terminal part of the molecule, were subsequently isolated  from a peptic 
hydrolysate of bovine αs2-CN (Recio & Visser, 1999). It is worth noting that in our prediction 
analyses (Figure 3.9), the bovine peptide f(164-179) displays a rather high probability (0.685) 
to have an antimicrobial (AMP) activity; whereas peptide f(183-207) for which a probability 
of 0.312 was found, would not have such an activity. In contrast, peptide f(192-207) is by far 
the one with the highest probability (0.915) to exhibit an AMP activity.  
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The picture is less positive with regard to the corresponding camel sequences, since 
peptides f(179-197) and f(179-187), according to the splicing variant (αs2-CN sv2 and αs2-CN 
sv1, respectively), as well as f(151-166) from αs2-CN sv1, compared with the bovine αs2-CN 
f(164-179), gave more contrasted results (Figure 3.9). Given the magnitude of the splicing 
events occurring in the camel αs2-CN pre-mRNA, it is not surprising that it would impact 
biological properties of αs2-CN C-terminal peptides, including antimicrobial activity, since 
several aa residues of this region were shown to be essential regarding AMP activity (Recio & 
Visser, 1999; Zucht et al., 1995). Indeed, the importance of specific amino acids (P and R 
residues) at the C-terminus of the bovine milk-derived αs2-CN f(183-207) peptide for its 
antibacterial activity against the food-borne pathogens Listeria monocytogenes and 
Cronbacter sakazakii, was recently demonstrated (Alvarez-Ordóñez et al., 2013). 
Nevertheless, this in silico screening remains a predictive approach, aimed at identifying 
sequences that would be potentially bioactive. It is therefore necessary to confirm 
experimentally, and possible discordances may occur between in silico and in vitro results. It 
is not because the sequence of a peptide is predicted as potentially bioactive that it will be 
actually active in vitro and if it is active in vitro, this does not mean that even though it will be 
active in vivo. McCann et al. (2005) identified 5 peptides from chymosin digests of a bovine 
sodium caseinate, all being once again from the C-terminal end of αs2-CN, including f(164–
207),  f(175–207) and f(181-207), and showing in vitro antibacterial activity against Listeria 
innocua. However, they stressed that it was not excluded that these cationic peptides may lose 
their antibacterial activity in vivo. From all these studies it appears, nevertheless, that the C-
terminal part of αs2-CN was predicted to yield peptides with defensin-like activity, which may 
aid the immune system in fighting bacteria (Farrell et al., 2009). 
Interestingly, further bioactive peptides with different properties such as AHT (Anti 
Hyper Tensive) activity were identified from camel αs2-CN (Figure 3.9). Indeed, according to 
the splicing patterns, including or not exon 16 extension, two peptide sequences 
(KTMTPWNHIKRYF and KTMTPWNHIKVKAYQIIPNLRYF) occur within the C-terminal 
part of the molecule (Figure 3.4), thus giving rise to different peptides after digestion by 
proteolytic enzymes from the digestive tract, including pepsin, trypsin and chymotrypsin 
(supplementary data S2). Several peptides, related to the inserted VKAYQIIPNL decapeptide 
characterizing camel αs2-CNsv2, were in silico identified as AHT peptides involved in the 
angiotensin I-converting enzyme (ACE) inhibitory activity, with SVM (Support Vector 
Machine) scores >1 (Figure 3.9). Two ACE-inhibitory dipeptides (f(185-186): VK and f(187-
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188): AY) were found exclusively in camel αs2-CNsv2 (and in the putative camel αs2-CNsv3). 
Interestingly, the AY dipeptide was also found in the B variant of the camel αs1-CN (Erhardt 
et al., 2016). A novel ACE inhibitory peptide (YQK) exhibiting an IC50 of 11.1 µM was 
recently isolated from a pepsin and trypsin hydrolysate of bovine αs2-CN (Xue et al., 2018). 
An oral administration, using a rodent hypertensive model, revealed a significant decrease of 
systolic blood pressure, thus demonstrating its AHT effects. Such a tripeptide sequence also 
occurs in the C-terminal part of the camel αs2-CN. 
 
Figure 3.9. In silico analyses of αs2-CN peptides for antimicrobial (yellow) and antihypertensive (green) 
activities 
* Peptide location is given in the longest camel amino acid sequence (putative as2-CNsv3).   
** Probability > 0.5 = Predicted AMP.       
*** pIC50 = -logIC50 with IC50 = peptide concentration (µmol/L) necessary to inhibit the angiotensin 
converting enzyme (ACE) activity by 50%.    
SVM (support vector machine) score: threshold = 0 (Kumar et al., 2015).    
Tripeptides YQK and MKP recently identified as an antihypertensive peptide (Xue et al., 2018; Yamada et al., 
2015)are bolded and in red.  
 
 
To summarize, the data reported here allowed identifying UP1 and UP2 detected in 
our previous study (Ryskaliyeva et al., 2018) as splicing isoforms of αs2-CN (αs2-CNsv1 and 
	   	   	  
Anti	  Microbial	  Peptide	  (AMP)	   Anti	  Hyper	  Tensive	  (AHT)	  
Peptide	  location*	   SeqID	   Sequence	   	  Probability	  **	   Classification	   SVM	  score	   Prediction	  
f(187-­‐197)	   Camel	  αs2-­‐CNsv2	   AYQIIPNLRYF	   0.444	   Non-­‐AMP	   2.05	   AHT	  
f(187-­‐195)	   Camel	  αs2-­‐CNsv2	   AYQIIPNLR	   0.428	   Non-­‐AMP	   1.40	   AHT	  
f(187-­‐194)	   Camel	  αs2-­‐CNsv2	   AYQIIPNL	   0.378	   Non-­‐AMP	   1.26	   AHT	  
f(185-­‐194)	   Camel	  αs2-­‐CNsv2	   VKAYQIIPNL	   0.061	   Non-­‐AMP	   1.75	   AHT	  
f(169-­‐175)	   Camel	  αs2-­‐CN	   TVYQYQK	   0.520	   AMP	   0.37	   AHT	  
f(176-­‐184)	   Camel	  αs2-­‐CN	   TMTPWNHIK	   0.140	   Non-­‐AMP	   0.54	   AHT	  
sv1	  f(179-­‐187)	   Camel	  αs2-­‐CNsv1	   PWNHIKRYF	   0.622	   AMP	   1.05	   AHT	  
sv2	  f(179-­‐197)	   Camel	  αs2-­‐CNsv2	   PWNHIKVKAYQIIPNLRYF	   0.367	   Non-­‐AMP	   	  	   	  	  
sv1	  f(151-­‐166)	   Camel	  αs2-­‐CNsv1	   LNKIYQYYQTFLWPEY	   0.092	   Non-­‐AMP	   	  	   	  	  
f(164-­‐179)	   Bovine	  αs2-­‐CN	   LKKISQRYQKFALPQY	   0,685	   AMP	   	  	   	  	  
f(192-­‐207)	   Bovine	  αs2-­‐CN	   PWIQPKTKVIPYVRYL	   0.915	   AMP	   	  	   	  	  
f(183-­‐207)	   Bovine	  αs2-­‐CN	   VYQHQKAMKPWIQPKTKVIPYVRYL	   0.312	   Non-­‐AMP	   	  	   	  	  
f(176-­‐180)	   Camel	  αs2-­‐CN	   TMTPW	   	  	   	  	   -­‐0,11	   non-­‐AHT	  
f(189-­‐194)	   Camel	  αs2-­‐CNsv2	   QIIPNL	  
	   	  
0,44	   AHT	  
f(181-­‐184)	   Camel	  αs2-­‐CN	   NHIK	  
	   	  
-­‐0,90	   non-­‐AHT	  
f(146-­‐149)	   Camel	  αs2-­‐CN	   DHQK	  
	   	  
-­‐0,31	   non-­‐AHT	  
f(162-­‐166)	   Camel	  αs2-­‐CN	   LWPEY	  
	   	  
1,42	   AHT	  
	  	   	  	   di-­‐	  and	  tripeptides	   	  	   	  	   pIC50***	  
f(151-­‐153)	   Camel	  αs2-­‐CN	   LNK	  
	   	  
3.96	   predicted	  
f(169-­‐171)	   Camel	  αs2-­‐CN	   TVY	  
	   	  
4.82	   predicted	  
f(187-­‐188)	   Camel	  αs2-­‐CNsv2	   AY	  
	   	  
4.85	   actual	  
f(185-­‐186)	   Camel	  αs2-­‐CNsv2	   VK	  
	   	  
4.89	   actual	  
f(154-­‐155)	   Camel	  αs2-­‐CN	   IY	  
	   	  
5.68	   actual	  
f(174-­‐175)	   Camel	  αs2-­‐CN	   QK	  
	   	  
3.05	   actual	  
f(171-­‐173)	  
f(190-­‐192)	  
Bovine	  αs2-­‐CN	  
Bovine	  αs2-­‐CN	  
YQK	  
MKP	  
	  	   	  	   4,56/4.96	  
4.60/6.37	  
actual	  
actual	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αs2-CNsv2, respectively). These isoforms arise from different processing of the CSN1S2 
primary transcript, giving rise to the insertion of exon 13 in αs2-CNsv1 and a downstream 
extension of exon 16 in αs2-CNsv2. Thus, αs2-CN was shown to be a mixture of at least 16 
isoforms differing in polypeptide chain length and phosphorylation levels, identified in both 
Camelus species (C. bactrianus and C. dromedarius), as well in hybrids. Such a situation is 
not specific to Camelids and is frequently observed in most of the mammalian species, 
particularly in small ruminants and Equidae. Little is known about the mechanisms 
identifying alternatively spliced exons. Do those deletions/insertions in camel αs2-CN simply 
reflect the lack of accuracy of an intricate processing mechanism whenever mutations induce 
conformational modifications of pre-mRNA, preventing the normal progress of the splicing 
process? There are more and more evidences to support the hypothesis that cis-acting 
sequences, both in introns and exons, are involved in the control of this process.  
Despite the extreme conservation of the organization of the "casein" locus during the 
course of evolution (Figure 3.1), the sequences of the proteins encoded by each of the genes 
that compose this locus have rapidly evolved. Given the exon modular structure of messenger 
RNAs, the real similarity between αs2-CN across species is significantly higher than it appears 
at first whether the exon modular structure is taken into account (Figure 3.4). The apparent 
divergence is in fact largely due to a splicing combinatorial assembly of exons specific of 
each species, as previously suggested by Martin et al. (2007), as far as αs1-CN is concerned. 
Therefore, differential splicing, as well as genetic polymorphisms as described with camel 
αs1-CN (Erhardt et al., 2016), generate a molecular diversity of sequences increasing the 
ability of camel caseins to generate potentially bioactive encrypted peptides. 
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Abstract 
Background: Whey acidic protein (WAP) is a major protein identified in the milk of several 
mammalian species with cysteine-rich domains known as four-disulfide cores (4-DSC). The 
organization of the eutherian WAP genes is highly conserved through evolution. It has been 
proposed that WAP could play an important role in regulating the proliferation of mammary 
epithelial cells. A bacteriostatic activity was also reported. Conversely to the other 
mammalian species expressing WAP in their milk, camel WAP contains 4 additional amino 
acid residues at the beginning of the second 4-DSC domain, introducing a phosphorylation 
site. The aim of this study was to elucidate the origin of this specificity, which possibly 
impacts its physiological functions.  
Results: Using LC-ESI-MS, we identified in C. bactrianus from Kazakhstan a 
phosphorylated whey protein, exhibiting a molecular mass (12,596 Da), 32 Da higher than the 
original WAP (12,564 Da) and co-eluting with WAP. cDNA sequencing revealed a transition 
G/A, which modifies an amino acid residue of the mature protein (V12M), accounting for the 
mass difference observed between WAP genetic variants. We also report the existence of two 
splicing variants of camel WAP precursors to mRNA, arising from an alternative usage of the 
canonical splice site recognized as such in the other mammalian species. However, the major 
camel WAP isoform results from the usage of an unlikely intron cryptic splice site, extending 
camel exon 3 upstream by 12-nucleotides encoding the 4 additional amino acid residues 
(VSSP) in which a potentially phosphorylable Serine residue occurs. Combining protein and 
cDNA sequences with genome data available (NCBI database), we report another feature of 
the camel WAP gene which displays a very rare GC-AG type intron. This result was 
confirmed by sequencing a genomic DNA fragment encompassing exon 3 to exon 4, 
suggesting for the GC donor site a compensatory effect in terms of  consensus at the acceptor 
exon position. 
Conclusions: Combining proteomic and molecular biology approaches we report: the 
characterization of a new genetic variant of camel WAP, the usage of an unlikely intron 
cryptic splice site, and the occurrence of an extremely rare GC-AG type of intron.  
Key words: Camel, milk, whey protein, splicing, genetic polymorphism  
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4.1 Background 
Camel milk is characterized by a high content of vitamin C (average content ranging 
between 50 and 250 mg/L), and endowed with a unique composition of protein components 
(Alhaider et al., 2013; Hinz, O’Connor, Huppertz, Ross, & Kelly, 2012; Ryskaliyeva et al., 
2018). Its protein content (35-50 g/L) is rather high (Konuspayeva, Faye, & Loiseau, 2009), 
with ca. 80% are caseins and 20% whey proteins that are soluble at pH 4.6 whereas caseins 
precipitate close to this pH. The casein fraction comprises 4 caseins (αs1-, αs2-, β- and κ-
casein) encoded by four autosomal genes (CSN1S1, CSN1S2, CSN2 and CSN3, respectively) 
mapped on chromosome 6 in cattle and goat (Hayes, Petit, Bouniol, & Popescu, 1993; 
Threadgill & Womack, 1990). This fraction is rather complex with many splicing variants and 
post-translational modifications (Ryskaliyeva et al., 2018). Whey proteins of camel milk 
mainly consist of α-lactalbumin (α-LA), glycosylation-dependent cell adhesion molecule 1 
(GlyCAM1) or lactophorin which is closely related to the bovine proteose peptone component 
3 (PP3), the innate immunity Peptido Glycan Recognition Protein (PGRP) and the Whey 
Acidic Protein (WAP).  
 WAP is a major whey protein identified in the milk of several species from eutherians 
as well as marsupial and monotremes (Sharp, Lefèvre, & Nicholas, 2007). It was first shown 
to be secreted in rodent milks (Hennighausen & Sippel, 1982), and a whey protein, rich in 
half-cystine residues (n=16), showing strong similarities with rodents WAPs was 
characterized two years later in camel milk (Beg, von Bahr-Lindstrom, Zaidi, & Jornvall, 
1986). Then, the WAP has been identified in rabbits (Devinoy, Hubert, Schaerer, Houdebine, 
& Kraehenbuhl, 1988), porcine (Ranganathan, Simpson, Shaw, & Nicholas, 1999), wallaby 
(Topcic et al., 2009), brushtail possum (Demmer, Stasiuk, Grigor, Simpson, & Nicholas, 
2001) and more recently in canine (Seki et al., 2012) milks. Camel WAP reaches an average 
concentration (157 mg/L) 10-folds lower than that (1,500 mg/L) in rodents milk (Kappeler, 
Farah, & Puhan, 2003), whereas it is a hundred times higher (15 g/L) in rabbit milk 
(Grabowski et al., 1991). Whey acidic protein (WAP) is expressed in the mammary gland 
under an extracellular matrix and lactogenic hormones regulation (Lin, Dempsey, Coffey, & 
Bissell, 1995). WAP gene expression is induced by prolactin, inhibited by progesterone, and 
strongly amplified by glucocorticoids (Devinoy et al., 1994).  
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 The overall organization of the eutherian WAP genes is highly conserved through 
evolution (P. Martin, Cebo, & Miranda, 2013; Sharp et al., 2007). It is composed of 4 exons: 
E1, E3, E4 and E6 (Figure 4.1). While the size of each exon remains rather conserved 
between species, intron size varies considerably. The first exon encodes the 5’-UTR, N-
terminal signal peptide of 19 aa residues, and the first 8-10 aa residues of mature eutherian 
proteins. Exons 3 and 4 encode two cysteine-rich domains (DI and DIIA) known as four-
disulfide cores (4-DSC) in eutherian species (Hennighausen & Sippel, 1982). A third domain 
(DIII) encoded by exon 2 (missing in eutherian genes) is found in Monotrema and Marsupial 
species (Sharp et al., 2007). Exon 6 encodes the last 5-9 aa residues and the 3’-UTR while 
exon 5 (DIIB) is only used in Platypus and Marsupial species (Sharp et al., 2007). Even 
though, the promoter region of WAP gene is similar to house-keeping genes with weak or 
absent TATA signal (Kappeler et al., 2003), WAP is not found in all eutherian milks. The 
functionality of the gene encoding WAP has been lost in ruminants and primates due to a 
frameshift mutation (Hajjoubi et al., 2006). Consequently, there is no WAP in the milk of 
ruminants and primates.  
The presence of 4-DSC domains in cysteine-rich proteins led to their classification as 
the WAP gene family. Proteins containing WAP domains with a characteristic 4-DSC occur 
not only in mammals but also in birds, reptiles, amphibians and fish (Smith, 2011). Each 
domain comprises eight cysteine residues with a core of six spatially conserved, while the 
remaining two are positioned at variable distances amino terminal from the core (Simpson & 
Nicholas, 2002).  
The sequence conservation of 4-DSC motifs across species is significant, and it seems 
likely that the region may be involved in the biological function of the molecule. WAPs share 
structural similarity with serine protease inhibitors containing WAP motif domains 
characterized by a four-disulfide core (4-DSC) (Hennighausen & Sippel, 1982). Possible 
physiological functions of WAP have been proposed, based on its similarity to protease 
inhibitor (Grabowski et al., 1991). Using in vitro and in vivo systems, Nukumi et al. (2007) 
suggested that WAP plays an important role in regulating the proliferation of mammary 
epithelial cells by preventing elastase-type serine proteases from carrying out extracellular 
matrix laminin degradation. In addition, the same authors report a bacteriostatic activity of rat 
WAP against Staphylococcus aureus (Iwamori et al., 2010). In marsupial, Sharp et al. (Sharp 
et al., 2007) suggest that WAP may play also a role in the development of the young. 
WFDC2, a second WAP-like protein, is differentially expressed in the mammary gland of the 
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tammar wallaby and provides immune protection to the mammary gland and the developing 
pouch young (Watt, Sharp, Lefevre, & Nicholas, 2012).  
 
Figure 4.1. Multiple sequences alignment of WAP among Eutherian species including camel (NCBI, 
LOC105095719), pig (O46655), dog (GenBank AAEX02035361, positions 25,184-23,606), rabbit (P09412), rat 
(G3V718), and mouse (Q7M748). Four exons: E1, E3, E4 and E6 (numbering of the putative ancestral gene, 
proposed by Sharp et al. (2007), are given in black boxes. Exons 3 and 4 represent 4-DSC domains (DI and 
DIIA), while exon 1 and 6 indicate the signal peptide (SP) with the N-terminal part (N-ter) of the mature protein 
and the C-terminal part (C-ter) of the protein, respectively. WAP motifs are boxed in pink. Conserved Cysteine 
residues (C) in each 4-DSC domain are pink shaded. Residues identical in more than 3 animal species are grey 
shaded. Gaps are introduced to maximize similarities. Tetrapeptide VSSP, that is specific to camel WAP, is 
highlighted in yellow.            
 
 The present study was undertaken first to search for WAP genetic polymorphism in 
camel species (Camelus bactrianus and Camelus dromedarius) from Kazakhstan. The 
alignment of sequences of WAP from 5 Eutherian species in which the WAP gene is 
expressed reveals the occurrence of an additional sequence of 4 amino acid residues in the 
camel WAP (Figure 4.1). We show that this insertion is due to the usage of an intron cryptic 
Exon 1
(SP/N-ter)
Exon 3 
(DI)
Exon 4 
(DIIA)
Exon 6 
(C-ter)
CAM
PIG
DOG
RAB
RAT
MUS
CAM
PIG
DOG
RAB
RAT
MUS
CAM
PIG
DOG
RAB
RAT
MUS
CAM
PIG
DOG
RAB
RAT
MUS
                 
    
CAM     MRCLASLALALLSLEAAFA LAPA----LSLP  
PIG     MRFLTSLALALIALEAALA LAPA----LNLP  
DOG     MRCLAGLALALLALGATLA LAPAPAPALTLP  
RAB     MRCLISLALGLLALEAALA LAPK----FIAP      
RAT     MRCFISLVLGLLALEVALA RNLQEH--VFNS  
MUS     MRCLISLVLGLLALEVALA QNLEEQ--VFNS  
 
    
CAM     GQAVCPELSSS-EDNACIISCVNDESCPQGTKCCARSPCSRSCTVPLM  
PIG     GLATCPELSSSSEDP-CVISCVNDESCPQGTKCCARSPCSRSCTVPLL  
DOG     GQAVCPEVSSSEEDT-CVVSCNSDDNCPQGTKCCPRSPCSRSCVVPFI  
RAB     VQVMCPEPSSSEE-TLCL----SDNDCLGSTVCCP-SAAGGSCRTPII  
RAT     VQSMCPDDSSS-EDTECI-NCQTNEECAQNDMCCP-SSCGRPCKTPVN  
MUS     VQSMFPKASPI-EGTECI-ICQTNEECAQNAMCCPGS-CGRTRKTPVN  
 
     
CAM     VSSPEPVLKDGRCPWVQTPLTAK--HCLEKNDCSRDDQCEGNKKCCFSSCAMRCLDPVT 
PIG     ----VPVPKAGRCPWVPAPLAPE--LCLEKNECSRDDQCRGNKKCCFSSCAMRCLDPDT 
DOG     ----VPVQKAGHCPRVQIPLTPE--PCLESSECSRDDQCVGHRKCCLSVCAMRCQDPEA 
RAB     ----VPTPKAGRCPWVQAPMLSQ--LCEELSDCANDIECRGDKKCCFSRCAMRYLEPIL 
RAT     ----IEVQKAGRCPWNPIQMIAA-GPCPKDNPCSIDSDCSGTMKCCNNGCIMSCMDPEP 
MUS     ----IGVPKAGFCPWNLLQMISSTGPCPMKIECSSDRECSGNMKCCNVDCVMTCTPPVP 
 
     
CAM     ED----SFQ 
PIG     EA----PLQ 
DOG     EE----PLQ 
RAB     ES----TPQ 
RAT     ESPTVVSFQ 
MUS     VI----TLQ 
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splice site. Finally, results reported here clarify discrepancies and erroneous data found in 
sequence databases (predicted sequence from genomic data) and literature. We also report that 
in camel, the gene encoding WAP comprises a rare GC-AG intron-type that represents less 
than 1% of annotated donor sites, which is at the origin of predicted sequence anomalies.   
4.2 Methods 
4.2.1 Milk Sample Collection and Preparation 
Raw milk samples were collected during morning milking on healthy dairy camels 
(n=179) that belonged to two species: C. bactrianus (n=72) and C. dromedarius (n=65), and 
their hybrids (n=42) at different lactation stages, ranging between 30 and 90 days postpartum. 
Those milk samples were skimmed as previously described (Ryskaliyeva et al., 2018) and 
skimmed milks and fat were stored at -20°C and -80°C, respectively, until analysis.  
4.2.2 Selection of Milk Samples for Analysis 
A set of 58 milk samples, including individuals from each camel species and grazing 
regions, was selected, based on lactation stages and number of parities (from 2 to 14), for 
SDS-PAGE analysis. Then, eight (C. bactrianus, n=3, C. dromedarius, n=3, and hybrids, 
n=2) of those 58 milk samples from three different regions exhibiting the most representative 
profiles were analyzed by LC-MS/MS (LTQ-Orbitrap Discovery, Thermo Finnigan) after 
tryptic digestion of excised gel bands. Additionally, 30 milk samples (C. bactrianus, n=10; C. 
dromedarius, n=10; hybrids, n=10), taken from the 58 milks analyzed by SDS-PAGE, were 
analyzed by LC-ESI-MS (Bruker Daltonics). One camel milk sample (C. bactrianus) 
displaying a WAP genetic polymorphism in LC-ESI-MS was selected for amplification of 
WAP cDNA by RT-PCR and cDNA sequencing.  
4.2.3 Milk Fat Globule Collection - RNA Extraction and Single-
Strand cDNA Synthesis  
Total RNA was extracted from milk fat globules (MFG) fraction stored at -80°C using 
LS Trizol (Invitrogen) following the protocol from the manufacturer, as described by Brenaut 
et al. (2012). Then, first-strand cDNA was synthesized as described (Ryskaliyeva et al., 
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2018). One microliter of 2 U/µL RNase H (Invitrogen Life Technologies) was then added to 
remove RNA from heteroduplexes. Single-strand cDNA thus obtained was stored at -20°C. 
4.2.4 Genomic DNA Isolation 
Genomic DNA (gDNA) was isolated from fresh blood of C. dromedarius collected in 
EDTA using the Wizard® Genomic DNA Purification Kit (Promega Corporation, Madison, 
USA). Briefly, for 3 mL sample volume, 9 mL of Cell Lysis Solution was added and 
centrifuged at 2,000 x g for 10 min at room temperature (RT), after incubating the mixture for 
10 min, at RT. The supernatant was removed and, 3 mL of Nuclei Lysis Solution was added 
to the resuspended white pellet containing red and white blood cells. Then, 1 mL of Protein 
Precipitation Solution was added to the nuclear lysate, and centrifuged at 2,000 x g for 10 
min, at RT. The supernatant was transferred to a tube containing 3 mL isopropanol and 
centrifuged at 2,000 x g for 1 min, at RT. After decanting the supernatant, one sample volume 
of 70% ethanol was added to the DNA and centrifuged at 2,000 x g for 1 min, at RT. The 
ethanol was aspirated using a drawn Pasteur pipette and the pellet was air-dried for 10-15 
min. DNA was rehydrated by adding 250 µL of DNA Rehydration Solution and incubated at 
65oC for 1 hour and stored at 4oC.   
4.2.5 PCR Amplification and DNA sequencing 
 cDNA and gDNA samples were amplified using primer pairs, of which sequences are 
given in Table 4.1, designed starting from the published Camelus gene sequence (NCBI, 
LOC105095719) and synthesized by Eurofins genomics (Ebersberg, Germany). PCR was 
performed in an automated thermocycler GeneAmp® PCR System 2,400 (Perkin-Elmer, 
Norwalk, USA) with GoTaq® G2 Flexi DNA Polymerase Kit (Promega Corporation, USA). 
Reactions were carried out in 0.2 mL thin-walled PCR tubes, as described by Ryskaliyeva et 
al. (2018), using the following PCR cycling conditions: denaturation of cDNA template at 
94°C for 2 min, 35 cycles at 94°C for 45 s (denaturation), 58°C for 30 s (annealing) and 72°C 
for 1 min (extension), with a final extension step of 5 min at 72°C. Sequencing of PCR 
fragments was performed using PCR primers from both strands, according to the Sanger 
method by Eurofins MWG GmbH (Ebersberg, Germany). 
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Table 4.1. Primers used to amplify the cDNA and gDNA target of the WAP gene  
*nucleotides 
 
4.2.6 1D Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) and protein identification by LC-
MS/MS analysis 
Both major and low-abundance proteins resolved by SDS-PAGE were identified by 
tandem mass analysis (LC-MS/MS) after excision of the relevant bands from the gel and 
trypsin digestion. The SDS-PAGE conditions was that from Laemmli (1970). 
4.2.7 LC-ESI-MS 
Fractionation of camel milk proteins and determination of their molecular masses were 
performed by coupling RP-HPLC to ESI-MS (micrOTOFTM II focus ESI-TOF mass 
spectrometer; Bruker Daltonics) as described (Ryskaliyeva et al., 2018). Clarified milk 
samples (25 µL) were directly injected onto a Biodiscovery C5 reverse phase column (300 Å 
pore size, 3µm, 150x2.1mm; Supelco, France). Eluted proteins were detected by UV-
absorbance at 214 nm and the effluent directly introduced to the mass spectrometer. Positive 
ion mode was used, and mass scans were acquired over a mass-to-charge ratio (m/z) ranging 
between 600 and 3000 Da (Ryskaliyeva et al., 2018). 
 
 
 
 
 Position Primer Sequence 5’->3’ nt* Amplicon 
sizes 
Tm, oC 
cDNA 5’-UTR 
3’-UTR 
Forward 
Reverse 
ATCTGTCACCTGCCTGCCACCTG 
TGAAGCTGAGTGGGTTTTTATTAGC 
23 
25 557 
66 
60 
gDNA intron 2 
intron 3 
Forward 
Reverse 
CAGCTGAGGCTGGCCCGCCTC 
GCTAGTCTGACACCCTCTCTCTA 
21 
23 561 
70 
62 
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4.3 Results  
4.3.1 Nucleotide sequence of camel WAP cDNA 
Using the rabbit and rodents WAP encoding gene sequences as references, we 
searched for the expected fourth exon of the WAP gene in the camel genome sequence 
(NCBI,  
LOC105095719). A pair of primers (Table 4.1) was thus designed, in the first exon upstream 
the coding sequence (forward) and overlapping the downstream putative AATAAA polyA 
signal (reverse), to amplify a cDNA fragment that was subsequently sequenced. The cDNA 
sequence of camel WAP thus obtained and given at Figure 4.2, consists of 563 nucleotides 
encoding a 136 aa polypeptide of Mr 14,510.72 Da, including the signal peptide. The 
molecular mass of the corresponding mature protein is: 12,564.32 Da.       
Figure 4.2. Nucleotide sequence of camel WAP cDNA. Primer pairs used for PCR and cDNA sequencing are 
highlighted in green. Start and stop codons are highlighted in fuchsia. AA residues encoded by triplet codons are 
bolded and in blue. The coding sequence and non-coding sequences are highlighted in cyan and grey, 
respectively.  
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4.3.2 Identification and characterization of a new WAP genetic 
variant in Bactrian camel milk  
LC-ESI-MS analysis of a Bactrian camel milk from the Shymkent region (Figure 4.3), 
revealed the presence, in peak III (Table 4.2), of two molecular masses differing by 80 Da 
(one phosphate group) 12,596 Da and 12,676 Da, besides the cognate WAP (12,564 Da and 
12, 644 Da). Such a result and the small mass difference (32 Da) strongly suggested the 
existence of a novel WAP genetic variant, which had not been described so far in camels.    
 
 
 
 
 
 
 
 
Figure 4.3. Milk protein profiling by LC-ESI-MS of a Bactrian camel milk from the Shymkent region. 
Eleven major milk protein fractions were identified from RP-HPLC profile (3.A) in the following order: 
glycosylated κ-CN A and B (I), non-glycosylated κ-CN A and B (II), WAP (III), shorter (∆ex16 and 13’) + short 
(∆ex16) isoforms of αs1-CN A and C (IV and V), α-LAC + αs1-CN A and C (VI), αs2-CN* (VII), PGRP + αs2-
CN* (VIII), LPO/CSA (IX), β-CN A and B (X) and γ2-CN A and B (XI). Multicharged-ions spectrum from 
compounds contained in fraction III (3.B). After deconvolution (3.C) the spectrum shows the presence of 
cognate camel WAP A-0P (12,546 Da) and 1P (12,644 Da) indicated in black, and molecular masses 
corresponding to a new WAP variant (named B) without (12,596 Da) and with (12,676 Da) one phosphate 
group, indicated in red.  
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Table 4.2. Identification of WAP from molecular mass determination using LC-ESI-MS of a clarified Bactrian 
milk  
Peak  Ret.Time, 
(min) 
Observed Mr 
(Da) 
Theoretical Mr 
(Da) 
Protein description UniProt 
accession 
Intensity 
III  24.31 12,564 12,564 WAP variant A, 0P P09837 896 
 12,596 n/a WAP variant B, 0P  n/a 652 
 12,644  WAP variant A, 1P  951 
 12,677  WAP variant B, 1P   1,059 
n/a - not applicable 
  
Nucleotide sequences of two unrelated individuals (including the Bactrian camel from 
the Shymkent region) were compared across the complete coding sequence of the camel WAP 
cDNA, in both directions. PCR yielded a fragment of the expected length (ca. 560 bp) for a 
complete mRNA open reading frame of 408 bp, demonstrating that the primary transcript was 
correctly spliced. However, examining the nucleotide sequence manually, a transition G/A 
may be easily noticed (Figure 4.4), leading to the fourth codon change (GTG/ATG) of exon 2, 
confirmed by the reverse complement sequence. This single base substitution corresponds to a 
V/M amino acid substitution in position 12 of the mature protein, in agreement with the mass 
difference of 32 Da (V12M, 99 Da => 131 Da), found between WAP variants detected in LC-
ESI-MS. We propose to name the camel WAP (V12) described by Beg et al. (1986) as variant 
A and the newly identified variant (M12) as variant B. Consequently, molecular masses 
observed by LC-ESI-MS (12,596 Da, 12,676 Da) precisely correspond to unphosphorylated 
and phosphorylated (1P) isoforms of WAP variant B, respectively. This B variant which was 
found in only one (Bactrian) of the 30 camel milk samples analyzed in LC-ESI-MS, at the 
heterozygous state, appeared therefore to be rare in the Kazakh population. As far as variant A 
is concerned, the unphosphorylated isoform seems to be prevalent, with relative proportions 
between unphosphorylated and phosphorylated protein ranging between 70/30 and 55/45, 
whereas the phosphorylated isoform is predominant (40/60) with the Bactrian camel 
heterozygous A/B.  
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 098765432109876543210987654321098765432109876543210987654321098765432109876543210987654321 
286251 
 
286161 
 
286071 
285981 
285891 
285801 
285711 
285621 
 
285531 
 
285441 
285351 
285261 
285171 
 
285081 
 
284991 
 
284901 
 
284811 
284721 
284631 
284541 
284451 
 
284361 
284271 
                                           ATCTGTCACCTGCCTGCCACCTGCCACCATGCGCTGTCTTGCCAGCC 
                                                                        M  R  C  L  A  S  
TGGCCCTGGCCCTGCTCTCCCTGGAGGCTGCCTTTGCACTGGCCCCAGCCCTCTCCTTGCCAGGTAAGCCCAGGAGGGGCATCCTGCCCT 
L  A  L  A  L  L  S  L  E  A  A  F  A  L  A  P  A  L  S  L  P                              
CCCTCTGCTCCAGGTCCCCCCACCCCCCGAAATGCTGCCCAGGCCTCACAGTTTGGTGACCAGGACAAGAGAGGGAGCAGAACGAGGGAG 
GTGCACCCTTGGGGTATCAGTGACAACAGAAGGGTGGGGTGCTGCCCAGAAATGCCCATGCATGGGGGGCCAAGAGCTGCAGGGCCGAGG 
CCACCGTCCCGGGATGCAAAGTGACCGGGCAGCTAGCTGGGTGTGGGGGGATCCTGTCCTCGGCCCTTCGGGGTCTTAACTCCACCTCCT 
GCAGTGGGCCTGTGGCCTCATTTCCTGACTTTCACAGCTGACTCACAATTTCTGTCAGCCATGTCGAATGTCAGTGTTGGGGTGCTGGAG 
ACCGGACTCCCCAAGGTTCTTGTCCGCGCCCCACCTTGCTTTTTCCTGAGGCGCCCCAGGGGAGGTGGGATCCAGCCAGCCCCCCACCTC 
CCCGCTGGTCTCGTGCGCAGGGCAGGCCGTGTGCCCAGAGCTCAGCTCCTCCGAGGACAACGCCTGCATAATCTCCTGTGTCAACGATGA 
                        
 G  Q  A  V  C  P  E  L  S  S  S  E  D  N  A  C  I  I  S  C  V  N  D  E 
GAGCTGTCCCCAAGGCACCAAGTGCTGCGCCAGGAGCCCCTGCAGCCGATCCTGCACGGTCCCCCTCATGGGTAAGGCCACGTCTGGACA 
  S  C  P  Q  G  T  K  C  C  A  R  S  P  C  S  R  S  C  T  V  P  L  M                      
GAGGGAGGAACCAGCTTTGTCAGGGGTCCTCCTTGAGTCTGCACTCCACACCCCTCTCTCGGTGAGCCCCCCAGCAGCCCCATAAACTCG 
GCCCGGCCATGGCACGGGTTCACCCACCTGAGGCCCAGCTGAGGCTGGCCCGCCTCCTCCCAGCATCACCTGCTGGGCCCGCAGGCCACA 
GTCTCCCTCCCAGCCTGGGCCCTGAAGGCTCCAGGCCACCAAGGGGGAGGGAAGGGGGGACCAGCTGCGGGGCGGCCCCAGCAGGCCAGC 
GGGTGATGACGGCCCGGCCAGTCTCTTCCCCAGAGCCTGTCCTGAAGGATGGCCGCTGCCCCTGGGTGCAGACCCCGCTGACCGCAAAGC 
                     V  S  S  P  E  P  V  L  K  D  G  R  C  P  W  V  Q  T  P  L  T  A  K   
ACTGTTTGGAGAAAAACGATTGCTCCAGGGACGACCAGTGTGAGGGCAACAAGAAATGCTGCTTCAGTTCGTGTGCCATGAGGTGTCTGG 
H  C  L  E  K  N  D  C  S  R  D  D  Q  C  E  G  N  K  K  C  C  F  S  S  C  A  M  R  C  L   
ACCCCGTCACAGGCAAGCGTCTCAGAGACCCTTCTCCTAGGCCACCTTCCCAGCCACCACCCTTCTTTCTCCCTTTGCCTGCACCGACCG 
D  P  V  T  G  K  R  L  R  D  P  S  P  R  P  P  S  Q  P  P  P  F  F  L  P  L  P  A  P  T   
TGGTGGCCTCTGCAAGGCTCTAAGAGCAATAAGATGCATGGAAGGGTGGGGGCTCAGGAGGCGGCGTGACCCGGGCCTGCGCCAGCTGCA 
V  V  A  S  A  R  L  *                 
GGCCCCTGCGGGCGCTCAGTGTGGCCATTGGGTTAGAGAGAGGGTGTCAGACTAGCAAAAGGGGCTCAGAGAAACCCAGAGACTTGCCTG 
GTGGGACCTGGTCCGGCCGGGTGGGCCCACCTGCAAGTCTGTGCCTTTGCCACTTAAGCCTGGGGAGGAGCTCTGAATTAGGAGCCCAGA 
GACGTGGTTCCCTGATAACAGTCCCTACCACCTGTGACCTGGCCGGCCTGCCTGCGGGTGATGGTGAGGGCCCAGGAGGGGTGGGTGTGG
AGGGCTTACTGGCCCACCTGCAGTGTCCCTCCCTCCCCTGACCCAACTGTGGCGGGGCTCCACCACCCCTGAGGCCTCCATGTCCCCTGC
AGAGGACTCTTTTCAATGAGGGGCATCCCTGGGAGCTGCCAGGAGTGACCAGCCTGAGTCTGCTCAGCAAGAACCTTCTCTCTCGGATCC 
   E  D  S  F  Q  * 
AGACAGCACAAGATGCCTCCTATCTGCTGCTAATAAAAACCCACTCAGCTTCATGTCTGTCTGTCTGTCTGCCCTCAGCACCTGCCAGGA
GAGACCAAGCACACAGGCCTTGCCTTCCAAGCAGGCTTGGAAGCTCCTGCAAACAGGCGATTCTGCCTGGGGACACGTGTGACGAAGTAG 
 
Figure 4.4. Partial sequence of WAP cDNA from C. bactrianus from Shymkent region. Nucleotides arising by 
manual reading, as G/A and C/T transitions, in forward (F) and reverse (R) sequences, respectively, are pointed 
out by vertical red arrows Nucleotides are clustered by three (codon) corresponding to aa residues (below codons 
in the forward sequence).     
 
4.3.3 Camel WAP may exist as two isoforms differing in size 
LC-MS/MS implemented to confirm the identification of major camel milk proteins 
(Ryskaliyeva et al., 2018) revealed the existence of two WAP isoforms. Indeed, two tryptic 
peptides: SCTVPLMVSSPEPVLK and SCTVPLMEPVLK identifying camel WAP and 
differentiating in the presence or absence of the VSSP tetrapeptide (Table 4.3) were found in 
four of the eight individuals analyzed, belonging to the three species. However, the amount of 
the isoform lacking the tetrapeptide VSSP appeared too weak (1 spectrum vs 10 spectra with 
VSSP) to be detected by LC-ESI-MS that is less sensitive than LC-MS/MS.  
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Table 4.3. Sequences of WAP tryptic peptides identified by LC-MS/MS in the milk of a C. bactrianus  
ID UniProt 
accession 
Species Peptide sequence aa residue Mr Spectra 
Start Stop 
1 P09837 C. dromedarius LAPALSLPGQAVCPELSSSEDN
ACIISCVNDESCPQGTK 1 39 4,174.90 1 
2 P09837 C. dromedarius LSLPGQAVCPELSSSEDNACIIS
CVNDESCPQGTK 5 39 3,822.69 1 
3 P09837 C. dromedarius IISCVNDESCPQGTK 25 39 1,707.77 1 
4 P09837 C. dromedarius VNDESCPQGTK 29 39 1,234.54 2 
5 P09837 C. dromedarius SCTVPLMVSSPEPVLK 49 64 1,743.90 6 
6 P09837 C. dromedarius SCTVPLMVSSPEPVLKDGR 49 67 2,072.05 3 
7 P09837 C. dromedarius PLMVSSPEPVLKDGR 53 67 1,624.87 1 
8 P09837 C. dromedarius DGRCPWVQTPLTAK 65 78 1,628.82 1 
9 P09837 C. dromedarius CPWVQTPLTAK 68 78 1,300.67 11 
10 P09837 C. dromedarius HCLEKNDCSR 79 88 1,318.56 2 
11 P09837 C. dromedarius HCLEKNDCSRDDQCEGNK 79 96 2,264.91 1 
12 P09837 C. dromedarius HCLEKNDCSRDDQCEGNKK 79 97 2,393.00 1 
13 P09837 C. dromedarius KCCFSSCAMR 97 106 1,322.51 1 
14 P09837 C. dromedarius CCFSSCAMR 98 106 1,161.39 1 
15 P09837 C. dromedarius CLDPVTEDSFQ 107 117 1,310.56 13 
16 S9XKL5 C. ferus SCTVPLMEPVLK 130 141 1,389.71 1 
 
The table is classified by the start aa residues from the N-terminal sequence. Obtained data matches against 
UniprotKB taxonomy cetartiodactyla (SwissProt + Trembl) database. Molecular masses (Mr) of peptides are 
expressed in Da. Spectra indicates the number of spectra permitting the identification of peptides. Charge 
corresponds to the number of charges (z) of multi-charged ions precursors having given the MS/MS spectra. 
Peptide sequences including or not the tetrapeptide VSSP, which is highlighted in green, are in bold. Numbering 
of the C. ferus peptide sequence is from KB016488 Genomic DNA Translation. 
 
4.4 Discussion 
Here we provide the complete camel WAP mRNA sequence (408 nucleotides open 
reading frame) that encodes a N-terminal signal peptide of 19 aa residues and a mature protein 
of 117 aa residues, of which the molecular mass is 12,564 Da, and we report the occurrence in 
C. bactrianus from Kazakhstan of a WAP genetic variant, exhibiting a molecular mass of 
12,596 Da (unphosphorylated isoform). cDNA sequencing revealed a transition G/A, which 
modifies an amino acid residue of the mature protein (V12M), accounting for the mass 
difference (32 Da) observed between this new genetic variant and the originally described 
variant (Beg et al., 1986). 
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4.4.1 Camel WAP is phosphorylated 
Camel WAP contains five potential phosphorylation sites (S-X-A code) per molecule 
(S17, S18, S19, S58, and S87), meanwhile rat WAP has only three potential phosphorylation 
sites (Dandekar, Robinson, Appella, & Qasba, 1982). Whereas rat WAP is phosphorylated, it 
was reported that mouse WAP is apparently non-phosphorylated (Hennighausen & Sippel, 
1982). From mass data, it is clear that only one site is phosphorylated in camel WAP. Given 
the extremely constrained and compact structure of the molecule with 8 S-S bridges, essential 
for folding and functionality of the protein, it is very likely that S58 which is located within 
the additional sequence connecting the two 4-DSC domains, is the only one seryl residue 
which is alternatively phosphorylated in camel. Therefore, the other potential phosphorylation 
sites, namely S17, S18, S19 and S87, should not be phosphorylated. Indeed, WAP contains 16 
cysteinyl (C) residues, all of which being involved in disulfide bridges. C residues appear in 
unique arrangements, divided into two domains. Camel WAP consists of two 4-DSC 
domains, which are located between aa residues 9 and 55 (DI) and 64 and 111 (DIIA). Each 
domain begins with a six aa WAP motif (9GQAVCP14 and 64KDGRCP69), containing the 
first C residue of the 8 found in the domain.  
4.4.2 The usage of an unlikely intron cryptic splice site is 
responsible for the insertion of 4 amino acid residues in the major 
camel WAP isoform 
Camel WAP shows the higher sequence identity at the aa level (76%) to porcine WAP 
and much lower aa sequence identities to the WAP from dog (65%), rabbit (51%), rat (40%) 
and mouse (39%). The comparison of camel WAP sequence with that of the other 5 eutherian 
species in which the WAP gene is expressed (Sus scrofa, Canis familiaris, Oryctolagus 
cuniculus, Rattus norvegicus and Mus musculus), shows a 4 aa residues (56VSSP59) insertion 
in the camel polypeptide chain at the beginning of the second 4-DSC domain (Figure 4.1). 
From the Camel dromedarius gene sequence (GenBank LOC105095719) this appears to be 
the consequence of the usage of an unlikely intron cryptic splice site extending camel exon 3 
on its 5’ side by 12-nucleotides, whereas in the other 5 species the canonic 3’ end of intron 2 
is used (Figure 4.5). Indeed, there are two potential intron donor splice sites responding to all 
requirements of splicing recognition signal: 
CCCGGCCAG│TCTCTTCCCCAG│AGCCTGTCCTG (vertical bars materializing possible 
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intron end recognition sites). Paradoxically it is the weakest site (CCCGGCCAG), with two 
purine residues (GG) interrupting the polypyrimidine tract, that is preferentially used by the 
splicing machinery. We confirmed this sequence, by sequencing a 580-bp fragment amplified 
from genomic DNA encompassing integrally exon 4 and flanking intron sequences (Figure 
4.5). 
 
 098765432109876543210987654321098765432109876543210987654321098765432109876543210987654321 
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285081 
 
284991 
 
284901 
 
284811 
284721 
284631 
284541 
284451 
 
284361 
284271 
                                           ATCTGTCACCTGCCTGCCACCTGCCACCATGCGCTGTCTTGCCAGCC 
                                                                        M  R  C  L  A  S  
TGGCCCTGGCCCTGCTCTCCCTGGAGGCTGCCTTTGCACTGGCCCCAGCCCTCTCCTTGCCAGGTAAGCCCAGGAGGGGCATCCTGCCCT 
L  A  L  A  L  L  S  L  E  A  A  F  A  L  A  P  A  L  S  L  P                              
CCCTCTGCTCCAGGTCCCCCCACCCCCCGAAATGCTGCCCAGGCCTCACAGTTTGGTGACCAGGACAAGAGAGGGAGCAGAACGAGGGAG 
GTGCACCCTTGGGGTATCAGTGACAACAGAAGGGTGGGGTGCTGCCCAGAAATGCCCATGCATGGGGGGCCAAGAGCTGCAGGGCCGAGG 
CCACCGTCCCGGGATGCAAAGTGACCGGGCAGCTAGCTGGGTGTGGGGGGATCCTGTCCTCGGCCCTTCGGGGTCTTAACTCCACCTCCT 
GCAGTGGGCCTGTGGCCTCATTTCCTGACTTTCACAGCTGACTCACAATTTCTGTCAGCCATGTCGAATGTCAGTGTTGGGGTGCTGGAG 
ACCGGACTCCCCAAGGTTCTTGTCCGCGCCCCACCTTGCTTTTTCCTGAGGCGCCCCAGGGGAGGTGGGATCCAGCCAGCCCCCCACCTC 
CCCGCTGGTCTCGTGCGCAGGGCAGGCCGTGTGCCCAGAGCTCAGCTCCTCCGAGGACAACGCCTGCATAATCTCCTGTGTCAACGATGA 
                        
 G  Q  A  V  C  P  E  L  S  S  S  E  D  N  A  C  I  I  S  C  V  N  D  E 
GAGCTGTCCCCAAGGCACCAAGTGCTGCGCCAGGAGCCCCTGCAGCCGATCCTGCACGGTCCCCCTCATGGGTAAGGCCACGTCTGGACA 
  S  C  P  Q  G  T  K  C  C  A  R  S  P  C  S  R  S  C  T  V  P  L  M                      
GAGGGAGGAACCAGCTTTGTCAGGGGTCCTCCTTGAGTCTGCACTCCACACCCCTCTCTCGGTGAGCCCCCCAGCAGCCCCATAAACTCG 
GCCCGGCCATGGCACGGGTTCACCCACCTGAGGCCCAGCTGAGGCTGGCCCGCCTCCTCCCAGCATCACCTGCTGGGCCCGCAGGCCACA 
GTCTCCCTCCCAGCCTGGGCCCTGAAGGCTCCAGGCCACCAAGGGGGAGGGAAGGGGGGACCAGCTGCGGGGCGGCCCCAGCAGGCCAGC 
GGGTGATGACGGCCCGGCCAGTCTCTTCCCCAGAGCCTGTCCTGAAGGATGGCCGCTGCCCCTGGGTGCAGACCCCGCTGACCGCAAAGC 
                     V  S  S  P  E  P  V  L  K  D  G  R  C  P  W  V  Q  T  P  L  T  A  K   
ACTGTTTGGAGAAAAACGATTGCTCCAGGGACGACCAGTGTGAGGGCAACAAGAAATGCTGCTTCAGTTCGTGTGCCATGAGGTGTCTGG 
H  C  L  E  K  N  D  C  S  R  D  D  Q  C  E  G  N  K  K  C  C  F  S  S  C  A  M  R  C  L   
ACCCCGTCACAGGCAAGCGTCTCAGAGACCCTTCTCCTAGGCCACCTTCCCAGCCACCACCCTTCTTTCTCCCTTTGCCTGCACCGACCG 
D  P  V  T  G  K  R  L  R  D  P  S  P  R  P  P  S  Q  P  P  P  F  F  L  P  L  P  A  P  T   
TGGTGGCCTCTGCAAGGCTCTAAGAGCAATAAGATGCATGGAAGGGTGGGGGCTCAGGAGGCGGCGTGACCCGGGCCTGCGCCAGCTGCA 
V  V  A  S  A  R  L  *                 
GGCCCCTGCGGGCGCTCAGTGTGGCCATTGGGTTAGAGAGAGGGTGTCAGACTAGCAAAAGGGGCTCAGAGAAACCCAGAGACTTGCCTG 
GTGGGACCTGGTCCGGCCGGGTGGGCCCACCTGCAAGTCTGTGCCTTTGCCACTTAAGCCTGGGGAGGAGCTCTGAATTAGGAGCCCAGA 
GACGTGGTTCCCTGATAACAGTCCCTACCACCTGTGACCTGGCCGGCCTGCCTGCGGGTGATGGTGAGGGCCCAGGAGGGGTGGGTGTGG
AGGGCTTACTGGCCCACCTGCAGTGTCCCTCCCTCCCCTGACCCAACTGTGGCGGGGCTCCACCACCCCTGAGGCCTCCATGTCCCCTGC
AGAGGACTCTTTTCAATGAGGGGCATCCCTGGGAGCTGCCAGGAGTGACCAGCCTGAGTCTGCTCAGCAAGAACCTTCTCTCTCGGATCC 
   E  D  S  F  Q  * 
AGACAGCACAAGATGCCTCCTATCTGCTGCTAATAAAAACCCACTCAGCTTCATGTCTGTCTGTCTGTCTGCCCTCAGCACCTGCCAGGA
GAGACCAAGCACACAGGCCTTGCCTTCCAAGCAGGCTTGGAAGCTCCTGCAAACAGGCGATTCTGCCTGGGGACACGTGTGACGAAGTAG	  
 
Figure 4.5. Complete sequence of C. dromedarius WAP gene available in GenBank (NCBI, LOC105095719). 
Primer pairs used for PCR and DNA sequencing are highlighted in green. Introns and intergenic sequences are in 
italics. Intron donor and acceptor sites are bolded. The effective intron donor site (GCAAG) is highlighted in 
fuchsia. The reading frame in WAP gene is preserved through a 2-1 exon phase (nucleotides involved at the 5’- 
and 3’-ends are highlighted in yellow). Triplet codons encoding aa are given in blue and encoding specific to 
camel WAP tetrapeptide VSSP in red. The wrong protein sequence is indicated in grey and polyA site 
(AATAAA) is in purple. Stop codons are indicated with *: the correct one is in blue and “algorithm” predicted is 
in grey.  
 Alternative pre-mRNA splicing generates multiple protein isoforms from a single 
gene. Leading to a shorter or longer peptide chain, a non-allelic exon-skipping event may 
occur during the course of the pre-mRNA splicing. It is thought to be provoked by the 
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weakness (unperfected complementarities between splice site signals and corresponding small 
ribonuclear protein particles that make up the spliceosome) in the consensus sequences, either 
at the 5’ and/or 3’ splice junctions or at the branch point, or both (Patrice Martin, 
Szymanowska, Zwierzchowski, & Leroux, 2002). As far as camel WAP is concerned, even 
though cDNA sequencing allowed characterizing a single transcript we could not exclude the 
existence of a non-allelic short isoform of camel WAP, encoded by a shorter mRNA arising 
from the usage, as in the other species, of the canonic 3’ splice site (TCTCTTCCCCAG), 
which is indeed strongly suggested by the results of LC-MS/MS analyses. 
4.4.3 Intron 3 of camel WAP gene is a GC-AG intron type 
During the maturation process of pre-mRNA, introns are precisely removed by a large 
ribonucleoprotein complex: the spliceosome. This splicing step requires splice signals at the 
5’ and the 3’ ends of the intron to be removed and a branch point (Burge, Tuschl, & Sharp, 
1999). In their vast majority, introns begin with the standard form dinucleotide GT at the 5’ 
splice site and terminate with the dinucleotide AG at the 3’ splice site, so-called GT-AG 
introns. This rule hold in most cases, however some exceptions have been found (Wu & 
Krainer, 1999). For example, at the 5’ terminus of a few introns, a dinucleotide GC can be 
occasionally found (Thanaraj T. A. & and Clark F., 2001). Based on the data sets derived 
from annotated gene structures, it has been reported that GC donor sites account for less than 
1% of annotated donor sites and possess a strong consensus sequence (Thanaraj T. A. & and 
Clark F., 2001). GC-AG introns are processed by the same splicing pathway (U2-type 
spliceosome) as conventional GT-AG introns (Aebi, Hornig, & Weissmann, 1987). GC-AG 
introns works in balance with alternative GT splice donor and uses alternative donor and 
acceptor splice sites, and lack a reasonable poly pyrimidine tract (Thanaraj T. A. & and Clark 
F., 2001). In humans, about 0.7% of GC-AG introns are involved in regulated splicing 
(Farrer, Roller, Kent, & Zahler, 2002). In Caenorhabditis elegans, experiments indicate that 
the conserved C at the +2 position of the tenth intron of the let-2 gene is essential for 
developmentally regulated alternative splicing (Farrer et al., 2002). In camel WAP gene, the C 
might allow the splice donor to function as a very weak splice site that works in balance with 
an alternative GT splice donor. In this respect, the only possibility would be the use of the 
GTCAC site, 7 nt upstream of the GCGAG. Such an assumption would modify the 3' acceptor 
splice site of intron 3 to maintain a frame of reading in phase and to cause the loss of 3 aa 
residues: V and T (5' side of intron 3) and E (3' side of intron 3) in the camel WAP sequence. 
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The C-terminal sequence of the protein described by Beg and co-workers (1986) terminates 
with the peptide sequence DPVTEDSFQ. The protein sequence deduced from our cDNA 
sequencing, in accordance with the molecular mass determined from LC-MS, terminates with 
the identical DPVTEDSFQ peptide sequence. The usage of the postulated alternative GT 
donor splice site cannot be excluded. However, then to preserve the reading frame in phase, 
the upstream intron should end with the second AG (284 453/4) highlighted in yellow at 
Figure 4.5. However, we were unable to detect a DPDSFQ C-terminal, as well in LC-MS/MS 
as through cDNA sequencing. Surprisingly, in WAP gene, available in GenBank (NCBI, 
LOC105095719) exon 3 is prolonged with 99 nucleotides encoding 33 aa residues until the 
occurrence of a potential TAA stop codon, which would make exon 4 ineffective. From our 
results, in agreement with the protein structure first reported (Beg et al., 1986) and our results, 
the use of this GC donor site is more than likely.  Especially since it was reported that 
alternative GC-AG introns show a compensatory effect in terms of a dramatic increase in 
consensus at the donor (AG-GCAAG) as well as at the polyYx(C/T)AG-G acceptor exon 
positions (Thanaraj T. A. & and Clark F., 2001).    
4.5 Conclusions 
In this study, combining proven proteomic and molecular biology approaches, three 
main findings in respect to camel WAP are provided. The first one is the identification of a 
new genetic variant (B), originating from a transition G => A, leading to a codon change 
(GTG/ATG) in the nucleotide sequence of a Bactrian cDNA, which modifies a single amino 
acid residue at position 12 of the mature protein (V12M). The second is the detection of two 
transcripts coding for camel WAP, of which the major one is arising from an improper and 
unusual processing of a unique pre-mRNA, due to a cryptic splice site usage. This 
phenomenon leads to the gain or loss of 4 amino acid residues (56VSSP59), of which one 
serine residue (in bold and underlined) is alternatively phosphorylated. Such a genetic 
polymorphism and splicing events generate a molecular sequence diversity that might account 
for physiochemical properties of camel WAP that would be quite different, and might 
contribute unique properties to camel milk. Finally, we report here the occurrence of a GC-
AG intron-type (intron 3) in camel gene encoding WAP, showing a compensatory effect in 
terms of a dramatic increase in consensus at the acceptor exon position.    
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Abstract 
 Extracellular vesicles were recovered by optimized density gradient ultracentrifugation 
from milk of C. dromedarius, C. bactrianus and hybrids reared in Kazakhstan, visualized by 
transmission electron microscopy and characterized by nanoparticle tracking analysis. 
Purified extracellular vesicles had a heterogeneous size distribution with diameters varying 
between 25 and 170 nm, with average yield of 9.49 x 108 – 4.18 x 1010 particles per milliliter 
of milk. Using a comprehensive strategy combining classical and advanced proteomic 
approaches an extensive LC-MS/MS proteomic analysis was performed of EVs purified from 
24 camel milks (C. bactrianus, n=8, C. dromedarius, n=10, and hybrids, n=6). A total of 
1,010 unique proteins involved in different biological processes were thus identified, 
including most of the markers associated with small extracellular vesicles, such as CD9, 
CD63, CD81, HSP70, HSP90, TSG101 and ADAM10. Camel milk-derived EV proteins were 
classified according to biological processes, cellular components and molecular functions 
using gene-GO term enrichment analysis of DAVID 6.8 bioinformatics resource. Camel milk-
derived EVs were mostly enriched with exosomal proteins. The most prevalent biological 
processes of camel milk-derived EV proteins were associated with exosome synthesis and its 
secretion processes (such as intracellular protein transport, translation, cell-cell adhesion and 
protein transport, and translational initiation) and were mostly engaged in molecular functions 
such as Poly(A) RNA and ATP binding, protein binding and structural constituent of 
ribosome. 
 
Key words: milk, camel, exosomes, extracellular vesicles, MFGM, proteome, tetraspanins 
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5.1 Introduction 
 Milk is usually considered as a complex biological liquid in which supramolecular 
structures (casein micelles and milk fat globules) are found beside minerals, vitamins and 
soluble proteins (whey proteins) as well as cells. In addition to these components, it was 
recently shown that milk contains also extracellular vesicles that are released by cells as 
mediators of intercellular communication. Indeed, cell communicate with neighboring cells or 
with distant cells through the secretion of extracellular vesicles (Tkach & Théry, 2016). 
Phospholipid bilayer-enclosed extracellular vesicles (EVs) are naturally generated and 
released from several cell domains of life (Bacteria, Archaea, Eukarya) into the extracellular 
space under physiological and pathological conditions (Delcayre et al., 1996). EVs are 
commonly classified according to their sub-cellular origin into three major subtypes, such as 
microvesicles, exosomes, and apoptotic bodies. Contents of vesicles vary a with respect to 
mode of biogenesis, cell type, and physiologic conditions (Abels & Breakefield, 2016). 
Exosomes represent the smallest population among EVs ranging in size from 30 to 150 nm in 
diameter (Hromada et al., 2017). They are generated inside multivesicular bodies in the 
endosomal compartment during the maturation of early late endosomes and are secreted when 
these compartments fuse with the plasma membrane (van der Pol et al., 2012). Found in all 
biofluids exosomes harbor different cargos as a function of cell type and physiologic state 
(Abels & Breakefield, 2016).  
 Milk is the sole source of nutrients for the newborn and very young offspring, as well 
as being an important means to transfer immune components from the mother to the newborn 
of which the immune system is immature (Kelleher & Lonnerdal, 2001). Milk is therefore 
thought to play an important role in the development of the immune system of the offspring 
(Hanson, 2007). Milk is also a source of delivers molecules, via exosomes and/or 
microvesicles, acting on immune modulation of neonates due to their specific proteins, 
mRNA, long non-coding RNA and miRNA contents. Exosomes have come in the limelight as 
biological entities containing unique proteins, lipids, and genetic material. It was shown that 
the RNA contained in these vesicles could be transferred from one cell to another, through an 
emerging mode of cell-to-cell communication (Colombo et al., 2014; Simons & Raposo, 
2009). RNAs conveyed by exosomes are translated into proteins within transformed cells 
(mRNA), and/or are involved in regulatory functions (miRNA). For this reason, exosomes are 
recognized as potent vehicles for intercellular communication, capable for transferring 
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messages of signaling molecules, nucleic acids, and pathogenic factors (Kabani & Melki, 
2016).  
 Over the last decade, exosomes were widely explored as biological nanovesicles for 
the development of new diagnostic and therapeutic applications as a promising source for new 
biomarkers in various diseases (Kanada et al., 2015). For example, exosomes secreted by 
dendritic cells have been shown to carry MHC-peptide complexes allowing efficient 
activation of T lymphocytes, thus displaying immunotherapeutic potential as promoters of 
adaptive immune responses (Keller et al., 2006). Recently, cell culture studies showed that 
bovine milk-derived exosomes act as a carrier for chemotherapeutic/chemopreventive agents 
against lung tumor xenografts in vivo (Munagala et al., 2016). Nevertheless, their 
physiological relevance has been difficult to evaluate because their origin, biogenesis and 
secretion mechanisms remained enigmatic.   
 Despite a significant number of publications describing the molecular characteristics 
and investigating the potential biological functions of milk-derived exosomes (Reinhardt et 
al., 2013; van Herwijnen et al., 2016), there are only one dealing with exosomes derived from 
camel milk (Yassin et al., 2016). These authors report for the first time isolation and 
characterization using proteomic (SDS-PAGE and western blot analysis) and transcriptomic 
analyses exosomes from dromedary milk at different lactation stages. However, there is no 
comprehensive investigation on exosomal protein variations and variability in composition 
between individual camels. Milk-derived EVs from Bactrian and hybrid milks have never 
been explored before. Therefore, to gain insight into the protein diversity of camel milk-
derived EVs, we herein provide results of isolation and in-depth morphological and protein 
characterization of milk-derived EVs from C. dromedarius, C. bactrianus and hybrids from 
Kazakhstan using a comprehensive strategy combining classical (SDS-PAGE) and advanced 
proteomic approaches (LC-MS/MS). Proteomic studies of camel milk and sub-fractions 
thereof, such as casein, whey, or the milk fat globule membrane (MFGM) have revealed a 
plethora of bioactive proteins and peptides beneficial for developing immune and metabolic 
systems (Casado et al., 2008; Kussmann & Van Bladeren, 2011). By contrast, camel milk-
derived EVs are still a largely uncharted proteomic terrain, although we know that milk-
derived EVs carry cell origin-specific cargo and transport both bioactivity and information 
between cells (de la Torre Gomez et al., 2018). 
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5.2 Materials and methods 
5.2.1 Ethics statements  
 All animal studies were carried out in compliance with European Community 
regulations on animal experimentation (European Communities Council Directive 
86/609/EEC) and with the authorization of the Kazakh Ministry of Agriculture. Milk 
sampling was performed in appropriate conditions supervised by a veterinary accredited by 
the French Ethics National Committee for Experimentation on Living Animals. No 
endangered or protected animal species were involved in this study. No specific permissions 
or approvals were required for this study with the exception of the rules of afore-mentioned 
European Community regulations on animal experimentation, which were strictly followed.  
5.2.2 Milk sample collection and preparation 
 Raw milk samples were collected during morning milking on healthy dairy camels 
belonging to two species: C. bactrianus (n=72) and C. dromedarius (n=65), and their hybrids 
(n=42) at different lactation stages, ranging between 30 and 90 days postpartum. Camels 
grazed on four various natural pastures at extreme points of Kazakhstan: Almaty (AL), 
Shymkent (SH), Kyzylorda (KZ), and Atyrau (ZKO). Whole-milk samples were centrifuged 
at 3,000 g for 30 min at 4oC (Allegra X-15R, Beckman Coulter, France) to separating fat from 
skimmed milk. Samples were quickly frozen and stored at -80°C (fat) and -20°C (skimmed 
milk) until analysis.  
5.2.3 Selection of milk samples for analysis 
 In total 24 camel milk samples (C. bactrianus, n=8, C. dromedarius, n=10, and 
hybrids, n=6) were selected for isolation of camel milk-derived EVs, based on lactation stages 
and number of parities of each camel group composed by the species and grazing regions. It 
should be emphasized that data available on animals: breed, age, lactation stage and calving 
number, were estimated by a local veterinarian, since no registration of camels in farms is 
maintained. Six samples of camel milk-derived EVs (C. bactrianus, n=2, C. dromedarius, 
n=2, and hybrids, n=2) were selected randomly for transmission electron microscopy (TEM) 
with negative staining (uranyl acetate). Then, 15 milk samples including the 6 examined by 
TEM (C. bactrianus, n=5, C. dromedarius, n=5, and hybrids, n=5) were analyzed by SDS-
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PAGE and LC-MS/MS analysis using a QExactive (Thermo Fischer Scientific) Mass 
Spectrometer after a tryptic digestion of excised gel bands.  
5.2.4 Isolation of camel milk-derived EVs  
 First, skimmed milk samples (40-45 mL) were incubated at 37°C for 30 min in a water 
bath to enhance free β-casein adsorption to casein micelles. Then, acetic acid was added to the 
total volume of milk, to obtain a final concentration of 10% and thus acidified milk was 
incubated at 37°C for 5 min for precipitation of caseins. Finally, 1M sodium acetate was 
added to obtain a final concentration of 10% for salting out at RT for 5 min, followed by 
centrifugation at 1,500 g for 15 min at 20°C (Beckman Coulter, Allegra X-I5R Centrifuge). 
After being passed through sterilized vacuum-driven filtration system Millipore Steritop, 0.22 
µm, the supernatant, namely the filtrated whey, was concentrated by centrifugation at 4,000 g 
and 20°C using Amicon 1,000K ultracentrifuge tube until to obtain 3 mL of concentrate 
remaining. The retentate thus obtained was ultra-centrifuged for pelleting the EVs at 33,000 g 
for 1h10 at 4°C (Beckman Coulter, Optima XPN-80, 50TI rotor). Next, the pellet was 
suspended in 500 µL of PBS and added to pre-prepared 11 mL of sucrose gradient 5-40% and 
ultra-centrifuged at 34,000 g for 18h at 4°C (Beckman Coulter, Optima XPN-80, SW41 
rotor). In total, 12 fractions of 1 mL were collected. Fractions previously demonstrated to be 
enriched in exosomes (10, 11 and 12) were finally suspended into 50 µL of PBS and stored at 
-80°C, until further analyses.  
5.2.5 Transmission electron microscopy (TEM) 
 The EVs were analyzed as whole-mounted vesicles deposited on EM copper/carbon 
grids during 5 min, and contrasted 10 sec in 1% uranyl acetate. Grids were examined with 
Hitachi HT7700 electron microscope operated at 80kV (Elexience – France), and images were 
acquired with a charge-coupled device camera (AMT). 
5.2.6 Nanoparticle tracking analysis 
 The size distribution and concentration of EVs were measured by NanoSight (NS300) 
(Malvern Instruments Ltd, Malvern, Worcestershire, UK) according to manufacturer’s 
instructions. A monochromatic laser beam at 405 nm was applied to the diluted suspension of 
vesicles. Sample temperature is fully programmable through the NTA software (version 3.2 
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Dev Build 3.2.16). A video of 30 sec was taken with a frame rate of 30 frames/s and particle 
movement was analyzed by NTA software. 
5.2.7 Proteomic analysis 
 To estimate the concentration of total EVs, the Coomassie Blue Protein Assay was 
used (Bradford, 1976). Absorbance at 595 nm was measured using the UV-Vis 
spectrophotometer (UVmini-1240, Shimadzu). The reference standard curve was done with 1 
mg/mL commercial bovine serum albumin (BSA, Thermo Fischer Scientific).  
  In order to identify proteins, mono dimensional electrophoresis (1D SDS-PAGE) 
followed by trypsin digestion and LC-MS/MS analysis, was used. Ten µg of each individual 
skimmed camel milk sample were loaded onto 4-15% Mini-PROTEAN® TGX™ Precast 
Gels (Bio-Rad, Marnes-la-Coquette, France) and subjected to electrophoresis. Samples were 
prepared with Laemmli Lysis-Buffer (Sigma-Aldrich) with β-mercapto ethanol and denatured 
at 100°C for 15 min. Separations were performed in a vertical electrophoresis apparatus (Bio-
Rad, Marnes-la-Coquette, France). After a short migration (0.5 cm) of samples, gels were 
stored at -80°C until LC-MS/MS analysis.   
 Reduction of disulfide bridges of proteins was carried out by incubating at 37°C for 
one hour with dithiothreitol (DTT, 10 mM, Sigma), meanwhile the alkylation of free cysteinyl 
residues with iodoacetamide (IAM, 50 mM, Sigma) at RT for 45 min in total obscurity. After 
gel pieces were washed twice, first, with 100 µL 50% ACN/50 mM NH4HCO3 and then with 
50 µL ACN, they were finally dried. The hydration was performed at 37°C overnight using 
digestion buffer 400 ng lys-C protease + trypsin. Hereby, peptides were extracted with 50% 
ACN/0.5% TFA and then with 100% ACN. Peptide solutions were dried in a concentrator and 
finally dissolved into 70 µL 2% ACN in 0.08% TFA.  
 The identification of peptides was obtained using UltiMate™ 3,000 RSLC nano 
System (Thermo Fisher Scientific) coupled to a QExactive (Thermo Fischer Scientific) mass 
spectrometer.  
 Four µL of each sample were injected at a flow rate of 20 µL/min on a precolumn 
cartridge (stationary phase: C18 PepMap 100, 5 µm; column: 300 µm x 5 mm) and desalted 
with a loading buffer 2% ACN and 0.08% TFA. After 4 min, the precolumn cartridge was 
connected to the separating RSLC PepMap C18 column (stationary phase: RSLC PepMap 
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100, 2 µm; column: 75 µm x 150 mm). Elution buffers were A: 2% ACN in 0.1% formic acid 
(HCOOH) and B: 80% ACN in 0.1% HCOOH. The peptide separation was achieved with a 
linear gradient from 0 to 35% B for 34 min at 300 nL/min. One run took 42 min, including the 
regeneration and the equilibration steps at 98% B.  
 Peptide ions were analyzed using Xcalibur 2.1 with the following machine set up in 
CID mode: 1) full MS scan in QExactive with a resolution  of 15,000 (scan range [m/z] = 
300-1,600) and 2) top 8 in MS/MS using CID (35% collision energy) in Ion Trap. Analyzed 
charge states were set to 2-3, the dynamic exclusion to 30 s and the intensity threshold was 
fixed at 5.0 x 102. 
 Raw data were converted to mzXML by MS convert (ProteoWizard version 3.0.4601). 
UniProtKB Cetartiodactyla database was used (157,113 protein entries, version 2015), in 
conjunction with contaminant databases were searched by algorithm X!TandemPiledriver 
(version 2015.04.01.1) with the software X!TandemPipeline (version 3.4) developed by the 
PAPPSO platform (http://pappso.inra.fr/bioinfo/). The protein identification was run with a 
precursor mass tolerance of 10 ppm and a fragment mass tolerance of 0.5 Da. Enzymatic 
cleavage rules were set to trypsin digestion (“after R and K, unless P follows directly after”) 
and no semi-enzymatic cleavage rules were allowed. The fix modification was set to cysteine 
carbamido methylation and methionine oxidation was considered as a potential modification, 
Results were filtered using inbuilt X!TandemParser with peptide E-value of 0.05, a protein E-
value of -2.6 and a minimum of two peptides.       
5.2.8 Bioinformatics and functional enrichment analysis 
 Functional enrichment analyses on camel milk-derived EV protein was performed 
using online software for gene annotation “The Database for Annotation, Visualization and 
Integrated Discovery (DAVID)” version 6.8 (https://david.ncifcrf.gov/home.jsp/), as 
described (Huang et al., 2009).    
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5.3 Results and Discussion  
5.3.1 Isolation of camel milk-derived EVs 
 EVs are complex and delicate systems requiring optimized isolation and 
characterization adapted to each fluid type of origin (de la Torre Gomez et al., 2018), which 
may be achieved by a variety of methods, including ultracentrifugation, filtration, 
immunoaffinity isolation and microfluidics techniques (Witwer et al., 2013). Choice of 
method should be guided by the required degree of EVs purity and concentration. General 
protocols to isolate EVs from cell culture supernatants and body fluids involve steps of 
differential ultracentrifugation and further purification on a sucrose density gradient 
(Zonneveld et al., 2014). Commercially produced kits for exosome isolation are nowadays 
available; however, they are not adapted to milk samples. Due to highly variable composition 
between different body fluids and even within milks of different species, special optimization 
steps are required. Isolating milk-derived EVs is complicated by milk composition that differs 
significantly across species, lactation stage, physiological and health status of individuals. In 
addition, the recovery of purified exosomes from milk for subsequent analysis requires, 
according to research objectives, to increase sample volume that is not compatible with 
classical protocols.   
 In our study, for milk-derived EVs isolation, the “gold standard method”, including 
differential ultracentrifugation with sucrose density gradient, was performed (Krupova et al., 
unpublished results). However, to achieve efficient and quantitative recovery of EVs from 
camel milk, commonly used protocol was modified. First, milk fat, cells and cellular debris 
were removed by differential ultracentrifugation. The resuspended pellet was loaded on top of 
a sucrose gradient and ultracentrifuged to allow for the separation and concentration of EVs. 
After ultracentrifugation, individual fractions were collected, and EVs enriched fractions (10 
to 12) were pooled.  
5.3.2 Morphology of isolated camel milk-derived EVs 
 The method comprising differential ultracentrifugation with density gradient 
ultracentrifugation was described as being suitable for efficient isolation and purification of 
higher quality EVs with native morphology intact (Yamada et al., 2012). To visualize and 
characterize the morphology and size distribution of camel milk-derived EVs, TEM and NTA 
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analyses was performed. In all 6 milk samples analyzed, we observed a high abundance of 
homogenous population of EVs enriched in spherical exosomes with average yield of 9.49 x 
108 - 4.18 x 1010 particles per milliliter. The average sizes varied between 25 and 170 nm in 
diameter. A classical EV-like morphology has been noticed with no significant differences 
between C. dromedarius, C. bactrianus and hybrids samples (Figure 5.1). Thus, results 
confirmed that we have isolated both higher purity and higher quality EVs with intact 
morphological structures. Based on earlier observations described for dromedary milk (Yassin 
et al., 2016) and on milk of other species, such as bovine (Reinhardt et al., 2012), porcine 
(Chen et al., 2016), horse (Sedykh et al., 2017) and human (Admyre et al. 2007), obtained 
characteristics for Camelus milk appear common to EVs across species. Thus, we can 
conclude that the method of differential ultracentrifugation with sucrose density gradient 
ultracentrifugation resulted in efficient and reliable isolation of camel milk-derived EVs.  
 
 
Figure 5.1. Representative electron micrographs of C. dromedarius, C. bactrianus and hybrid camel milk-
derived EVs. Scale bar represents a) 1 µm, b) 500 nm, c) 200 nm.  
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5.3.3 In-depth proteomic analysis of camel milk-derived EVs  
 Apart from the morphology, specific protein composition enables to characterize EVs. 
To identify proteins present in camel milk-derived EVs extensive analyses involving trypsin 
digestion, LC-MS/MS (Q Exactive, Thermo Fisher Scientific) and database searches were 
performed. Recently, using a similar approach a total of 1,963 proteins were identified in 
human milk-derived EVs (van Herwijnen et al., 2016), and 2,107 unique proteins were 
described in bovine milk-derived EVs (Reinhardt et al., 2012). Here, from EV samples 
derived from 15 camel milks (C. bactrianus, n=5, C. dromedarius, n=5, and hybrids, n=5), a 
total of 1,010 functional groups of proteins (proteins belonging to a same group share 
common peptides) were detected (S11). About 890 proteins were common between the three 
camel species as shown in Figure 5.2 (a), while there are several proteins indicated as unique 
to C. bactrianus (31), C. dromedarius (5), and hybrids (12). Using UniprotKB taxonomy 
cetartiodactyla (SwissProt + Trembl) database, proteins were identified as authentically 
matching with proteins in Camelus protein databases (C. dromedarius, C. bactrianus, and C. 
ferus), and with the other mammalian species such as, Lama glama, Lama guanicoe, Bos 
taurus, Bos mutus, Sus scrofa and Ovis aries protein databases and others. Including the 
major exosomal protein markers identified, the higher number of low abundant and several 
differentially expressed proteins enhance the opportunity for revealing the crucial proteins, 
which can affect exosome synthesis and secretion pathways. By comparison, the proteome of 
camel milk-derived EVs identified in this study is relatively larger compared to the camel 
milk proteome reported in a previous study (Ryskaliyeva et al., 2018). A total of 391 
functional groups of proteins have been identified from 8 camel milk samples using a less 
sensitive LC-MS/MS (LTQ Orbitrap XLTM Discovery, Thermo Fisher Scientific), of which 
235 proteins were observed as common across camel species. We cannot exclude that there 
may be several reasons for the significant difference in the number of proteins identified in 
camel milk-derived EVs, comparatively to previously published data on camel milk proteome. 
First and foremost the instruments (Q Exactive vs LTQ Orbitrap), since the Q Exactive 
analyzer was reported to provide significant improvement over the Orbitrap mass 
spectrometers (Michalski et al., 2011) in terms of sensitivity. Comparing the proteomes 
between camel milk and camel milk-derived EVs, identified 222 proteins as common (Figure 
5.2 (b)), the list of which are provided as a supplementary data (S21). 
                                                
1	  S1	  and	  S2	  will	  be	  available	  on	  request	  once	  the	  manuscript	  published	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Figure 5.2. a) Venn diagram comparing proteins identified in C. dromedarius, C. bactrianus and hybrids milk-
derived EVs. The diagram illustrates common and unique EV proteins between the three species b) Venn 
diagram comparing proteins identified in camel milk-derived EVs and proteins detected in camel milk reported 
in our previous study (Ryskaliyeva et al., 2018).  
 
 To get more insight into the subcellular origin of proteins identified, gene-GO term 
enrichment analysis was performed using DAVID bioinformatics resources 6.8. This analysis 
helps to understand the function of proteins and addresses them into different biological 
pathways (Lu et al., 2014). In total 890 and 235 common proteins expressed in camel milk-
derived EVs and camel milk, respectively, have been classified according to cellular 
components. However, despite the limitations of the gene annotations not all camel proteins 
have been annotated, therefore only 517 exosomal and 96 milk proteins could to be converted 
to DAVID gene IDs. Thereby, 463 exosomal and 84 milk proteins matched to GO terms 
under the cellular components headings. As shown in Figure 5.3, both milk-derived EVs and 
milk samples were mostly enriched with extracellular exosomal proteins (31.09% vs 35.41%, 
respectively), the specific subset of cellular proteins that are targeted specifically to 
exosomes.  These results coincide with data reported previously on human milk and milk-
derived EVs, where a high percentage of proteins linked to GO terms like “exosomes” (van 
Herwijnen et al., 2016). The next biggest group represented a large number of cytoplasmic 
proteins (19.58% EVs vs 14.58% milk) found in milk-derived EVs and nucleus proteins 
(13.24% EVs vs 15.62% milk) in camel milk. Cytoplasmic proteins might originate from 
“cytoplasmic crescents”, which are trapped between the membrane layers of the MFGM 
during the budding process when the fat globule leaves the epithelial cell (McManaman & 
Neville, 2003). Thus, the MFGM can reflect dynamic changes within the MEC and may 
provide a “snapshot” of mammary gland biology, under particular patho-physiological 
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conditions. About 13.24% and 12.50% were reported to be membrane proteins identified in 
camel milk-derived EVs and milk samples. Membrane trafficking proteins represent Rab 
proteins, which belong to the Ras superfamily of small GTPase. Function of these proteins is 
central regulation of vesicle budding, motility and fusion. They play a role in endocytosis, 
transcytosis and exocytosis processes (Lu et al., 2014). In addition, some membrane proteins 
from intracellular organelles such as cytosol, mitochondrion and Golgi apparatus were highly 
expressed in camel milk-derived EVs.  
 
  
Figure 5.3. Functional annotations of camel milk and milk-derived EV proteins classified into cellular 
components using DAVID bioinformatics resources 6.8. 
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Next, we classified proteins expressed in camel milk-derived EVs according to 
biological processes, molecular functions, and KEGG pathways. Camel milk-derived EV 
proteins observed were involved in twenty-six GO biological process terms as shown in figure 
5.4. The most prevalent biological processes of camel milk-derived EV proteins were 
associated with exosome synthesis and its secretion processes, such as intracellular protein 
transport (5.57%), translation (3.45%), cell-cell adhesion and protein transport (3.26%), and 
translational initiation. Exosomes are increasingly recognized as mediators of intercellular 
communication due to their capacity to merge with and transfer a repertoire of bioactive 
molecular content (cargo) to recipient cells (Keller et al., 2006). In addition, EV proteins were 
mostly engaged in cellular functions such as Poly(A) RNA and ATP (9.60%) binding, protein 
binding and structural component of ribosome (3.65%). About 3.84% proteins are considered 
to be associated with GTP binding function (Figure 5.4), regulating membrane-vesicle 
trafficking process. Proteins expressed in camel milk-derived EVs were categorized into 34 
different KEGG pathways. As shown in Table 5.1, camel milk-derived EV proteins were 
mostly associated with endocytosis (5.57%), Epstein-Barr virus infection (4.03%), ribosome 
(3.84%), proteasome (3.45%), RNA transport and viral carcinogenesis (2.50%) KEGG 
pathways. It is known that exosomes display a wide variety of immuno-modulatory 
properties. This is highlighted by findings showing that exosomes secreted by Epstein-Barr 
virus (EBV)-transformed B cells are able to stimulate CD4+ T cells in an antigenic-specific 
manner (Keller et al., 2006).  
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Figure 5.4. GO enrichment analysis of camel milk-derived EV proteins classified into biological processes and 
molecular functions using DAVID bioinformatics resources 6.8. 
 
Table 5.1. KEGG pathway analysis of camel milk-derived EVs   
KEGG pathway term % PValue Fold  
enrichment 
Endocytosis 5.57 8.0E-11 4.32 
Epstein-Barr virus infection 4.03 8.7E-8 4.23 
Ribosome 3.84 1.1E-9 5.77 
Proteasome 3.45 4.1E-16 15.14 
RNA transport 2.69 2.2E-4 3.41 
Bacterial invasion of epithelial cells 2.11 2.5E-5 5.53 
Tight junction 2.11 2.7E-3 3.11 
Vasopressin-regulated water reabsorption 1.92 1.9E-6 8.41 
Synaptic vesicle cycle 1.92 2.9E-5 6.14 
Adherens junction 1.92 5.4E-5 5.69 
Salmonella infection 1.73 1.3E-3 4.19 
Fc gamma R-mediated phagocytosis 1.34 2.2E-2 3.19 
Legionellosis 1.15 1.5E-2 4.07 
mTOR signaling pathway 1.15 1.7E-2 3.93 
Biosynthesis of amino acids 1.15 4.1E-2 3.14 
Endocrine and other factor-regulated calcium reabsorption 0.96 2.2E-2 4.61 
Collecting duct acid secretion 0.77 3.1E-2 5.73 
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5.3.4 Exosomes are a rich source of potential milk biomarkers  
 Isolation of EVs from milk is complicated by the high lipid content of milk (Witwer et 
al., 2013). Lipids are released in milk as fat globules (MFGs) by mammary epithelial cells. 
These MFGs are droplets of lipids surrounded by a complex phospholipid trilayer containing 
proteins and glycoproteins (Lopez & Ménard, 2011), and thus are a type of EVs. MFGs are 
largely heterogeneous in size, and their buoyant densities are different from those of EVs. 
Because of their plasma membrane origin, vesicular nature, and high abundance in milk, 
however, MFGs may be co-isolated with other EVs populations present in milk (Reinhardt et 
al., 2012; Witwer et al., 2013). As expected, camel milk-derived EVs analyzed were mostly 
enriched with MFGM-enriched proteins associated with milk, such as fatty acid synthase 
(FAS), MFG-E8 (also termed lactadherin), butyrophilin (BTN) and xanthine dehydrogenase. 
FAS, BTN and MFG-E8 are negative co-stimulatory molecules inhibiting anti-tumor immune 
responses, which have become novel target pathways for cancer- and immunotherapy 
development (Cubillos-Ruiz & Conejo-Garcia, 2011; Kuhajda, 2000; Neutzner et al., 2007).  
 Camel milk-derived EVs analyzed were highly enriched with ubiquitous, cell-specific 
and cytosolic proteins, including proteins associated with the endosomal pathway, involved in 
mechanisms responsible for exosome biogenesis. All populations of EVs analyzed expressed 
in abundance the small Rab GTPases, such as RAB1A, RAB11B, RAB5C, RAB18, RAB2A, 
RAB7A and RAB21. Rab GTPases are key regulators of intracellular membrane trafficking, 
from the formation of transport vesicles to their fusion with membranes. Additionally, 
exosomes derived from all camel milk analyzed were significantly enriched with certain 
multifunctional proteins, such as Alix (programmed cell death 6 interacting protein 
PDCD6IP) and TSG101 (tumor susceptibility gene 101). These Endosomal Sorting 
Complexes required for Transport (ESCRT) protein components of vesicular trafficking 
process are believed to be a specific exosome-segregated biomarker during its biogenesis 
(Samuel et al., 2017; Yassin et al., 2016). Recently, it was reported that syndecan-syntenin-
ALIX is an important regulator of membrane trafficking and heparan sulphate-assisted 
signaling, which influences pathological processes, including cancer, the propagation of 
prions, inflammation, amyloid deposition and neurodegenerative disease (Baietti et al., 2012). 
Moreover, HSP70 and HSP90 proteins implicated in innate immune responses and antigen 
presentation (Srivastava, 2002), involved in signal transduction protein kinases and 14-3-3 
proteins, and metabolic enzymes such as peroxidases, pyruvate kinases, and α-enolase were 
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also observed in camel milk-derived EVs. Cell membrane proteins, such as MHC I and MHC 
II, demonstrating vesical nature of the analyzed materials, were identified as well in all camel 
milk-derived EVs analyzed, as well as, cytosolic proteins such as tubulin, actin, and actin-
binding proteins were highly expressed.     
 As a consequence of their endosomal origin, most of exosomes are composed of 
proteins involved in membrane transport and fusion, in multivesicular body biogenesis, in 
processes requiring heat shock proteins, integrins and tetraspanins (Simons & Raposo, 2009). 
While some of the proteins that are found in the proteome of many exosomal membrane 
preparations may merely reflect the cellular abundance of the protein, others are specifically 
enriched in exosomes and can therefore be defined as exosome-specific marker proteins. 
Apart from providing nourishment to the offspring, these proteins play a role in intercellular 
communication via transfer of biomolecules between cells. However, it is currently unknown 
whether exosomes found in milk originate from immune cells present in milk, from mammary 
epithelial cells, from circulating cells coming from elsewhere in the body or from bacterial 
species present in the mammary gland under mild permanent infection (sub-clinical mastitis). 
 Available proteomic studies define specific markers of the EVs (membrane and 
cytosolic proteins) and a specific subset of cellular proteins that are targeted specifically to 
exosomes, the functions of some of them still remain unknown (Théry et al., 2002). This is 
particularly interesting in relation to their possible involvement in human diseases. The 
knowledge of exosome proteomics can help not only in understanding their biological roles 
but also in supplying new biomarkers (Raimondo et al., 2011). Among the membrane proteins 
most enriched in exosomes are tetraspanins, which play a critical role in exosome formation 
and are involved in morphogenesis, fission and fusion processes (Rana & Zöller, 2011). 
Recently CD9, CD63, and CD81 tetraspanins have been defined as novel markers 
characterizing heterogeneous populations of EVs subtypes (Kowal et al. 2016), the presence 
of which, including CD82 and TSPAN14 proteins, were confirmed in camel milk-derived 
EVs. However, some exosome samples analyzed were devoid of CD63. The absence of this 
tetraspanin in secreted exosomes by some cell types was previously reported, and the 
necessity of analyzing instead either CD81- or CD9-bearing EVs was reported (Kowal et al., 
2016). 
 Even in the case of markers with strong evidence for EVs subtype specificity, the 
presence of such markers does not rule out that other types of vesicles are present in a 
preparation simultaneously (Witwer et al., 2013). Not only the desired populations must be 
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confirmed as present; contaminants must be demonstrated to be absent. The purity of the 
exosomes isolated is highly variable due to the presence of contaminating particles, vesicles 
and molecules such as proteins and/or nucleic acids as well as other cellular components 
(Vaswani et al., 2017), which	   may co-purify in vesicle preparations and confound analysis 
(Mathivanan, Ji, & Simpson, 2010; Witwer et al., 2013). Minimizing contamination in the 
isolation of exosomes is vital in providing reliable information upon which to base new 
paradigms (Vaswani et al., 2017). It was reported that exosomes isolated by differential 
ultracentrifugation with density gradient ultracentrifugation method can be used to examine 
the relationship of EV proteins to physiological or disease status of the host without any 
involvement or contamination of other free proteins in milk (Yamada et al., 2012). Density 
gradients add stringency by efficiently separating particles of different density, which allows 
removing contaminating non-vesicular particles. Thus, the purity of the camel milk-derived 
vesicles isolated from contaminations with other multivesicular bodies has been examined and 
confirmed by the absence of microvesicle surface markers such as p-selectin and CD40, an 
endoplasmic reticulum marker calnexin, mitochondrial protein mitofilin, and an ER-
associated protein GP96. Even though, we have applied a filtration step of the milk 
supernatant prior to the EVs pelleting step, camel milk-derived EVs were contaminated with 
caseins, the expression of which have been also detected previously in dromedary (Yassin et 
al., 2016), human (van Herwijnen et al., 2016) and bovine milk exosomes (Reinhardt et al., 
2012).  
5.4 Conclusions 
Using an optimized isolation protocol, we obtained milk-derived exosomes originating from 
15 camel (C. dromedarius, C. bactrianus and hybrids) milk samples that satisfied the typical 
requirements for exosomal morphology, size and protein content. LC-MS/MS analyses 
allowed identifying a thousand of different proteins that represents to our knowledge, the first 
comprehensive proteome of camel milk-derived EVs that appears wider than the milk 
proteome. As mentioned previously in other species camel milk-derived EVs contain proteins 
also present in other milk components. This is particularly the case for lactadherin/MFG-E8, 
Ras-related proteins or CD9 that have been reported to occur in MFG. Our results strongly 
suggest that milk-derived exosomes have different cellular origin. Indeed, besides exosomes 
originating from mammary epithelial cells there are milk-derived exosomes from immune 
cells. If we consider that milk-derived exosomes also carry microRNAs, these vesicles have to 
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be recognized as another important bioactive component of milk that might be involved in 
transmitting signals from the mother to the newborn but also represents a source of factors 
potentially responsible for the properties attributed to camelids milk and its health value. 
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 The general objective of this thesis was to explore the protein fraction of camelid 
milks in order to identify original molecules (peptide, proteins) potentially responsible for the 
properties attributed to camel milk. 
 The analysis of the proteins of the milk fat globule membrane (MFGM) having been 
the subject of an in-depth study carried out previously (Saadaoui et al., 2013), we initially 
committed to analyze globally the composition of the milk protein fraction of camelids 
(proteomic approach), focusing mainly on caseins and the molecular diversity of caseins. 
 Regarding WPs, various options were possible, given the originality of camel milk in 
this regard.	  Detected in mammary secretions of porcine and camel (Kappeler et al., 2004), 
PGRP that binds to murein peptidoglycans (PGN) of Gram-positive bacteria, was a good 
candidate. This pattern receptor, involved in innate immunity, may kill Gram-positive bacteria 
by interfering with peptidoglycan biosynthesis. Lactophorin (GlyCAM1) which is highly 
expressed in camel milk was also an interesting WP since this phosphoglycoprotein, a 
component of the milk fat globule membrane, inhibits spontaneous lipolysis in milk by the 
lipoprotein lipase (Girardet et al., 1993). GlyCAM1 is also suspected to be a scaffold for 
carbohydrates that mediate functions such as epithelium protector in addition to cell adhesion 
(Dowbenko et al., 1993). Given the time we had, we made choices and we focused our efforts 
on the whey acidic protein (WAP) whose protease inhibitory properties are well established 
and which is an originality of camelids (only large mammals with the pig expressing this 
protein in milk).  
 Finally, we started to isolate extracellular vesicles from milk, which are known to 
carry genetic information (mRNA and microRNA) and proteins involved in the 
communication between cells and organisms, in order to characterize their proteome. 
 Variations observed in camel milk composition could be attributed to several 
environmental factors, such as geographical locations, seasonal variations, feeding conditions, 
and samples being taken from different breeds, in addition to other parameters including 
lactation stage, age and calving number (Al haj & Al Kanhal, 2010; Konuspayeva, Faye, et 
al., 2009). Therefore, for this study, we collected about 180 milk samples from two camel 
species (C. bactrianus and C. dromedarius, and their hybrids), at different lactation stages. 
Camels were grazed on four various natural pastures distant for more than 3,500 kms between 
the regions at extreme points of Kazakhstan: Almaty (AL) at the foot of Tien Shan Mountain, 
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Shymkent (SH) along deserts Kyzylkum and Betpak-Dala, Kyzylorda (KZ) on the edge of the 
steppe, and Atyrau (ZKO) at the mouth of the Caspian Sea.  
 These milks were submitted to different proven analytical techniques and proteomic 
approaches (SDS-PAGE, LC-MS/MS and LC-ESI-MS). This study also aimed to evaluate 
possible differences between species (genetic variability). 
6.1 Global analysis: complexity of the camel milk proteome 
 To get an overview of the protein complexity of camel milk, and on its potential 
impact on milk characteristics, we provided a complete profiling of the milk protein fraction 
of Bactrian and dromedary camels from Kazakhstan, including a detailed characterization of 
camel CN and whey proteins, including variants related to genetic polymorphisms, splicing 
defects, phosphorylation levels. In addition, we introduce a reference point for further 
investigation on milk protein polymorphisms in the camel species. The main attractive point 
in searching for milk protein polymorphisms is to understand the biological significance of 
the genetic variations, which can be highlighted by evolutionary studies (Caroli et al., 2009). 
It has been already established clearly that mutations responsible for polymorphisms in milk 
proteins, occurring at the genomic level either alone or in combinations, might influence milk 
protein composition at the quantitative as well as at the qualitative levels (Martin et al., 2002). 
 A detailed characterization of 50 protein molecules, relating to genetic variants and 
isoforms arising from post-translational modifications and alternative splicing events, 
belonging to nine protein families (κ-, αs1-, αs2-, β-; and γ-CN, WAP, α-LAC, PGRP, 
CSA/LPO), was achieved by LC-ESI-MS. Against all expectations, peptides with sequence 
similarity with bovine β-lactoglobulin, the major allergen in bovine milk, were identified in 
the 8 camel milk samples (Bactrian, dromedary and hybrids), analyzed by LC-MS/MS. The 
coverage percentage ranged between 30 and 60% in individual milk samples, and reached 
71% cumulating all the peptides found. Five peptides related to bovine β-lactoglobulin were 
also detected by Alhaider et al., (2013) in camel milk from Saudi Arabia and the United 
States. Youcef et al., (2009) revealed a weak cross reaction between dromedary WPs and IgG 
anti bovine β-lactoglobulin. Such findings disagree with the usually admitted notion that β-
lactoglobulin is absent in camel milk (Hinz et al., 2012; Restani et al., 1999). Even though we 
cannot exclude a possible contamination by bovine milk (however this seems unlikely with 
the 8 camel milk samples analyzed by LC-MS/MS) or the presence in camel milk of a 
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Progesterone Associated Endometrial Protein (PAEP) displaying strong similarities with β-
lactoglobulin. However, significant similarities between human PAEP and the peptides 
having allowed the identification of β-lactoglobulin in C. bactrianus milk were not found. So 
far, camel milk has never (or only rarely) been extensively studied with the cutting-edge 
proteomics.    
 
Table 6.1. The nine major camel milk proteins including genetic and splicing variants  
Protein Var. AA sequences MW, 
Da 
AA 
residues 
αs1-CN A E30 RPKYPLRYPEVFQNEPDSIEEVLNKRKILELAVVSPIQFRQENIDELKDTRNEPTEDHIMEDTERKESGSSSSEEVVSSTTEQKDILKEDMPSQRYLEELHRLNKYKL
LQLEAIRDQKLIPRVKLSSHPYLEQLYRINEDNHPQLGEPVKVVTQEQAYFHLE
PFPQFFQLGASPYVAWYYPPQVMQYIAHPSSYDTPEGIASEDGGKTDVM         
PQWW 
25,307 215 
RPKYPLRYPEVFQNEPDSIEEVLNKRKILELAVVSPIQFRQENIDELKDTRNEP
TEDHIMEDTERKESGSSSSEEVVSSTTEQKDILKEDMPSQRYLEELHRLNKYKL
LQLEAIRDQKLIPRVKLSSHPYLEQLYRINEDNHPQLGEPVKVVTQPFPQFFQL
GASPYVAWYYPPQVMQYIAHPSSYDTPEGIASEDGGKTDVMPQWW 
24,289 207 
C D30 RPKYPLRYPEVFQNEPDSIEEVLNKRKILDLAVVSPIQFRQENIDELKDTRNEP
TEDHIMEDTERKESGSSSSEEVVSSTTEQKDILKEDMPSQRYLEELHRLNKYKL
LQLEAIRDQKLIPRVKLSSHPYLEQLYRINEDNHPQLGEPVKVVTQEQAYFHLE
PFPQFFQLGASPYVAWYYPPQVMQYIAHPSSYDTPEGIASEDGGKTDVMPQWW 
25,293 215 
RPKYPLRYPEVFQNEPDSIEEVLNKRKILDLAVVSPIQFRQENIDELKDTRNEP
TEDHIMEDTERKESGSSSSEEVVSSTTEQKDILKEDMPSQRYLEELHRLNKYKL
LQLEAIRDQKLIPRVKLSSHPYLEQLYRINEDNHPQLGEPVKVVTQPFPQFFQL
GASPYVAWYYPPQVMQYIAHPSSYDTPEGIASEDGGKTDVMPQWW 
24,275 207 
αs2-CN sv0 KHEMDQGSSSEESINVSQQKFKQVKKVAIHPSKEDICSTFCEEAVRNIKEVESA
EVPTENKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTRAYPFIPTVNTEQLS
ISEESTEVPTEESTEVFTKKTELTEEEKDHQKFLNKIYQYYQTFLWPEYLKTVY
QYQKTMTPWNHIKRYF 
21,266 178 
sv1 KHEMDQGSSSEESINVSQQKFKQVKKVAIHPSKEDICSTFCEEAVRNIKEVESA
EVPTENKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTRAYPFIPTVNTEQLS
ISEESTEVPTEENSKKTVDTESTEVFTKKTELTEEEKDHQKFLNKIYQYYQTFL
WPEYLKTVYQYQKTMTPWNHIKRYF 
22,268 187 
sv2 KHEMDQGSSSEESINVSQQKFKQVKKVAIHPSKEDICSTFCEEAVRNIKEVESA
EVPTENKISQFYQKWKFLQYLQALHQGQIVMNPWDQGKTRAYPFIPTVNTEQLS
ISEESTEVPTEESTEVFTKKTELTEEEKDHQKFLNKIYQYYQTFLWPEYLKTVY
QYQKTMTPWNHIKVKAYQIIPNLRYF 
22,406 188 
β-CN A 
I186 
REKEEFKTAGEALESISSSEESITHINKQKIEKFKIEEQQQTEDEQQDKIYTFP
QPQSLVYSHTEPIPYPILPQNFLPPLQPAVMVPFLQPKVMDVPKTKETIIPKRK
EMPLLQSPVVPFTESQSLTLTDLENLHLPLPLLQSLMYQIPQPVPQTPMIPPQS
LLSLSQFKVLPVPQQMVPYPQRAIPVQAVLPFQEPVPDPVRGLHPVPQPLVPVI
A 
24,632 217 
TAGEALESISSSEESITHINKQKIEKFKIEEQQQTEDEQQDKIYTFPQPQSLVY
SHTEPIPYPILPQNFLPPLQPAVMVPFLQPKVMDVPKTKETIIPKRKEMPLLQS
PVVPFTESQSLTLTDLENLHLPLPLLQSLMYQIPQPVPQTPMIPPQSLLSLSQF
23,685 210 
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KVLPVPQQMVPYPQRAIPVQAVLPFQEPVPDPVRGLHPVPQPLVPVIA 
RKEMPLLQSPVVPFTESQSLTLTDLENLHLPLPLLQSLMYQIPQPVPQTPMIPP
QSLLSLSQFKVLPVPQQMVPYPQRAIPVQAVLPFQEPVPDPVRGLHPVPQPLVP
VIA 
12,357 111 
B 
M186 
REKEEFKTAGEALESISSSEESITHINKQKIEKFKIEEQQQTEDEQQDKIYTFP
QPQSLVYSHTEPIPYPILPQNFLPPLQPAVMVPFLQPKVMDVPKTKETIIPKRK
EMPLLQSPVVPFTESQSLTLTDLENLHLPLPLLQSLMYQIPQPVPQTPMIPPQS
LLSLSQFKVLPVPQQMVPYPQRAMPVQAVLPFQEPVPDPVRGLHPVPQPLVPVI
A 
24,650 217 
TAGEALESISSSEESITHINKQKIEKFKIEEQQQTEDEQQDKIYTFPQPQSLVY
SHTEPIPYPILPQNFLPPLQPAVMVPFLQPKVMDVPKTKETIIPKRKEMPLLQS
PVVPFTESQSLTLTDLENLHLPLPLLQSLMYQIPQPVPQTPMIPPQSLLSLSQF
KVLPVPQQMVPYPQRAMPVQAVLPFQEPVPDPVRGLHPVPQPLVPVIA 
23,703 210 
RKEMPLLQSPVVPFTESQSLTLTDLENLHLPLPLLQSLMYQIPQPVPQTPMIPP
QSLLSLSQFKVLPVPQQMVPYPQRAMPVQAVLPFQEPVPDPVRGLHPVPQPLVP
VIA 
12,375 111 
κ-CN A 
F11 
EVQNQEQPTCFEKVERLLNEKTVKYFPIQFVQSRYPSYGINYYQHRLAVPINNQ
FIPYPNYAKPVAIRLHAQIPQCQALPNIDPPTVERRPRPRPSFIAIPPKKTQDK
TVNPAINTVATVEPPVIPTAEPAVNTVVIAEASSEFITTSTPETTTVQITSTEI 
18,254 162 
B 
C11 
EVQNQEQPTCCEKVERLLNEKTVKYFPIQFVQSRYPSYGINYYQHRLAVPINNQ
FIPYPNYAKPVAIRLHAQIPQCQALPNIDPPTVERRPRPRPSFIAIPPKKTQDK
TVNPAINTVATVEPPVIPTAEPAVNTVVIAEASSEFITTSTPETTTVQITSTEI 
18,210 162 
C 
C11, 
I111,  
V131  
EVQNQEQPTCCEKVERLLNEKTVKYFPIQFVQSRYPSYGINYYQHRLAVPINNQ
FIPYPNYAKPVAIRLHAQIPQCQALPNIDPPTVERRPRPRPSFIAIPPKKTQDK
TVIPAINTVATVEPPVIPTAEPVVNTVVIAEASSEFITTSTPETTTVQITSTEI 
18,236 162 
α-LAC  KQFTKCKLSDELKDMNGHGGITLAEWICIIFHMSGYDTETVVSNNGNREYGLFQ
INNKIWCRDNENLQSRNICDISCDKFLDDDLTDDKMCAKKILDKEGIDYWLAHK
PLCSEKLEQWQCEKW 
14,430 123 
GlyCAM1  SLNEPKDEIYMESQPTDTSAQVIMSNHQVSSEDLSMEPSISREDLVSKDDVVIK
SARRHQNQNPKLLHPVPQESSFRNTATQSEETKELTPGAATTLEGKLVELTHKI
IKNLENTMRETMDFLKSLFPHASEVVKPQ 
15,442 137 
LTF  ASKKSVRWCTTSPAESSKCAQWQRRMKKVRGPSVTCVKKTSRFECIQAISTEKA
DAVTLDGGLVYDAGLDPYKLRPIAAEVYGTENNPQTHYYAVAIAKKGTNFQLNQ
LQGLKSCHTGLGRSAGWNIPMGLLRPFLDWTGPPEPLQKAVAKFFSASCVPCVD
GKEYPNLCQLCAGTGENKCACSSQEPYFGYSGAFKCLQDGAGDVAFVKDSTVFE
SLPAKADRDQYELLCPNNTRKPVDAFQECHLARVPSHAVVARSVNGKEDLIWKL
LVKAQEKFGRGKPSGFQLFGSPAGQKDLLFKDSALGLLRISSKIDSGLYLGSNY
ITAIRGLRETAAEVELRRAQVVWCAVGSDEQLKCQEWSRQSNQSVVCATASTTE
DCIALVLKGEADALSLDGGYIYIAGKCGLVPVLAESQQSPESSGLDCVHRPVKG
YLAVAVVRKANDKITWNSLRGKKSCHTAVDRTAGWNIPMGLLSKNTDSCRFDEF
LSQSCAPGSDPRSKLCALCAGNEEGQNKCVPNSSERYYGYTGAFRCLAENVGDV
AFVKDVTVLDNTDGKNTEQWAKDLKLGDFELLCLNGTRKPVTEAESCHLAVAPN
HAVVSRIDKVAHLEQVLLRQQAHFGRNGRDCPGKFCLFQSKTKNLLFNDNTECL
AKLQGKTTYEEYLGPQYVTAIAKLRRCSTSPLLEACAFLMR 
75,250 689 
WAP A V12 LAPALSLPGQAVCPELSSSEDNACIISCVNDESCPQGTKCCARSPCSRSCTVPL
MVSSPEPVLKDGRCPWVQTPLTAKHCLEKNDCSRDDQCEGNKKCCFSSCAMRCL
DPVTEDSFQ 
12,564 117 
B 
M12 
LAPALSLPGQAMCPELSSSEDNACIISCVNDESCPQGTKCCARSPCSRSCTVPL
MVSSPEPVLKDGRCPWVQTPLTAKHCLEKNDCSRDDQCEGNKKCCFSSCAMRCL
DPVTEDSFQ 
12,596 117 
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PGRP  REDPPACGSIVPRREWRALASECRERLTRPVRYVVVSHTAGSHCDTPASCAQQA
QNVQSYHVRNLGWCDVGYNFLIGEDGLVYEGRGWNIKGAHAGPTWNPISIGISF
MGNYMNRVPPPRALRAAQNLLACGVALGALRSNYEVKGHRDVQPTLSPGDRLYE
IIQTWSHYRA 
19,143 172 
Amino acid sequences of mature proteins with potential phosphorylation sites. Potential phosphorylation sites 
are bolded: Seryl and Threonyl residues matching the S/T-X-A motif are in red and blue, respectively. Threonyl 
residues matching the S/T-X-X-A motif are in green. Aa residues generated by genetic polymorphism and 
alternative splicing are marked bold in red and highlighted in yellow. 
 
6.2 Complexity of the "casein" fraction: the case of αs2-CN and 
potential impact in terms of function 
 Up to now, the composition of camel casein fraction appeared to be relatively well 
established. However, analyzing milk of camelids originating from Kazakhstan, both in C. 
dromedarius, C. bactrianus and their hybrids, differences, lead us to consider more subtle 
composition though having obvious consequences at the technological and nutritional levels. 
Indeed, a great diversity of molecular species, originating in genetic variants, post-
translational modifications but also in the processing of primary transcripts (splicing variants), 
was highlighted. This situation is particularly conspicuous regarding αs2-CN for which three 
splicing variants were identified, including exon skipping and cryptic splice site usage. Camel 
αs2-CN was shown to be a mixture of three splicing isoforms differing in polypeptide chain 
length. Isoform αs2-CNsv0, initially reported in the literature, was the main isoform of αs2-CN. 
Isoforms sv1 and sv2 were splicing isoforms of αs2-CN arising from alternative processing of 
primary transcript and differing from αs2-CNsv0 with the insertion of exon 13 
(ENSKKTVDT) in sv1 and an extension of exon 16 (VKAYQIIPNL) in sv2, with 
phosphorylation levels for each of them ranging between between 7 and 12 Phosphate groups.  
 With 11 potentially phosphorylated aa residues matching the S/T-X-A motif, camel 
αs2-CN displays the highest phosphorylation level of camel caseins. To reach such a 
phosphorylation level, besides the nine SerP, two putative ThrP (T118 and T132) have to be 
phosphorylated. In all the Kazakh milk samples analyzed in LC-ESI-MS we found αs2-CN 
with 12 P groups, as the molecular mass of 22,226 Da observed corresponds to the mass of 
the peptide backbone (21,266 Da) increased by 960 Da, a mass increment which coincides 
with 12 P groups. That means that at least another S/T residue that does not match with the 
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canonic sequence (S/T-X-A) recognized by the mammary kinase(s), is potentially 
phosphorylated.  
 In the camel αs2-CN, two threonine residues (T39 and T129) are located in a motif 
S/T-X-X-E/D/pS, which is a recognition motif for CN-kinase II (CK2). Indeed, albeit the 
consensus sequences of CK2 and the genuine casein kinase isolated from the Golgi apparatus 
of the lactating mammary gland (G-CK) are definitely distinct, they could be similar and 
sometimes overlapping (Tibaldi et al., 2015). The hypothesis that there are two different 
phosphorylation systems (kinases) suggested by Bijl et al., (2014) and then by Fang et al., 
(2016) takes therefore a little bit more consistency. This warrants further investigation. 
Fam20C which seems to be the major secretory pathway protein kinase (Tagliabracci et al., 
2015) is very likely responsible for the phosphorylation of S and T residues within S/T-X-A 
motifs, whereas at least one T residue occurring in a S/T-X-X-A motif (T39 or T129) might 
be phosphorylated by a CK2-type kinase. 
 Such results provide useful novel information for the understanding of the evolution of 
the casein genes and their expression across Mammals. With the growing number of genes 
encoding milk proteins sequenced and displaying complex patterns of splicing, thus 
increasing the coding capacity of genes, the extreme protein isoform diversity generated from 
a single gene can no longer be considered as an epiphenomenon. Is it a fortuitous or a 
scheduled event to expand molecular diversity of milk caseins? Structural diversity and 
variability in expression level are both responsible for modifications in the organization and, 
consequently, changes in the physico-chemical properties of the casein micelle. A 
parsimonious vision of this issue addresses a major question: does this convey any biological 
significance? It has been established, that milk proteins represent a reservoir of biologically 
active peptides, capable of modulating different functions; the molecular diversity generated 
by differential splicing mechanisms can only increase their content. Thus, alternative splicing 
events produce novel potentially bioactive peptides. Important new insights are expected, in 
this field, in the near future.  
6.3 WAP: originality of the protein and of the gene in the camel 
species 
 Camel WAP is a 117 aa residues protein (136 aa residues for the pre-protein)  that 
shows the higher sequence identity at the aa level (76%) to porcine WAP (113 aa residues). It 
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contains five potential phosphorylation sites per molecule (S17, S18, S19, S58, and S87), 
whereas the rat WAP (118 aa) and the rabbit WAP (108 aa) have only three and two potential 
phosphorylation sites, respectively. It was reported, that mouse WAP (115 aa) is apparently 
not phosphorylated (Hennighausen & Sippel, 1982). From mass data (LC-MS) it appears that 
only one serine can be phosphorylated. Given the extremely constrained and compact 
structure of the molecule with 8 S-S bridges, essential for folding and functionality of the 
protein, we hypothesized that S58 which is located within the additional sequence connecting 
the two 4-DSC domains, is the seryl residue which is alternatively (ca. 50%) phosphorylated 
in camel.  
 The comparison of camel WAP sequence with that of the other 5 eutherian species in 
which the WAP gene is expressed (pig, dog, rabbit, rat and mouse), displays an insertion of 4 
aa residues (56VSSP59) which extend the sequence inter 4-DSC domains. From the Camel 
dromedarius gene sequence (GenBank 105095719) this appears to be the consequence of the 
usage of an unlikely intron cryptic splice site extending camel exon 3 on its 5’ side by 12-
nucleotides, whereas in the other 5 species the canonic 3’ end of intron 2 is used. There are 
actually two potential intron donor splice sites responding to all requirements of splicing 
recognition signal: CCCGGCCAG│TCTCTTCCCCAG│AGCCTGTCCTG, and 
paradoxically it is the weakest site, a polypyrimidic stretch interrupted by a GG doublet, 
which seems to be preferentially used by the splicing machinery. Indeed, the existence of a 
non-allelic short isoform of camel WAP, encoded by a shorter mRNA arising from the usage, 
as in the other species, of the canonic 3’ splice site seems plausible. This assumption was 
supported by the occurrence of two tryptic peptides (SCTVPLMVSSPEPVLK and 
SCTVPLMEPVLK) identifying camel WAP in LC-MS/MS that differentiate by the presence 
or absence of the tetrapeptide 56VSSP59. Such a result confirms that the usage of a cryptic 
splice site during the splicing of precursors to WAP mRNA is responsible for the insertion of 
4 amino acid residues between the two 4-DSC domains of the camel WAP. 
 However, this is not the only originality of this gene that exhibits in the camel species, 
extremely rare fact, an intron (intron 3) of the GC-AG type. The existence of variants to the 
standard (canonical) GT-AG introns is known but extremely rare (Burge et al., 1999; Burset, 
2000). Burset and co-workers (2001) observed that GC splice sites account for 0.5% of 
annotate donor sites and that GC donor sites possess a strong consensus sequence. Since the 
maturation process is ensured by the same splicing machinery (U2-type spliceosome), 
whatever the intron is, GT-AG or GC-AG type, there is a mismatch between the donor site 
162 
 
 
  
sequence and the U1 snRNA. To compensate for such a weakening base pairing, the 
consensus sequence at the GC donor site has strengthened. It should be noted that such a rare 
event led to an erroneous annotation of this gene in genome database, since automated 
algorithms based on consensus sequences are used to predict donor and acceptor sites of 
introns. 
6.4 EVs: Beyond their role in the communication between cells, 
what possible effects on the consumer (newborn or adult humans) 
 Using an optimized isolation protocol, we obtained milk-derived EVs from camel milk 
samples that satisfied the typical requirements for “exosomal” morphology, size and protein 
content. Thus, we provide, to our knowledge, a first comprehensive proteome of camel milk-
derived exosomes that appears, with ca. one thousand different proteins identified, wider than 
the camel milk proteome (391 functional groups of proteins). As previously mentioned, camel 
milk-derived exosomes contain proteins, such as lactadherin/MFG-E8, Ras-related proteins or 
CD9 also present in MFG (Saadaoui et al., 2013). In addition, our results strongly suggest that 
EVs isolated from camel milks have different cellular origin, since besides EVs originating 
from mammary epithelial cells there are very likely EVs from immune cells.  
 Théry et al., (2002) established specific markers of the EVs (membrane and cytosolic 
proteins) and a specific subset of cellular proteins targeted specifically to exosomes, the 
function of which still remain unknown. This is particularly interesting in relation to their 
possible involvement in human diseases. Therefore, the knowledge of exosome proteomics 
can help not only in understanding their biological roles but also in supplying new biomarkers 
(Raimondo et al., 2011). 
 If we consider that milk-derived EVs also carry microRNAs, these vesicles have to be 
recognized as another important bioactive component of milk that might be involved in the 
transfer of immune components from the mother to the newborn, but also represents a source 
of factors potentially responsible for the properties attributed to camelids milk and its health 
value. Several publications suggest that EVs in foods, specifically bovine and human milk, 
carry a wide range of compounds with biological activities such as, lipids, proteins, 
noncoding RNAs (including microRNAs), and mRNAs. Exosomes seem to be a particularly 
important class of EVs since they protect labile cargos against degradation and provide a 
vehicle for cargo uptake through endocytosis of exosomes in virtually all tissues (Benmoussa 
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et al., 2016; Gu et al., 2012; Izumi et al., 2012; Izumi et al., 2015; Raposo & Stoorvogel, 
2013; Wolf et al., 2015; Zempleni et al., 2017).  
 Humans of all ages consume worldwide milk from various sources and since 
microRNAs are highly conserved across mammals, one can expect that microRNA from milk-
derived EVs may mediate the beneficial effects of dairy milk consumption in rheumatoid 
arthritis (Arntz et al., 2015) or in immune functions (Melnik et al., 2014). This is probably one 
of the greatest challenges facing milk science in the immediate future: to provide the food 
industry and consumers with the basis for health-promoting properties before their inclusion 
as ingredients into functional foods (Martin et al., 2013). 
6.5 What should be implemented now? 
One of the actions that should now be implemented as a priority would be to profile the 
RNA content (mRNA and microRNA) of extracellular vesicles isolated from camelids milk 
(Bactrian and camel) so that such profiles can be compared, in particular in microRNAs, with 
those produced from milks of other species including large and small ruminants. This requires 
the implementation of functional tests on animal models in vivo and/or ex vivo (cell cultures) 
to evaluate potential effects of the content of EVs from camelids milk and more generally 
milk on the consumers' physiology. As example, we can mention the case of a polyarthritis 
model in mice, used by Arntz et al., (2015) to highlight attenuation effects of bovine milk-
derived EVs. We can still quote the work of Chen et al., (2016) who reported that porcine 
milk-derived exosomes can facilitate intestinal cell proliferation and intestinal tract 
development, thus giving a new insight for milk nutrition and newborn development and 
health. 
Regarding the beneficial properties of camel milk, among them its antimicrobial 
activity, no doubt, that it can be attributed to the high content of protective proteins such as 
PGRP-1 and possibly WAP. This protein first described as an anti-protease able to limit tissue 
damage during inflammation, displays in fact a variety of other functions, including direct 
antimicrobial activity. However, several studies (Alvarez-Ordóñez et al., 2013; Farrell et al., 
2009; McCann et al., 2005; Recio & Visser, 1999; Zucht et al., 1995) have demonstrated the 
antibacterial properties of bovine peptides derived from the C-terminal part of αs2-CN. Given 
the possible extension of the repertoire of bioactive peptides of milk camelids in connection 
with splicing variants arising from camel αs2-CN precursors to mRNA, it would be interesting 
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now to test biological activities and potentially the health value of peptides derived from 
camel αs2-CN. 
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Title : Exploring the fine composition of Camelus milk from Kazakhstan with emphasis on protein components 
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Abstract: This study aimed to explore the protein fraction of 
camelid milks from different regions of Kazakhstan, in order to 
identify original molecules (peptides, proteins) potentially 
responsible for the health-promoting properties attributed to 
camel milk. Various proven analytical techniques and proteomic 
approaches (SDS-PAGE, LC-MS / MS and LC-ESI-MS) have 
been implemented to characterize the molecular diversity of the 
major milk proteins, particularly caseins. Thus, two isoforms, 
hitherto unknown, of camel αs2 casein resulting from alternative 
splicing have been characterized. Sequencing of the 
corresponding transcripts revealed that one of these isoforms 
results from the use of an additional exon of which the presence 
has been confirmed at the genomic level, encoding the 
ENSKKTVDM peptide. The second isoform, which results from 
the use of a cryptic intronic splice site, has an additional peptide 
sequence (VKAYQIIPNL), encoded by an intron extension 
downstream from exon 16 of the gene. We also report the 
existence of a phosphorylation variant of this casein, suggesting 
very likely the existence in the mammary gland of a second 
enzymatic system involved in the phosphorylation of caseins.  
With regard to whey proteins, a new genetic variant of the Whey 
Acidic Protein (WAP) has been identified in Camelus bactrianus. 
The predominant isoform of this original protein, expressed in the 
milk of a few mammals, has an insertion of 4 amino acid residues 
(56VSSP59) into the peptide segment connecting the two 4-DSC 
domains of the protein. This insertion results from the use of a 
cryptic splice site leading to an intron extension of 12 nucleotides 
upstream of exon 3 of the gene. Moreover, we show that intron 3 of 
the WAP gene is, in camelids, an extremely rare GC-AG type 
intron. Finally, camelids milks were analyzed for extracellular 
vesicles, morphologically characterized in Transmission Electron 
Microscopy and Nanoparticles Tracking Analysis. These vesicles, 
which are involved in the communication between cells and 
organisms, are vectors of genetic information (mRNA and 
microRNA) but also export many proteins. A thousand of these 
proteins, involved in multiple cellular functions, in particular in 
transport and secretion of vesicles and transport of intracellular 
proteins, were identified by LC-MS/MS. 
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Titre : Analyse de la composition fine du lait des Camelidés du Kazakhstan en ciblant plus spécifiquement la fraction 
protéique 
Mots clés : caséines, WAP, polymorphisme génétique, variant d’épissage, vésicules extracellulaires 
Résumé : Cette étude visait à explorer la fraction protéique des 
laits de camélidés de différentes régions du Kazakhstan, afin 
d’identifier des molécules originales (peptides, protéines) 
potentiellement responsables des « health-promoting properties » 
attribuées au lait de chamelle. Différentes techniques analytiques 
éprouvées et approches protéomiques (SDS-PAGE, LC-MS/MS 
et LC-ESI-MS), ont été mises en œuvre pour de caractériser la 
diversité moléculaire des lactoprotéines majeures, et 
particulièrement des caséines. Ainsi, deux isoformes, jusqu’ici 
inconnues, de la caséine αs2 de chamelle, résultant d'épissages 
alternatifs ont pu être caractérisées. Le séquençage des transcrits 
correspondants a révélé que l’une d’elles résulte de l’utilisation 
d’un exon additionnel dont la présence a été confirmée au niveau 
génomique, spécifiant le peptide ENSKKTVDM. La seconde 
isoforme, qui résulte de l’utilisation d’un site cryptique 
d’épissage intronique, comporte une séquence peptidique 
additionnelle (VKAYQIIPNL), spécifiée par une extension 
intronique en aval de l’exon 16 du gène. Nous rapportons par 
ailleurs, l’existence d'un variant de phosphorylation de cette 
caséine, suggérant l'existence probable dans la glande mammaire 
d’un second système enzymatique impliqué dans la 
phosphorylation des caséines. 
S’agissant des protéines du lactosérum, un nouveau variant 
génétique de la Whey Acidic Protein (WAP) a été identifié chez 
Camelus bactrianus. L’isoforme prédominante de cette protéine 
originale, exprimée dans le lait de quelques mammifères, présente 
une insertion de 4 résidus d'acides aminés (56VSSP59) dans le 
segment peptidique reliant les deux domaines 4-DSC de la 
protéine. Cette insertion résulte de l'utilisation d'un site cryptique 
d'épissage conduisant à une extension intronique de 12 nucléotides 
en amont de l’exon 3 du gène. De plus, nous montrons que l'intron 
3 du gène de la WAP est chez les camélidés, fait extrêmement rare, 
un intron de type GC-AG. Enfin, nous avons isolé des laits de 
camélidés analysés des vésicules extracellulaires, caractérisées 
morphologiquement, en Microscopie Electronique à Transmission 
et par « Nanoparticles Tracking Analysis ». Ces vésicules qui sont 
impliquées dans la communication entre cellules et organismes, 
sont vecteurs d’informations génétiques (ARNm et microARN) 
mais exportent aussi de nombreuses protéines. Un millier de ces 
protéines, impliquées dans de multiples fonctions cellulaires et 
notamment dans le transport et la sécrétion des vésicules et le 
transport de protéines intracellulaires, ont pu être identifiées par 
LC-MS/MS. 
 
